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Abstract 
 
This thesis describes the development of catalytic aza enolate reactions and a study of their 
applications in a range of reactions. Detailed herein are advances in three main areas of aza 
enolate chemistry, namely; the development of a novel catalytic aza enolate aldol reaction; 
the investigation of aza enolate reactions with challenging electrophiles (such as epoxides); 
and the discovery of a multi-component reaction for the formation of oxazolidines.  
 
The first chapter gives a brief overview of organocatalysis, summarising the main activation 
modes. This is followed by a detailed overview of aza enolate chemistry.  
 
The second chapter describes the development of a catalytic aza enolate aldol reaction. This 
methodology  was  explored  in  more  detail  with  different  substrates  and  asymmetry  was 
investigated, with varying degrees of success.  
 
The third chapter describes the study of aza enolate reactions with a variety of challenging 
electrophiles. With epoxides and their derivatives, encouraging results were obtained. A new 
3-component synthesis of oxazolidines from amines, ketones and epoxides was discovered 
during  the  course  of  this  work  and  the  synthesis  of  several  novel  oxozolidines  was 
investigated.  Contents 
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Chapter 1 - Introduction 
 
 
1.1  Organocatalysis  
Chemical transformations that use organic catalysts, or organocatalysts (a term coined by 
David MacMillan to mean purely organic molecules that can act as catalysts), have been 
documented sporadically over the past century but until recently the field remained relatively 
dormant. It was not until the late 1990s that the field of organocatalysis was ‘born’ coalescing 
around a small number of articles that inspired an explosion of research.
1 From a mechanistic 
viewpoint, there are only a rather limited number of ‘‘mechanistic categories’’ to which all 
these reactions can be assigned.
1 The mechanisms by which metal-free enzymes (the majority 
of enzymes do not contain catalytically active metals) achieve rate accelerations have been a 
major  field  of  research  in  bio-organic  chemistry  for  decades.
2-7  However,  the  same 
mechanisms and categories of enzymatic catalysis also apply to organocatalytic reactions.
1 
The catalysis of aldol reactions is a good example - in class I aldolases lysine provides the 
catalytically  active  amine  group  whereas  typical  organocatalysts  for  this  purpose  are 
secondary  amines,  the  most  simple  being  proline  (Schemes  1  and  2).  Organocatalytic 
reactions can be divided into two subgroups, those that proceed via ‘‘covalent catalysis’’ and 
those that involve ‘‘non-covalent catalysis’’ (Scheme 3). The former describes processes that 
involve  the  formation  of  covalent  adducts  between  catalyst  and  substrate(s)  within  the 
catalytic cycle, the latter rely on non-covalent interactions such as hydrogen bonding or the 
formation of ion pairs (Scheme 3).
1 
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Scheme 1 - Proline organocatalysis 
 
Scheme 2 – Class I aldolases 
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Scheme 3 – Organocatalysis split into subgroups, covalent and non-covalent catalysis  
 
1.1.1  Brief overview of organocatalytic activation modes 
There  are  various  activation  modes  used  in  organocatalytic  reactions,  below  is  a  brief 
summary of the most commonly used activation modes that cover a large portion of the 
organocatalysis landscape (Scheme 4). As described earlier, organocatalysis can be split into 
two  areas,  covalent  and  non-covalent  catalysis  (Scheme  3).  Covalent  catalysis  includes 
enamine, iminium and SOMO activation modes, whereas, non-covalent catalysis includes 
hydrogen  bonding  and  counterion  activation  modes  (phase  transfer  and  Brønsted  acid) 
(Scheme 3 and 4).  Chapter 1 - Introduction 
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Scheme 4 – Most common organocatalytic activation modes 
 
1.1.2  Brief history of organocatalysis 
The development of enamine catalysis parallels that of iminium catalysis (Scheme 5). Like 
iminium catalysis, the concept took a long time to mature, and required a key discovery to 
stimulate interest, the discovery of intermolecular proline-catalysed aldol reactions by List et 
al. in 2000 set the field in motion.
8,9 Scheme 5 illustrates the catalytic cycles of iminium (A) 
and enamine catalysis (B).  
 
Scheme 5 - Catalytic cycles of iminium (A) and enamine catalysis (B) 
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1.1.3  Enamine catalysis (HOMO activation) 
The first enantioselective enamine catalysed process, however, was the intramolecular aldol 
reaction known as the Hajos-Parrish-Eder-Sauer-Wiechert (HPESW) process (Scheme 6).
10,11 
This involves using an achiral triketone as the starting material with a catalytic amount of 
proline to obtain the ketol in 52% yield and 74% ee, followed by dehydration to obtain the 
product in a yield ranging from 52-100% and an ee ranging from 71-63% (Scheme 6). This 
process  was  discovered in  the early 1970s and although the significance of the  HPESW 
reaction was recognized almost from the beginning, it was another 30 years until the first 
proline-catalysed intermolecular aldol reactions were described.
12  
 
I (S)-Proline (3 mol %), DMF, rt, 72 h. 
II p-TsOH, benzene, reflux. 
Scheme 6 – Intramolecular aldol reaction (HPESW process) 
 
The reason for the long delay was partly due to the mechanism proposed in the initial studies 
by Agami,
13 who found a small non-linear effect which suggested the presence of more than 
one molecule of proline in the transition state (Scheme 7).
13-17  
 
Scheme 7 – Proline transition state(s) 
 
It was not until early 2000 with the discovery of the intermolecular proline-catalysed reaction 
(Scheme 8),
12 further studies by List et al. and several key modelling studies by the Houk 
group that enamine catalysis became widely accepted.
12,18,19  Chapter 1 - Introduction 
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I Proline (30 mol %), DMSO, rt. 
Scheme 8 – Intermolecular proline-catalysed reaction 
 
The most widely known example of enamine catalysis is the intermolecular proline catalysed 
reaction developed by List et al.
12 (Scheme 8). Other recent examples of enamine catalysis 
include aldehyde–aldehyde cross aldol coupling,
20,21 Mannich reaction,
8 Michael reaction,
22,23 
ʱ-amination,
24 ʱ-oxygenation,
25 ʱ-halogenation,
24,26-31 ʱ-sulphenylation,
24 ʱ-alkylation and so 
forth.
32,33 These reactions are often described as involving HOMO activation and in HOMO 
activation, the energy of the highest-occupied molecular orbital (HOMO) is increased due to 
the lone pair electrons of a nitrogen atom being higher in energy than those of an oxygen 
atom, further enhancing its reactivity compared to an enol. Enamines react readily with a 
wide variety of electrophiles, and the range of reactions are summarised in scheme 9. 
 Chapter 1 - Introduction 
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Scheme 9 – Summary of enamine reactions with a wide variety of electrophiles  
 
1.1.4  Iminium catalysis (LUMO activation) 
MacMillan reported the first example of iminium catalysis with use of the imidazolidinonium 
salt 1·HCl to generate iminium ion intermediates identifying a new catalytic strategy for the 
activation of ʱ,β-unsaturated carbonyl compounds towards cycloaddition,
34 and more recently 
conjugate addition reactions have been reported using the same catalyst (Scheme 10).
9  
 
Scheme 10 – Iminium catalysis  Chapter 1 - Introduction 
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In  LUMO  activation,  the  energy  of  the  lowest-unoccupied  molecular  orbital  (LUMO)  is 
decreased. This is due to the reversible formation of the active iminium ion species, which 
mimics the π-electronics and equilibrium dynamics traditionally associated with Lewis acid 
activation of ʱ,β-unsaturated carbonyl compounds, lowering the energy level of the LUMO 
associated with the π-system and activating a subsequent reaction (Scheme 11). 
 
Scheme 11 – Concept of LUMO activation 
 
Other  examples  include;  conjugate  Friedel–Crafts  reactions,
35  exo-selective  Diels–Alder 
reactions,
36 cyclopropanations,
37 epoxidations
38 and many others (Scheme 12).
39-41 
 
Scheme 12 – Summary of iminium catalysis 
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1.1.5  SOMO catalysis (SOMO activation) 
Given the capacity of enamines and iminium ions to rapidly interconvert (an enamine has 
four π electrons and iminium ion has two π electrons, Scheme 13),
42 MacMillan’s group 
hypothesised that it may be possible to interrupt this equilibrium chemically and thereby to 
access  a  mode  of  catalytic  activation  that  electronically  bisects  enamine  and  iminium 
formation (Scheme 13).
43 This would be via a one-electron oxidation of an enamine species 
and would generate a three-π-electron radical cation with a singly occupied molecular orbital 
(SOMO), that is  activated  for a  range of  transformations.
20 A variety  of enantioselective 
transformations  have  been  accomplished  using  this  concept  including  ʱ-allylation,
42  ʱ-
vinylation,
44,45 ʱ-heteroarylation
42 and ʱ-alkylation
46,47 (Scheme 13). Impressive as this is, 
there are still limitations. For example, each mole of aldehyde requires two equivalents of the 
oxidizing  agent.  It  would  be  more  efficient  if  the  oxidant  could  be  recycled  during  the 
reaction, possibly by air, so that a much smaller amount could be used. 
 
 
I CAN (2 eq.), NaHCO3, DMF, −20 °C, 24 h. 
Scheme 13 – SOMO catalysisChapter 1 - Introduction 
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1.1.6  Hydrogen bonding-catalysis (LUMO activation) 
The first real use of hydrogen-bonding catalysis in organocatalysis was the work conducted 
independently by Corey et al.
48 and Jacobsen et al.
49 in reporting an asymmetric variant of 
the Strecker reaction. Since then a variety of examples have been reported,
50 which include 
the Mannich reaction,
51 the Biginelli reaction,
52 the Pictet–Spengler reaction,
53 and the Aza-
Henry reaction.
54 A recent example is the enantioselective Michael addition to nitroalkenes 
catalysed via thioureas (Scheme 14).
55 
 
I Benzoic acid, Tol, rt. 
Scheme 14 – Hydrogen bonding catalysis 
 
1.1.7  Counter-ion catalysis  
Jacobsen expanded on the work with hydrogen bonding catalysis to develop a novel form of 
organocatalytic activation that directs highly enantioselective additions to in-situ generated 
N-acyl-iminium  ions
56  and  oxocarbenium  ions  (Scheme  15).
57,58  In  this  system,  chiral 
thiourea  catalysts,  electrostatically  bind  to  and  ionise  the  weak  carbon-chlorine  bonds  of 
chloroamides  and  chloroacetals  to  generate  an  ion  pair.  The  resulting  anionic  catalyst-
chloride complex behaves as a chiral counter-ion; this directs the approach of nucleophiles to 
a single face of the transient ʱ-heteroatom stabilised cationic species.
58  
I BCl3, CH2Cl2, 0 °C to rt. 
II Cat. (10 mol %), TBME, −78 °C, 6 h.  
Scheme 15 – Counter-ion catalysisChapter 1 - Introduction 
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Another example of counter-ion catalysis is phase transfer catalysis (PTC). This involves the 
use of PTCs to facilitate the transfer of a molecule or ion from one reaction phase to another 
and by doing so it can greatly accelerate the rate of heterogeneous  (polyphasic) reaction 
processes (Scheme 16).
59 An example is the work from Lygo et al. with the use of Chinchona 
alkaloid derivatives as enantioselective PTCs in the asymmetric alkylation of glycine imines 
to generate a range of ʱ-amino acid derivatives in good enantioselectivity (Scheme 16).
60 
 
Scheme 16 - Phase transfer catalysis 
 
1.1.8  Limitations of organocatalysis 
Recently organocatalysis has grown immensely; however, there are still limitations with each 
of the generic activation modes involved. In enamine catalysis, the relatively narrow substrate 
scope is a limiting factor as particularly reactive electrophiles have to be used.
61 Even though 
iminium catalysis is a maturing field, some obstacles would need to be addressed before it Chapter 1 - Introduction 
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becomes a method of choice for large scale synthesis.
62 This includes catalyst activity, for 
example, and the lowering of the high catalyst loading required for asymmetric induction. A 
better understanding of the subtleties involved in the amount of water present in the reaction 
and  the  role  of  co-acid  additives  would  also  be  beneficial.
62  To  date,  only  a  handful  of 
activation  modes  are  used  to  accomplish  many  new  asymmetric  transformations.  SOMO 
catalysis
47 was recently developed as an alternative activation mode to enable multiple new 
transformations. With SOMO catalysis, there are still limitations, for example, each mole of 
aldehyde requires two  equivalents of the oxidising agent.
62 Therefore, in order to further 
expand the scope of organocatalysis and to overcome some of the limitations, new activation 
modes will need to be developed. The aim of this project is to develop a new method for the 
catalytic formation of aza enolates, providing a new organocatalytic activation mode. It is 
hoped that this will enable the use of relatively unreactive electrophiles in organocatalytic 
reactions and thus expand the scope of organocatalysis.  
 
1.2  Introduction to aza enolate chemistry  
Aza enolates are generated from imines, which are prepared by reaction of a primary amine 
with an aldehyde or ketone. Treatment of an imine with a base leads to an aza enolate which 
is highly nucleophilic. Aza enolates have been shown to undergo reactions with a variety of 
unreactive electrophiles such as epoxides (Chapter 3). A major advantage of the use of aza 
enolates compared to normal enolates (derived from aldehydes or ketones), is that they do not 
normally undergo self-condensation reactions (Scheme 17).  Chapter 1 - Introduction 
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Scheme 17 – Generation of aza enolates 
 
1.2.1  A note on aza enolate nomenclature 
Over the past forty-fifty years various names have been used to describe anions derived from 
imines  including  metalloenamines  (and  metallated  enamines)
63,  metallated  Schiff  bases
64, 
imine anions
65,66, enamides
67-69, hydrazones
70-72 and more recently aza-enolates.
73  The latter 
is preferred for the purpose of this thesis as it emphasises both the source of these species and 
their high reactivity, whereas, metallated enamines suggests that the anions are derived from 
enamines and not imines.
74  
 
1.2.2  Hard and soft enolisation of imines  
Hard enolisation (deprotonation) is normally irreversibly achieved using a strong base. A 
good example is where imines may be transformed into their conjugate bases (aza enolates) 
with a base such as LDA or a Grignard reagent (Scheme 18).  Chapter 1 - Introduction 
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Scheme 18 – Hard enolisation of imines 
 
Soft enolisation provides a milder approach to the deprotonation of imine compounds and 
occurs when a relatively weak amine base and an imine activating component (such as a 
Lewis acid) act in concert to effect reversible deprotonation (Scheme 19).
75 
 
Scheme 19 – Soft enolisation of imines 
 
1.2.3  Generation and reaction of aza enolates via hard enolisation 
In 1963 both Stork et al.
76 and Wittig et al.
64 reported on the reactions of aza enolates by ʱ-
deprotonation of imines with strong bases. Wittig
64 demonstrated the use of lithiated aza 
enolates derived from aldehydes as nucleophiles for achieving a direct aldol reaction, and for 
a reaction with alkyl halides (Scheme 20).
64  
 
Scheme 20 – Lithiated aza enolates derived from aldehydes as nucleophiles Chapter 1 - Introduction 
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Simultaneously, Stork and Dowd demonstrated that monoalkylation of a ketone could be 
accomplished in high yield via reaction of a magnesium aza enolate with alkyl halides and 
sulfonates (Scheme 21).
76  
Scheme 21 – Monoalkylation of a ketone via reaction of a magnesium aza enolate 
 
From this innovative work, Gates et al, demonstrated the alkylation of an aza enolate derived 
from  an  imine  2  with  3-cyclopentyl  tosylate  3  in  1974  (Scheme  22).
77  The  imine  was 
prepared using a procedure developed by Stork (vide infra),
76 subsequent reaction with a 
Grignard led to the formation of the aza enolate then the product 4 in a 27% yield. 
 
I EtMgBr, THF, 2, reflux, 1 h, then 0 °C, 3, then reflux 18 h.  
Scheme 22 – Alkylation of aza enolates with 3-cyclopentyl tosylate (3) 
 
Leading on from this, Dauben et al., demonstrated the use of aza enolates from imine 5 for 
the  synthesis  of  a  fourteen-membered  diterpene  (±)-Cembrene  8.  The  key  step  was  the 
formation  of  the  aza  enolate  with  LDA  followed  by  reaction  with  6,
78,79  then  to  afford 
hydroxyaldehyde 7 in 77% yield (Scheme 23).
80   
I Dry Et2O, DIPA, CH3-Li, 1 h, 0 °C. 
II Imine 5, −78 °C, 6, 25 min, then 25 h at −78 °C. 
Scheme 23 – (±)-Cembrene synthesis 
 Chapter 1 - Introduction 
 
 
16 
 
In 1976, Silverstein demonstrated the use of aza enolates in the synthesis of optically active 
Multistriatin 13. Initial attempts to form Multistriatin (13) yielded only small amounts of the 
product (5%) via a non aza enolate approach; therefore, an alternative method was attempted 
using aza enolates derived from imine 9 and a Grignard reagent. The key intermediate 12 was 
synthesised in a 71% yield by reaction of aza enolate 10 with the tosylate 11 in THF (Scheme 
24).
81  Following  this,  epoxidation  of  12  with  m-CPBA  and  then  cyclisation  using  SnCl4 
formed the product Multistriatin 13.  
 
I EtMgBr, THF, rt, then at reflux for 8 h, then 5 °C then tosylate 11, 45 min, then at reflux 1 h.
81 
Scheme 24 – Multistriatin synthesis 
 
In the same year, Normant et al.
82 and Schlessinger et al.
83 independently demonstrated the 
reaction of aza enolates with a variety of alkyl halides. Firstly, Normant et al. demonstrated 
the reaction of aza enolates derived from imine 14 with alkyl halide 15 in the synthesis of 
aldehyde 16 in good yields ranging from 61-85% (Table 1).
82  
 
Entry  R1  R2  Yield (%) 
1  Me  H  79 
2  Et  H  83 
3 
nC4H9  H  85 
4  Et  Et  68 
I LDA, HMPT, THF −60 °C, 14, then −10 °C, 2 h, then 15, −60 °C, 5 h.
82 
Table 1 – Reaction of aza enolates derived from imines with alkyl halides 
 
Schlessinger  et  al.  demonstrated  the  use  of  aza  enolates  derived  from  ʱ,β-unsaturated 
ketones
83 and aldehydes
83 to undergo clean alkylation with alkyl halides at the ʱ- instead of γ-
position in excellent yields (Table 2).  Chapter 1 - Introduction 
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Alkyl halide  Reaction time (h)   Yield (%) 
Me-I  4.5  98 
  4.5  100 
 
3.5  95 
 
4.0  100 
 
20.0  95 
I LDA, 0 °C, HMPT, 10 min, then −78 °C, 30 min. 
II Alkyl halide, reaction time, −78 °C.
83 
Table 2 - Aza enolates derived from α,β-unsaturated ketones and aldehydes 
 
In 1976 Meyers reported the alkylation of aza enolates containing an acyclic amino acid-
based auxiliary and accomplished good yields and high enantioselectivities with an imine 
derived from cyclohexanone (Scheme 25).
70,71 
 
I LDA, THF. 
II RX.
70 
Scheme 25 – Aza enolates containing an acyclic amino acid based auxilary   
 
In  2001,  Florio  et  al.  reported  the  coupling  of  oxazoline-derived  aza  enolates  17  with 
aldehydes using a variety of different metal aza enolates such as titanium, boron, aluminium, 
and tin. Titanium aza enolates produced the best yields with good diasteromeric ratios of the 
product 18 (Scheme 26).
84  
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I LDA, THF, 1 min, 100 °C, then, Bu2BOTf or Ti(iPrO)4 or Et2AlCl or SnOTf, 30 min, 100 °C. 
II PhCHO, THF, 
then rt. 
III NaOH, 
iPrOH 
Scheme 26 - Oxazoline-derived aza enolates with aldehydes 
 
In  2003,  Ellman  et  al.  demonstrated  the  use  of  magnesium  and  zinc  aza  enolates  in  a 
diastereoselective aldol reaction. This involved using an N-sulfinyl imines derived from a 
ketone, treating the imine with LDA at −78 °C in the presence of a Lewis acid (ZnBr2 or 
MgBr2) to generate the aza enolate, then reacting this with the corresponding aldehyde to 
give  a  β-hydroxyimine.  These  were  then  selectively  reduced  by  either  catecholborane  or 
LiBHEt3 to produce syn- and anti-1,3-amino alcohols in good diasteroselectivities and yields 
(Scheme 27).
85 Ellman et al. have also carried out reactions of similar aza enolates with 
Michael acceptors.
86 
 
I LDA, −78 °C, THF, 45 min, then, MgBr2 or ZnBr2, −78 °C, 45 min, then R2CHO, −78 °C, 3h. 
II Reduction. 
Scheme 27 - Diastereoselective aldol reaction using magnesium and zinc aza enolates 
 
In that same year, Nakamura et al. reported an enantioselective synthesis of ʱ-substituted 
ketones through three-component coupling of an optically active zinc aza enolate, alkene, and 
an  electrophile  (E
+)  (Table  3,  selected  examples).
67,68  The  significant  step  involves  the 
addition of a zinc aza enolate such as 20 derived from imine 19 (prepared from (S)-valinol or Chapter 1 - Introduction 
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(S)-t-leucinol)  to  an  unactivated  alkene  to  give  the  corresponding  product  21.  Nakamura 
reported that the alkoxy substituent on the nitrogen enamide plays a significant role for tuning 
the reactivity and thermal stability of the nucleophile. The reactions generally proceed in high 
yield and give products with high enantiomeric excess. Chapter 1 - Introduction 
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Entry  Zinc enamide  Product  ee (%), yield (%) 
1 
 
R1 = 
tBu, R2 = Me3Si, R3 = Me 
 
 
95, 91 (99, 29)
a 
2 
 
R1 = 
iPr, R2 = Me, R3 = Me 
 
91, 93 (94, 38)
a 
3 
 
R1 = 
tBu, R2 = Me3Si, R3 = Me 
 
96, 82 (99, 34)
a 
4 
 
R1 = 
tBu, R2 = Me3Si, R3 = Me 
 
96, 93 
5* 
 
R1 = 
tBu, R2 = Me3Si, R3 = Me 
 
93, 47 (98, 15)
a 
I MesLi, 0 °C, Et2O. 
II ZnCl2. 
III R3Li, hexane. 
IV Ethylene (20 atm), 40 °C, 24 h. 
V E
+, H3O
+. 
a The data in 
parentheses refer to the yield and selectivity determined for the ketone product obtained. 
* Propene atmosphere 
(8 atm), 60 °C for 48 h.  
Table 3 - Three-component coupling of an optically active zinc aza enolate, alkene, and 
an electrophile (E
+) 
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Following on from this, Nakamura et al. reported the reaction of the initial addition products 
(Entry 2, table 3) via palladium- and copper-catalysed reactions (Scheme 28).
68 
 
(a) Allyl bromide (2 eq.)/CuBr•SMe2 (20 mol %). (b) β-bromostyrene (2 eq., >99.9%E)/Pd(PPh3)4 (5 mol %). 
(c) Iodobenzene (2 eq.)/ Pd(PPh3)4 (5 mol %). (d) Ethyl-2-(bromomethyl)acrylate (2 eq.)/CuBr•SMe2 (1 eq.). 
Scheme 28 – Nakamura work continued
68 
 
1.2.4  Alkylation reactions with alkyl chlorides and fluorides  
Building upon this work the Nakamura group reported that the use of magnesium enamides 
bearing an internal nitrogen coordination site expands the scope of aza enolate alkylation 
reactions  to  unreactive  alkyl  halides,  particularly  alkyl  chlorides  and  fluorides.  Initial 
screening was carried out to discover the best reaction conditions and under the optimised 
conditions chlorocycloheptane and imine 22 reacted to give the alkylated product 23 in an 
88%  yield  (Scheme  29).  In  addition,  cycloheptene  24  was  also  produced  in  11%  yield, 
suggesting competitive elimination reactions were taking place (Scheme 29).
69 
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I MesMgBr, THF, rt, then, 80 °C, 1 h. 
II Chlorocycloheptane, THF, 45 °C, 24 h, then, 60 °C, 12 h, then H3O
+. 
Scheme 29 - Aza enolate alkylation reactions with chlorocycloheptane 
 
The optimised conditions were applied to a range of different aza enolates and alkyl halides 
(Table 4 – selected examples).  
Entry  Enamide  Alkyl halide  Temp, time  Product (% yield) 
1 
 
 
 
 
60 °C, 12 h 
 
2 
 
 
 
 
 
60 °C, 36 h 
 
3 
 
 
 
 
60 °C, 12 h 
 
Table 4 – Optimised alkylation reactions 
 
1.2.5  Reactions with epoxides and their derivatives via hard enolisation 
The first use of aza enolates to ring open epoxide and oxetane was reported by Tarbell et al.
87 
and Hudrlik et al.
88. Firstly, Tarbell and Harvey
87 reported the use of cyclohexanone imine 
25, which was treated with EtMgBr and then reacted with two different epoxides to produce 
the corresponding products 26 and 27 (Scheme 30). Chapter 1 - Introduction 
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I EtMgBr, THF, reflux, 2 h, then 0 °C then epoxide, then rt, 25 h, HCl.
87  
Scheme 30 – Aza enolates derived from imines ring opening epoxides 
 
Hudrlik et al. expanded on the work by Tarbell and Harvey by improving the yield of the 
reaction  with  epoxide  28,  by  using  milder  acid  hydrolysis  to  give  products  29  and  30 
(Scheme 31).
88 In addition, Hudrlik et al. reported the first use of aza enolates as nucleophiles 
for the ring opening of oxetane 31 in good yield to give the cyclic enol ether 33 (Scheme 31). 
 
I EtMgBr or 
nBuLi, THF, reflux, 2 h, then 0 °C then either 
II Oxetane 23 or 
III Propylene oxide 22, then rt, 25 h, 
AcOH.
88 
Scheme 31 – Aza enolates derived from imines ring opening epoxides and oxetane 
 
In  1971,  Aguiar  et  al.  demonstrated  the  reaction  of  lithium  aza  enolates  derived  from 
phosphono imines with a variety of epoxides in moderate yields (Table 5).
89 Aguiar et al. also 
extended this methodology to the use of thiophosphonates.
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R  R1  R2  Yield (%) 
nC4H9  C6H5  C6H5  58 
nC4H9
  nC3H7  C6H5  58 
nC4H9
  nC3H7  Me  40 
nC4H9
  tC4H9  C6H5  65 
I 
nBuLi, THF, -78 °C, then epoxide, 12 h. 
II H3O
+.
89 
Table 5 - Lithium aza enolates derived from phosphono imines ring opening epoxides 
 
Recently,  Shipman  et  al.  reported  the  use  of  methyleneaziridines  in  a  four-component 
reaction for the formation of ʱ-amino phosphonates (Scheme 32).
91,92 The reaction involves 
opening of the aziridine 34 at C-3 by using a Grignard reagent under Cu(I) catalysis, resulting 
in the generation of a magnesium aza enolate which reacts with the corresponding carbon 
electrophile (R2-X) to form a variety of products in a 42-65% yield (Scheme 32).  
 
I EtMgCl, cat. CuI, THF, then I(CH2)3I, then LiP(O)(OEt)2. 
II R1MgCl, cat. CuI, THF, then R2-X, then 
PhP(O)H(OEt), then H3O
+. 
Scheme 32 – Ring opening of aziridines for the formation of α-amino phosphonates 
 
Shipman et al. expanded this work to include other electrophiles (Table 6). However, a major 
limitation  to  this  chemistry  was  the use of  excess  Grignard reagent  (3 eq.) to  drive this 
reaction to completion.
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Entry  R1  R2  X  Yield (%) 
1  Bu  Bu  Cl  78 
2  Octyl  H2C=CHCH2  Br  80 
3  Octyl  H2C=CHCH2 CH2  OTs  67 
4  Bu  4-MeC6H4CH2  Cl  75 
5  Bu  4-MeC6H4CH2  Cl  80 
I R
1MgCl, CuI (20 mol %), THF, −30 °C, then rt, 24 h. 
II R
2X then H3O
+ 
Table 6 – Summary of ring opening of aziridines with different electrophiles 
 
1.2.6  Aza enolates derived from hydrazones via hard enolisation 
Since excellent reviews
93-96 have already been published on the subject, so the formation and 
reactions of hydrazone-derived aza enolates will only be briefly presented.  
 
1.2.6.1  Short history of synthetic applications of hydrazones 
In 1971, Stork and Benaim reported the concept of using the anions derived by deprotonation 
of disubstituted hydrazones for achieving ʱ-alkylation of ʱ,β-unsaturated ketones (Scheme 
33).
63 
 
I NaH, HMPT, THF. 
II 
nC4H9Br, THF. 
III HCl. 
Scheme 33 – Stork hydrazone chemistry 
 
From  this  pioneering  work,  it  took  another  five  years  before  the  use  of  N,N-
dialkylhydrazones  gained  widespread  application,  particularly,  until  the  landmark  papers 
published by Corey and Enders (Scheme 34)
72,97-101 and independently by Normand et al.
102  Chapter 1 - Introduction 
 
 
26 
 
 
I LDA, 0 °C, 20 h, then CH3I, 0 °C, 10 h. 
II Sodium periodate, THF, rt.
72,103 
Scheme 34 – Corey and Enders dialkylhydrazone chemistry 
 
For  the  asymmetric  alkylation  of  ketones  and  aldehydes,  a  highly  practical  method  was 
developed  by  the  Enders  group  using  hydrazones.
93,97,104-108  These  now  widely  used 
auxiliaries  are  known  as  SAMP  and  RAMP  (acronyms  for  S-or  R-1-amino-2-
methoxymethyllpyrrolidine).  This  constitutes  an  asymmetric  version  of  the  dimethyl 
hydrazone methodology originally developed by Corey and Enders in 1976 (vide supra). 
These auxiliaries are available from either proline or pyroglutamic acid (Scheme 35).
107,109  
 
Scheme 35 – SAMP/RAMP chiral auxiliaries and their derivatives 
 
After work-up, the crude ʱ-substituted hydrazones can be purified by distillation or column 
chromatography.  Subsequent  cleavage  of  the  hydrazone  restores  the  original  carbonyl 
function  to  provide  substituted  ketones  or  aldehydes  (Scheme  36).
110  After  alkylation, 
cleavage may be affected with a number of reagents. Among these are oxidative cleavage 
(ozonolysis, sodium perborate,
111 or magnesium peroxyphthalate),
112 and acidic hydrolysis 
(methyl iodide and dilute HCl,
106,113 or BF3 and water
101,102). Chapter 1 - Introduction 
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Scheme 36 – Examples of possible cleavage products 
 
Prior to 2000, the vast majority of reactions were ʱ-alkylations (Table 7, selected examples). 
This involved ʱ-branched acyclic and cyclic ketones,
94 dioxanones,
114 and β-keto esters.
94 
The alkylating agents used include alkyl, allyl, and benzyl halides (Br, I), tosyl-aziridines and 
methyl sulfate.
93,94  Chapter 1 - Introduction 
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Product  Electrophile  % Yield  % ee  Ref 
 
EtI, 
C6H13I 
71 
52 
95 
>95 
113 
 
 
Me2SO4 
 
66 
 
86 
113 
 
 
Me2SO4 
 
70 
 
>99 
113 
 
 
MeI 
 
59 
 
94 
113 
 
 
BrCH2CO2
tBu 
 
53 
 
>95 
113 
 
 
EtI 
 
44 
 
>97 
106 
   
 
80 
 
>98 
93 
Table 7 – Examples of products using hydrazone chemistry 
 
1.2.6.2 Stereochemistry of SAMP/RAMP reactions 
Deprotonation of SAMP hydrazones by LDA (or other Li bases) results in the formation of 
aza-enolates,  which can be trapped by electrophiles to obtain diaseteromerically enriched 
compounds (35) (Scheme 37).
100,104,105,115 The absolute configuration of the products results 
from the diastereotopic face selective attack of the electrophilic reagent on one of the sides of 
the SAMP or RAMP hydrazone aza enolate (Scheme 37).
96 The stereochemical outcome of 
the reaction can be explained by a so-called SE2’ front mechanism
116 meaning front side 
attack leading to retention of configuration. Because of the reaction pathway, it is possible to 
predict  the  resulting  diastereomer.  The  synthesis  of  the  desired  product  can  therefore  be 
controlled by the use of either SAMP or RAMP as the chiral auxiliary.
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Scheme 37 – Stereochemistry of SAMP/RAMP reactions  
 
1.2.6.3 Recent synthetic applications of hydrazones via soft enolisation 
The Enders group were able to demonstrate a TiCl4 mediated aza enolate aldol reaction, 
combined with subsequent 1,2-addition of organocerium to an aldehyde hydrazone. This led 
to the effective synthesis of syn-configured N,O-protected 1,3-amino alcohols in good yields 
(18-58%) and with good diastereoselectivities (83-96%) (Scheme 38).
117  
 
I TiCl4, DIPEA, −78 °C. 
II R2CHO. 
III TBSCl, DIPEA. 
IV R3Li/CeCl3. 
Scheme 38 – Soft enolisation using hydrazones 
 
A more recent example was the use of titanium aza enolates of SAMP/RAMP hydrazones 36 
with benzylprotected 3-hydroxypropanal in an asymmetric total synthesis of Pironetin 39, a 
polyketide with immunosuppressive, antitumor, and plant-growth-regulating activities.
110 The 
TBS-protected product 38 (Scheme 39) was obtained in good yield (80% over two steps), 
with moderate diastereoselectivity (55%). The synthesis of the natural product required in Chapter 1 - Introduction 
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addition to the aza enolate aldol reaction to form 37, a Mukaiyama aldol reaction, asymmetric 
alkylation and a ring-closing metathesis as other key steps.  
 
I TiCl4 DIPEA, −78 °C. 
II BnO(CH2)2CHO. 
III TBSOTf, lutidine. 
Scheme 39 - Asymmetric total synthesis of Pironetin (39) 
 
1.2.7     Generation of aza enolates by aziridine ring opening via soft enolisation 
Shimizu et al. reported the ring opening of aziridines 40 with TiI4 to form titanium oxime aza 
enolates,  which  in  turn  was  subjected  to  an  aldol  reaction  with  aldehydes  to  give  aldol 
products in good yields and good diastereoselectivities (Table 8). This is very similar to the 
work reported by Shipman et al. with the use of methyleneaziridines in a four-component 
reaction for the formation of ʱ-amino phosphonates via hard enolisation (Scheme 32, vide 
supra). 
 
Entry  R1  % Yield  (E)-syn:(Z)-syn
a  (E)-anti:(Z)-anti
a 
1  4-MeOC6H4  100  7:14  2:77 
2  4-ClC6H4  93  6:21  4:69 
3  cyclo-C6H11  54  0:23  0:77 
4  PhCH2CH2  25  0:30  7:63 
I TiI4 (3 eq.), R1CHO (1.5 eq.), BF3•OEt2, EtCN, −78 °C to rt, 15 h. 
a based on isolated isomers.
118  
Table 8 – Aza enolate generation via aziridine ring opening 
 
1.2.8  Generation of aza enolates via soft enolisation 
In  1979,  Sugasawa  and  Toyoda  demonstrated  the  use  of  boron  aza  enolates  in  an 
enantioselective aldol reaction using aza enolates derived from chiral imines 41 to obtain 
moderate  ee’s  between  3-42%  (Table  9).
119  Importantly,  this  was  the  first  example  of 
generating aza enolates from imines via soft enolisation using a mild base and a Lewis acid.  Chapter 1 - Introduction 
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Entry  Chiral imine  % yield  % ee 
1  41a  33.8  41.5 
2  41b  41.5  34.5 
3  41b  6.3  19.1 
4  41b  15.2  7.0 
5  41c  29.9  2.5 
I Imine, BCl3, Et3N, −45 °C, then aldehyde , CH2Cl2, 0 °C, 6 h rt, then H3O
+.
119 
Table 9 – Boron aza enolates via soft enolisation 
 
It was not until approximately another 17 years before this soft enolisation methodology was 
probed further by Nagao et al., who reported the use of Lewis acid-amine base reagents in a 
similar imine aldol reaction (Table 10).
120 This involved using imine 25 with Et3N and MgBr2 
to form the aza enolate 42, which then reacts with the aldehyde to form anti-43 and syn-44 
products (Table 10). Chapter 1 - Introduction 
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Entry  Aldehyde  Conditions A 
anti/syn (% yield) 
Conditions B 
anti/syn (% yield) 
1 
 
83/17 (85)  10/90 (92) 
2 
 
90/10 (89)  12/88 (87) 
3 
 
69/31 (84)  9/91 (86) 
4 
 
70/30 (54)  49/51 (11) 
A MgBr2, Et3N, MeCN, −45 °C, 1 h, then ArCHO, −45 °C, 1 h then rt for 11-15 h. 
B MgBr2, Et3N, MeCN, −45 
°C,   1 h, then ArCHO, −45 °C, 11-15 h. Isolated yield is a mixture of anti and syn compounds. 
Table 10 – Magnesium aza enolates via soft enolisation 
 
Building on this work, Nagao et al. reported in 2007 that the stereoselectivity of the reaction 
could be varied by changing the magnesium salts and amine bases in the imine aldol reaction 
(Table 11)
121 It was observed that on changing the base from Et3N to TMEDA the opposite 
stereoselectivity was observed (Entries 2 and 3, table 11).  Chapter 1 - Introduction 
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Entry  MgX2  Et3N 
syn/anti (% yield) 
TMEDA 
syn/anti (% yield) 
1  MgF2  - (0)  - (0) 
2  MgCl2  7/93 (90)  91/9 (93) 
3  MgBr2  10/90 (92)  81/19 (82) 
4  Mg(OTf)2  5/95 (72)  16/84 (22) 
5  Mg(ClO4)2  75/25 (84)  90/10 (90) 
I MgX2, amine base, MeCN, −45 °C, 1 h, then PhCHO, −45 °C, 16 h. 
II 1M AcOH, rt. 1.5 h. 
Table 11 – Examples of different magenisum salts influencing stereoselectivity 
 
Nagao et al.
120 described a plausible mechanism to explain the stereoselectivity (Scheme 40). 
This involves reaction of the aza enolate via an open chain transition state(s) (38) or a chair 
transition  state 45. The chair transition  state  46 will have  unfavourable  1,3-diaxial steric 
hindrance interactions and thus reaction via 46 is disfavoured. Therefore, the open chain 
transition state 45 leading to the unstable imine 47 is favoured. This can then undergo a retro 
aldol  reaction  followed  by  an  aldol  reaction  at  room  temperature  to  produce  48.  After 
hydrolysis this gives the thermodynamic anti-product 43.
122,123 It was also observed that by 
increasing the amounts of Lewis acid and base, the unstable imine 47 can be stabilised by 
formation of MgBr-enamine 49 which after hydrolysis produces the kinetic syn-product 44 
(Scheme 40). This enabled the aldol reaction to be made either reversible or irreversible 
depending on the base and Lewis acid used (Table 11, Entry 5).
120,124  
 Chapter 1 - Introduction 
 
 
34 
 
Scheme 40 – Nagao’s
120 mechanism to explain the observed stereoselectivity 
 
1.2.9  Conclusions  
Since the work of Stork in the 1960s, aza enolate reactions have been successfully employed 
for a range of reactions that cannot be readily achieved with enamines or ketone enolates. 
This  includes  alkylation  reactions  with  simple  substrates  to  more  interesting  reactions 
involving ring opening of epoxide derivatives.
74 With hydrazone methodology, aza enolate 
chemistry has grown, particularly in asymmetric synthesis with the use of SAMP/RAMP. 
Currently, C-heteroatom (Si, Se, S, O, P, N, F) bond formation and C-C bond formation using 
both  achiral  and  chiral  hydrazone  methods  are  well-known  synthetic  transformations. 
However,  there  are  still  some  limitations  with  hydrazone  methodology  as  stoichiometric 
amounts of the chiral auxiliary need to be used. This project explores the development of 
catalytic aza enolate reactions that attempt to combine reversible imine formation with soft 
enolisation to generate aza enolates directly from carbonyl compounds in a catalytic manner. Chapter 1 - Introduction 
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It is hoped that this will overcome some of the current limitations of organocatalysis and will 
enable a range of useful aza enolate reactions to be achieved catalytically for the first time.  
 
1.3  Aim and objectives 
At present, organocatalysis is a highly active area of research as it provides new efficient 
ways  of  introducing  asymmetry  with  high  enantioselectivity.  In  addition,  a  catalytic 
transformation provides the best ‘‘atom economy’’, because the stoichiometric introduction 
and removal of (chiral) auxiliaries can be avoided.
1,125 However, in the vast majority of these 
reactions there are a limited number of activation modes; therefore to expand the scope of 
organocatalysis new activation modes are needed.
58 This project explores the development of 
a  new  mode  of  activation  via  aza  enolates  intermediates,  and  its  application  to  catalytic 
transformations  that  are  not  currently  viable  using  existing  methods.  In  particular,  this 
activation  mode  can  potentially  be  used  to  achieve  reactions  with  relatively  unreactive 
electrophiles such as epoxides.  
 
It  was  envisioned  that  an  aza  enolate  catalytic  cycle  (Scheme  41)  would  involve  imine 
formation  between  a  primary  amine  (50)  and  a  ketone/aldehyde  (51),  followed  by  co-
ordination  of  the  resulting  imine  (52)  to  the  Lewis  acid  (e.g.  MgX2)  and  subsequent 
deprotonation to give the aza enolate (53). Aza enolate 53 can then undergo a reaction with 
an electrophile (E
+) to generate the imine (54), which can then subsequently be hydrolysed to 
generate the product ketone (55) and regenerate 50. As a result, this reaction can be catalytic 
in 50 and depending on the nature of the electrophile, could also be catalytic in Lewis acid 
and  tertiary  amine  base  and  therefore  this  gives  several  alternative  possibilities  for 
introducing asymmetry. Initially, it was decided to investigate Mg salts as they have been 
demonstrated in the literature to be a suitable Lewis acids for the soft enolisation of imines.  Chapter 1 - Introduction 
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Scheme 41 – Proposed aza enolate catalytic cycle using soft enolisation 
 
The enolisation of the imine should occur rather than enolisation of the parent ketone as the 
Lewis acid should preferentially coordinate to the nitrogen of the imine due to its higher 
basicity. Furthermore, it is desired that the electrophile will react with the aza enolate and not 
with the amine or base. Initially, it was decided to explore the reaction of pre-formed imines 
in  order to  test  the feasibility of the aza  enolate reactions,  before moving on to  explore 
catalytic systems. Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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Chapter 2 – Development of a catalytic aza enolate aldol reaction 
 
2.1  Results and Discussion 
2.1.1  Synthesis of imine derivatives 
Work in this area began with the synthesis of a number of imine derivatives for use in the 
proposed methodology (Section 1.3). As described in section 1.2.4, Nakamura  et al. had 
employed  an  imine  where  the  corresponding  aza  enolate  bears  an  internal  nitrogen  co-
ordination site which significantly alters the reactivity (Scheme 42).
126 
 
I MesMgBr. 
II X-R, H3O
+.
126 
Scheme 42 – Literature work with internal nitrogen co-ordination site 
  
Therefore, imine 56 was selected alongside the standard imine 25 for initial testing and the 
two  imines  were  synthesised  in  excellent  yields  by  reacting  cyclohexanone  with  the 
corresponding amine 57 or 58 (Scheme 43). 
 
I 57, 4 Å molecular sieves, 80 °C, 18 h. 
II 58, Et2O, 4 Å molecular sieves, rt, 14 h. 
Scheme 43 – Synthesis of imines 25 and 56 
 
Using aldehydes in place of cyclohexanone, several aldehyde derived imines (59-62) were 
produced following literature procedures
127-130 (Table 12). Imines 59 and 60 (Entries 1 and 2, 
Table 12) were chosen together with sulfoximines 61 and 62 (Entries 3 and 4, Table 12). The 
sulfoximines are more stable systems that can readily be purified chromatographically. These Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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systems can also be prepared in enantiopure form if needed for the study of enantioselective 
reactions (Table 12).  
 
Entry  Amine  Aldehyde  Imine  Procedure 
1   
 
 
 
 
I 
2   
 
 
 
 
II 
3   
 
 
 
 
III 
4   
 
 
 
 
III 
I  −5 °C, 30 min, rt, KOH pellets, 24 h. 
II CH2Cl2, MgSO4, reflux, 2 h. 
III CH2Cl2, PPTS, MgSO4, rt., 24 h.  
Table 12 – Synthesis of aldehyde derived imines (59-62) 
 
Following  a  literature  procedure,
131  (R)-1-phenylethanamine  63  was  reacted  with 
cyclohexanone and 
iPrCHO to produce chiral imines 64 and 65 respectively (Scheme 44). 
 
I Cyclohexanone, CH2Cl2, MgSO4, rt, 14 h. 
II iPrCHO, CH2Cl2, MgSO4, rt, 14 h. 
Scheme 44 – Synthesis of chiral imines 64 and 65 
 Chapter 2 – Development of a catalytic aza enolate aldol reaction 
 
 
39 
 
With these substrates in hand, it was then possible to begin testing these intermediates in the 
proposed aza enolate reactions. 
 
2.1.2  Stoichiometric aldol reactions 
Initial investigations involved examining literature methods for an aza enolate aldol reaction. 
Firstly, imine 25 was used in an aldol reaction with 4-chlorobenzaldehyde 66 following a 
literature procedure
120 (Scheme 45). Examination of the crude 
1H NMR indicated only a low 
conversion to the product 67 (19%). Following purification, keto alcohol product 67 was 
obtained in a low yield of 12%. 
 
I MgBr2, Et3N, MeCN, −45 °C, 1 h, 66, MeCN, −45 °C, 1 h; rt, 12 h. 
Scheme 45 – Aldol reaction using imine 25 
 
An analogous reaction was carried out using 59 and aldehyde 66. Again, examination of the 
crude 
1H NMR indicated only a 25% conversion to the product 68. Purification produced the 
corresponding keto alcohol product 68 in a 20% yield (Scheme 46). 
 
I MgBr2, Et3N, MeCN, −45 °C, 1 h, 66, MeCN, −45 °C, 1 h, rt, 12 h. 
Scheme 46 – Aldol reaction using aldehyde derived imine 59 
 
It was then decided to explore whether the imine could be formed in situ in the aldol reaction. 
This involved using cyclohexanone (94) directly with aldehyde 66 in the presence of amine, 
Mg salt and base affording the desired keto alcohol product 67 in 14% yield as a 1:1 mixture 
of diasteroisomers (Table 13, entry 1). Examination of the crude 
1H NMR indicated only a 
21% conversion to the product 67. Large quantities of unreacted imine 69, derived from Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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condensation of cyclohexanone with Cy-NH2, were observed in the crude 
1H NMR spectrum. 
Changing the magnesium counterion from bromide (Table 13, entry 1) to chloride, triflate or 
perchlorate (Table 13, entries 2-4) had a significant impact on the conversion to the keto 
alcohol product 67, with magnesium perchlorate providing the highest conversion, 35%, and 
cleanest crude 
1H NMR. Evidence for an aza-enolate intermediate was provided by control 
reactions, which excluded one of the three key reagents from the reaction mixture: primary 
amine, magnesium salt, triethylamine (Table 13, entries 5-7). No apparent conversion to the 
keto alcohol product 67 was observed in each case, clearly suggesting a synergistic operation 
of the primary amine, magnesium salt, and triethylamine in the reaction mechanism. 
 
Entry  Et3N 
equiv. 
Cy-NH2 
equiv. 
MgX2  Conversion
a  Yield 
X =  equiv. 
1  2.4  1  Br  1.2  19%  14% 
syn:anti (1:1) 
2  2.4  1  Cl  1.2  10%  n.d. 
3  2.4  1  OTf  1.2  25%  n.d. 
4  2.4  1  ClO4  1.2  35%  n.d. 
5  0  1  ClO4  1.2  <5%  n.d. 
6  2.4  0  ClO4  1.2  <5%  n.d. 
7  2.4  1  ClO4  0  <5%  n.d. 
I Cy-NH2, MeCN then MgX2, Et3N, MeCN, −45 °C, 1 h then aldehyde (66), MeCN, −45 °C, 1 h then rt, 12 h. 
a 
% conversion determined by 
1H NMR (CDCl3). n.d. = not determined 
Table 13 – Lewis acid screen and control reactions 
 
With these results (Table 13), a cross-aldol reaction of aldehydes was  investigated using 
aldehyde 70 instead of cyclohexanone under the same reaction conditions and this reaction 
afforded the aldol product 68 in a 20% yield (Scheme 47).  Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I Cy-NH2, MeCN then MgX2, Et3N, MeCN, −45 °C, 1 h then aldehyde (66), MeCN, −45 °C, 1 h then rt, 12 h.  
Scheme 47 - Cross-aldol reaction of aldehydes 
 
2.1.3  Catalytic aza enolate aldol reactions 
Having  demonstrated  that  stoichiometric  aza  enolate  reactions  with  MgX2/Et3N  and  a 
primary amine led to a keto alcohol product (above), the next step was to investigate if a 
catalytic aza enolate reaction of the imine was possible. Initially, an authentic sample of the 
keto alcohol product 72 was produced by using L-proline as the catalyst in 42% yield and in a 
70% ee using a literature procedure
132 and analysed by chiral HPLC with the major isomer 
being determined as 4R (Scheme 48). 
 
I L-Proline, DMSO:acetone (4:1), then 66, 12 h, rt. 
Scheme 48 – Synthesis of authentic sample of 72 
 
With an authentic sample in hand, a catalytic reaction was investigated. This involved using 
acetone 71 with catalytic quantities of Cy-NH2, Et3N and Mg(ClO4)2 and 1 equiv. of aldehyde 
66,  affording  the  keto  alcohol  product  72  in  a  low  isolated  yield  of  12%  (Scheme  49). 
Inspection of the crude 
1H NMR  indicated an  18% conversion to  the  product  72.  Large 
quantities of unreacted imine 73 derived from condensation of Cy-NH2 with acetone 71, were 
present in the crude 
1H NMR spectrum.  
 
I Cy-NH2 (50 mol %), (Mg(ClO4)2 (50 mol %), DMSO, Et3N (50 mol %), then aldehyde (66), then rt, 12 h. 
Scheme 49 – Preliminary catalytic reaction 
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Again, evidence for an aza enolate intermediate was provided by a series of control reactions, 
which excluded one of the three key reagents from the reaction mixture: Cy-NH2, Mg(ClO4)2, 
Et3N (Table 14, entries 1-3). No apparent conversion to the keto alcohol product 72 was 
observed in the absence of any one of the three components,  again, clearly suggesting a 
synergistic operation of the primary amine, magnesium salt, triethylamine in the reaction 
mechanism.  
 
Entry  Et3N 
equiv. 
Cy-NH2 
equiv. 
Mg(ClO4)2 
equiv. 
Solvent  Conversion
a 
1  0  0.5  0.5  DMSO  <5% 
2  0.5  0  0.5  DMSO  <5% 
3  0.5  0.5  0  DMSO  <5% 
I Cy-NH2, (Mg(ClO4)2, solvent, Et3N, then aldehyde (66), then rt, 12 h. 
a % conversion determined by 
1H NMR 
(CDCl3). 
Table 14 – Catalytic control reactions 
 
To improve the conversion (Scheme 49, above), a solvent screen was attempted with the use 
of acetone 71 as a reagent and co-solvent in a 4:1 ratio (solvent:acetone) (Table 15, entries 1-
8) as this was shown to be the best ratio when using L-proline as the catalyst.
132 From these 
observations, it was a clear that a solvent system involving DMSO and acetone 71 (Table 15, 
entry 5) led to the best conversion (30%), with an isolated yield of 26%. A range of different 
co-solvents was then investigated with 1 eq. of acetone 71 being used only as a reagent 
(Table 15, entries 9-16). It was clear that MeOH and MeCN gave the best conversions of 
24% and 26% respectively at room temperature (Table 15, entries 10-11). Importantly, upon 
inspection of the crude 
1H NMR spectra in all of these reactions (Table 15, entries 1 and 4-
13), it was apparent that low conversions were due to the formation of large quantities of 
imine 74, derived from condensation of Cy-NH2 with aldehyde 66. This suggests that the 
formation of imine 74 maybe irreversible.  
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Entry  Acetone 
eq. 
Co-solvent 
eq. 
Solvent  Conversion
a  Yield 
1  -  4:1  MeOH:acetone  21%   
2  -  4:1  CH2Cl2:acetone  Intractable mixture   
3  -  4:1  CHCl3:acetone  Intractable mixture   
4  -  4:1  EtOAc:acetone  18%   
5  -  4:1  DMSO:acetone  30%  26% 
6  -  4:1  Tol:acetone  5%   
7  -  4:1  THF:acetone  10%   
8  -  4:1  MeCN:acetone  24%   
9  1  0.5  DMSO:EtOAc  18%   
10  1  0.5  DMSO:MeOH  24%   
11  1  0.5  DMSO:MeCN  25%   
12  1  0.5  DMSO:Et2O  12%   
13  1  0.5  DMSO:THF  12%   
14  1  0.5  DMSO:Tol  Intractable mixture   
15  1  0.5  DMSO:CH2Cl2  Intractable mixture   
16  1  0.5  DMSO:CHCl3  Intractable mixture   
I Cy-NH2 (50 mol %), (Mg(ClO4)2 (50 mol %), solvent, Et3N (50 mol %), then aldehyde (66), rt, 12 h. 
a % 
conversion determined by 
1H NMR (CDCl3). 
Table 15 – Solvent screen 
 
 
To investigate if the formation of imine 74 was reversible under the reaction conditions and 
hence whether it is involved further in the catalytic cycle, a pure sample of imine 74 was 
reacted with acetone 71. This involved using catalytic quantities of Et3N and Mg(ClO4)2 in 
DMSO:acetone (4:1) to see if any of the keto alcohol product 72 was generated (Scheme 50). 
Regrettably, the formation of imine 74 appears not to be reversible under these conditions, as 
the anticipated keto alcohol product 72 was not observed. Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I (Mg(ClO4)2 (50 mol %), DMSO:acetone (4:1), Et3N (50 mol %), rt, 12 h. 
Scheme 50 – Reaction to investigate the reversibility of the aldehyde derived imine 
 
This  indicates  that  due  to  the  (irreversible)  formation  of  imine  74,  the  catalytic  cycle  is 
inhibited  and  leads  to  the  primary  amine  being  consumed,  leading  to  lower 
conversions/yields being obtained (Scheme 51). Thus, to improve conversions/yields and to 
limit  the amount of imine  74  formed; the  chosen aldehyde(s)  were added dropwise  to  a 
mixture of the other reagents in subsequent reactions. 
 
Scheme 51 – Irreversible formation of the aldehyde derived imine 
 
2.1.4  Optimisation of catalytic aza enolate reactions 
The next step was to optimise the catalytic aza enolate aldol reaction by investigating the 
quantities  of  primary  amine,  Et3N  and  Mg(ClO4)2  used  in  the  reactions.  Preliminary 
investigations  had  shown  that  diamine  75  led to  the  best  conversion  to  the  keto  alcohol 
product 72, 40%, compared to when 81 (33%) and 82 (25%) were used (Scheme 52). 
I Amine (50 mol %), (Mg(ClO4)2 (50 mol %), DMSO:Acetone, Et3N (50 mol %), then aldehyde (66), rt, 12 h. 
Scheme 52 – Preliminary amine screen 
 
Therefore, diamine 75 was chosen for further optimisation of the aza enolate conditions with 
acetone 71 and aldehyde 66 (Table 16). Interestingly, varying the mol % of the amine 75 
from 5 mol % (Table 16, entry 1) to 10 mol % (Table 16, entries 2-8) had a significant impact 
on the conversion to the keto alcohol product 72, from 10% to 64% conversion by crude 
1H Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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NMR spectroscopy analysis. As expected, decreasing the amount of acetone from twenty 
equivalents  to  five  equivalents  leads  to  lower  conversions  (Table  16,  entries  2  and  3). 
Increasing the mol % of Mg(ClO4)2 from 10 mol % to 50 mol % has  no real effect on 
conversions (Table 16, entries 4 and 5). However, increasing the mol % of Et3N from 10 mol 
% to 20 mol % increased the conversion from 24% to 52% and increased the isolated yield 
from 15% to 43% (Table 16, entries 6 and 7). Using 10 mol % of the amine 75 and 20 mol % 
of Et3N and Mg(ClO4)2 with 10 equiv. of acetone 71 provided the highest conversions (Table 
16, entries 7-8), 52% and 64% respectively. In addition, due to the volatility of acetone 71, 
sealing the reaction vessel also increased the conversion and led to an isolated yield 60% 
(Table 16, entry 8). Increasing the mol % of the amine 75 by two-fold to 20 mol % decreased 
the conversion to the keto alcohol product 72, from 49% to 45% (Table 16, entries 9-14). 
Reversing the addition of reagents by adding Et3N first, followed by Mg(ClO4)2, acetone 71, 
amine  75,  and  lastly  the  aldehyde  (dropwise)  lowered  the  conversion  to  34%  from  52% 
(Table 16,  entry 15 cf. to entry 7). Increasing the mol % of the amine 75 further to 50 mol %, 
decreased the conversion of the keto alcohol product 72 to approximately 33% (Table 16, 
entries 16-17). Greater than 50 mol % of the amine 75, led to slightly smaller conversion to 
the  keto  alcohol  product  72  of  approximately  29%  (Table  16,  entries  18-19),  the  major 
products observed in these two cases were the two imines 76 and 77 (Table 16). Changing the 
co-solvent from DMSO:acetone to DMSO:H2O and DMF:H2O led to a significant drop in 
conversion to the keto alcohol product 72 from 52% to 37% respectively (Table 16, entries 
20-21 cf. to  entry 7).  In summary, 10   mol % of  75, 20 mol % of Et3N, 20 mol % of 
Mg(ClO4)2, and 10 equiv. of 71 with a sealed reaction vessel was  found to result in the 
highest conversion.  Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I 75 (X mol %), 71 (X equiv.), (Mg(ClO4)2 (X mol %), DMSO:acetone (4:1), Et3N (X mol %), then 66, rt, 12 h. 
 
Entry 
 
71 
(equiv.) 
75 
(mol %) 
(Mg(ClO4)2 
(mol %) 
Et3N 
(mol %) 
conversion*  Yield 
 
1  10  5  20  20  10%  5% 
2  5  10  20  20  19%  - 
3  20  10  20  20  37%  - 
4  10  10  10  20  32%  - 
5  10  10  50  20  36%  30% 
6  10  10  20  10  24%  15% 
7  10  10  20  20  52%  43% 
8
a   10  10  20  20  64%  60% 
9  10  12  20  20  49%  38% 
10  10  14  20  20  45%  - 
11  10  16  20  20  42%  - 
12  10  18  20  20  40%   
13  10  20  20  20  37%   
14  20  20  20  20  35%  24% 
15
b  10  20  20  20  34%  - 
16  20  50  20  20  33%  9% 
17  10  50  20  20  31%  - 
18  10  70  20  20  30%  - 
19  10  100  20  20  27%  - 
20
c  10  20  20  20  37%  - 
21
d  10  20  20  20  37%  - 
a Sealed reaction vessel with argon balloon. 
b Reverse addition of reagents. 
c Solvent DMSO:H2O (99:1). 
d 
Solvent DMF:H2O (99:1). * % conversion determined by 
1H NMR (CDCl3). 
Table 16 – Optimisation of the aza enolate conditions 
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To illustrate the results from increasing the quantity of amine 75 from table 16 in a different 
format, Graph 1 is shown below. The graph shows that increasing the mol % from 10 mol % 
to 12 mol % and further to 100 mol % decreased the conversion to the product with 10 mol % 
being the optimum mol % of amine 75 (Graph 1).  
 
 
I 75 (X mol %), 71 (10 equiv.), (Mg(ClO4)2 (20 mol %), DMSO:acetone (4:1), Et3N (20 mol %), then 66, rt, 12 h. 
Graph 1 – Increasing the quantity of amine 75. 
 
To evaluate the scope of this catalytic reaction, a more in depth amine study was carried out 
with acetone 71 and aldehyde 66 subjected to the optimised reaction conditions with a variety 
of amines as catalysts (Scheme 53). The chelating amines 75 and 78 produced moderate to 
good yields of 72, 60% and 48%, whereas the aromatic amines 79 and 80 produced 72 in low 
yields of 14% and 18%, possibly due to the aromatic amines being less nucleophilic. The 
aliphatic amines 81, 82 and 83 produced 72 in low to moderate yields of 12%, 40%, and 14% 
respectively. The commercially available amine 84 was not initially considered, but towards 
the end of the project a reaction with 84 was carried out, giving an excellent yield of 78% 
(Scheme 53).  Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I 71, Mg(ClO4)2 (20 mol %), Amine (10 mol %), DMSO:acetone, Et3N (20 mol %), then 66, rt, 12 h.* % 
conversion determined by 
1H NMR (CDCl3). 
Scheme 53 – Amine study 
 
The high yield obtained using sulfinamide 84 may be due to the fact that the reaction between 
84 and the aldehyde 66 to form the imine may now be reversible (Scheme 54). 
 
I 71, Mg(ClO4)2 (20 mol %), Amine 84 (10 mol %), DMSO:acetone, Et3N (20 mol %), then 66, rt, 12 h. 
Scheme 54 – Possible reversibility using sulfinamide 84. 
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As amine 84 was only investigated later in this project, amine 75 was selected for further 
optimisation of the aza enolate reaction. Reactions with a variety of different aldehydes were 
conducted  with  acetone  71  and  chelating  amine  75  (Scheme  55).  Aliphatic  aldehydes 
produced lower yields (Scheme 55, 85-89), possibly due to the enolisable protons available 
(not  available  in  the  aromatic  aldehydes),  leading  to  possible  aldehyde-aldehyde  cross-
reactions. Aromatic aldehydes produced the best yields (Scheme 55, 90-93), presumably as 
they  do  not  readily  undergo  competing  reactions.  Electron  withdrawing  groups  on  the 
aromatic ring make the aldehydes more reactive and lead to greater yields (Scheme 55, 90 
and 72) being obtained. The moderate yield obtained with aldehyde 93 (Scheme 55, 93) may 
be due to the low purity of the commercially available aldehyde.  
 
 
I 71, Mg(ClO4)2 (20 mol %), 75 (10 mol %), DMSO:acetone, Et3N (20 mol %), then aldehyde, rt, 12 h. 
* Isolated as a mixture of aldehyde and product. 
Scheme 55 – Aldehyde study 
 
Following  on  from  these  results  (Scheme  55),  a  small  study  on  ketone  substrates  was 
conducted  with  amine  75  and  4-chlorobenzaldehyde  66  as  the  electrophile  (Scheme  56). 
Cyclohexanone and acetone (Scheme 56) led to the best yields of 69% and 55%. Tetralone 95 
gave a moderate yield of 23%, which may be due to i) conjugation of the ketone to the 
aromatic  ring,  leading  to  lower  reactivity  and  ii)  fewer  enolisable  protons  compared  to 
ketones 67 and 72.  Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I Ketone, Mg(ClO4)2 (20 mol %), amine 75 (10 mol %), DMSO, Et3N (20 mol %), then 66, rt, 12 h. 
*10 equivalents used 
Scheme 56 – Ketone study 
 
2.1.5  Synthesis of chiral amines  
The next logical step was to investigate if asymmetry could be introduced into the catalytic 
reaction by employing a chiral primary amine. For this a range of chiral amines are required. 
Initially, chiral amine 96 was selected as it has been shown by Soos et al. to catalyse a highly 
enantioselective conjugate addition reaction.
133 Compound 96 was produced in a 70% yield 
via a Mitsonubu/Staudinger reaction (Scheme 57). 
 
I PPh3, dry THF, 0 
oC, then DIAD, Diphenyl phosphoryl azide, THF, 0 
oC, then 12 h, rt. 
Scheme 57 – Synthesis of chiral amine 96 
 
We  also  wished  to  explore  chiral  analogues  of  the  chelating  amine  75.  Therefore, 
commercially  available  chiral  amine  97  was  reacted  with  aldehyde  66  to  produce 
intermediate 98 in a quantitative yield, which was then treated with NaBH4 to produce the 
diamine 99 in a modest yield of 47% (Scheme 58).  Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I EtOH, 66; 
II NaBH4, MeOH, 15 min, rt. 
Scheme 58 – Synthesis of chiral amine 99 
 
Chiral amine 101 was also synthesised in a 48% yield by methylating commercially available 
100 following a literature procedure
134 (Scheme 59). 
 
I KH, THF, 0 
oC to rt, 12 h, then MeI, THF, 0 
oC, rt, 45 min. 
Scheme 59 – Synthesis of chiral amine 101 
 
In  order  to  determine  whether  the  chiral  amines  were  providing  any  level  of 
enantioselectivity we needed to be able to measure the ee of the aldol products. We therefore 
carried out the aldol reaction to form 72 using (L)-proline as the organocatalyst to provide an 
authentic sample (Scheme 60) of the product (with the R isomer as the major enantiomer). 
 
I L-Proline, DMSO:acetone (4:1), then 66, 12 h, rt. 
Scheme 60 – Synthesis of authentic sample of 72 
 
Analysis of the L-proline reaction using chiral HPLC enabled us to separate the enantiomers 
and we obtained a comparable ee to the reported reaction (Table 17). Comparison of the 
HPLC data enabled us to determine that the major product from the aza-enolate reaction with 
amine 102 had the same absolute configuration as that obtained with L-proline as the catalyst 
(Table 17). Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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Catalyst, conditions  L-Proline  L-Proline  Chiral amine 102 
All  HPLC  samples  were 
columned  under  the  same 
conditions. CHIRALPAK AD, 
hexane/i-PrOH  =  80/20,  flow 
rate = 1 mL. 
 
 
   
ee from HPLC  (R)-76%
135  (R)-70%  
This work 
(R)-40% 
This work 
[ʱ]
22
D  Lit. +46.2° (c = 1, 
CHCl3).
135 
+38.5° (c = 1, 
CHCl3) 
n.d. 
n.d. = not determined 
Table 17 – How major isomer was determined 
  
With the above chiral amines in hand and a method to determine the assignment of the major 
isomer available, it was then possible to begin testing a range of different chiral amines in the 
aza enolate aldol reaction (Scheme 61). Unfortunately, upon testing eleven different chiral 
amines gave only low enantioselectivity. However, the best result was obtained with amine 
102, with an ee of 40% and an isolated yield of 41% (Scheme 61, 102). The commercially 
available  chiral  sulfinamide  (Scheme  61,  106)  also  gave  a  moderate  ee  of  38%  and  an 
excellent yield of 81%. The previously prepared amine 96 gave the S-isomer as the major 
product but only gave 8% ee which is fairly small. This may be because there is no chelating 
atom close to the primary amine group in amine 96. 
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I 71, Mg(ClO4)2 (20 mol %), chiral amine (10 mol %), DMSO:acetone, Et3N (20 mol %), then 66, rt, 12 h. 
a ee 
was determined by chiral HPLC analysis (Chiralpak AD, Daicel Chemical Industries, Ltd.) comparing with the 
authentic sample 72.* Any ee below 5% is classed as racemic. 
Scheme 61 – Chiral amine study 
 
To explain the selectivity in the case of chelating amines such as 102, we propose a chair 
transition state for the aldol reaction (Scheme 62). There are four possible chair transition 
states as shown in Scheme 62. The most favoured transition state would be  102a as the 
isopropyl group is facing away from the aldehyde as it approaches the enolate and the ‘R’ 
group is equatorial. 102b does have the isopropyl group facing away from the aldehyde but 
the aldehyde ‘R’ group is now axial and this will raise the energy of this transition state. 
Chair transition states 102c and 102d are disfavoured as the isopropyl group is facing towards 
the aldehyde as it approaches the enolate (Scheme 62). 
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Note: Methyl groups are removed for clarity 
Scheme 62 – Four possible chair transition states using chiral amine 102 as an example 
 
The (R)-product is obtained from transition state 102a as shown in Scheme 63 in agreement 
with the observed selectivity from the reactions. 
 
Scheme 63 – Product of transition state 102a  
 
Amine 102 was selected for further optimisation of the asymmetric aza enolate reaction. To 
enhance the enantioselectivity, a solvent screen was attempted (Table 18). It is clear that 
polar  solvents  increase  the  %  conversion  (Table  18,  entries  2,  3  and  4),  however, 
enantioselectivity  is  lowered.  Encouragingly,  with  CHCl3  an  apparent  ee  of  72%  was 
observed when the crude product was analysed by chiral HPLC (Table 18, entry 8). However, 
upon purification only a disappointing ee of 17% was seen and an isolated yield of 40%. The 
apparent ee of 72% was presumably observed due to by-products having similar retention 
times to one enantiomer of the product leading to inaccurate peak heights in the HPLC trace 
obtained from the crude product.  Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I Mg(ClO4)2 (20 mol %), 102 (10 mol %), DMSO:acetone, Et3N (20 mol %), then 66, rt, 12 h. 
Entry  Solvent  % conversion*/% ee  Entry  Solvent  % conversion*/% ee 
1  MeCN  22%/15%  5  Et2O  39%/22% 
2  EtOAc  50%/16%  6  THF  47%/8% 
3  MeOH  58%/12%  7  CH2Cl2  34%/23% 
4 
iPrOH  53%/2%  8  CHCl3  40%
a/17% 
* % conversion determined by 
1H NMR (CDCl3) on crude material. ee determined by chiral HPLC analysis 
(Chiralpak AD, Daicel Chemical Industries, Ltd.) by comparison to racemic sample of 72. 
a Isolated yield. 
Table 18 – Solvent screen with amine 102 
 
In summary, after synthesising a variety of chiral amines and testing these intermediates in 
the  aza  enolate  aldol  reaction  alongside  some  commercially  available  chiral  amines,  two 
positive results were obtained. Firstly with amine 102 the reaction gave an ee of 40% and an 
isolated yield of 41% and secondly, sulfinamide 106 gave a moderate ee of 38% and an 
excellent isolated yield of 81%. No further improvement was observed in the ee in attempts 
to optimise the reaction, and hence no further work was carried out with these asymmetric 
reactions. 
 
2.1.6  Diastereoselectivity of the aza enolate aldol reactions 
As  previously  mentioned  in  section  1.2.8,  Nagao  et  al.  reported  that  variable 
diastereoselectivity can  be observed  in  aza enolate aldol reactions  between a  pre formed 
imine 25 and aromatic aldehydes in the presence of magnesium salts and a base (Et3N or 
TMEDA) (Table 19).
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Entry  MgX2  Et3N 
syn/anti (% yield) 
TMEDA 
syn/anti (% yield) 
1  Mg(OTf)2  92/8 (86)  16/84 (22) 
2  Mg(ClO4)2  33/67 (84)  90/10 (90) 
I MgX2, amine, base, MeCN, −45 °C, 1 h, then aldehyde 66, −45 °C, 16 h. 
II 1M AcOH, rt, 1.5 h. (Nagao et 
al.)
123,124 
Table 19 – Literature example showing diastereoselectivity  
 
With this information, a one-pot catalytic aza enolate aldol reaction was carried out using the 
optimised  conditions  developed  above  (Section  2.2.4)  to  observe  if  similar  changes  in 
diastereoselectivity are obtained in the catalytic process using amine 75. It was found that in 
this case, the diastereoselectivity was similar regardless of which Mg salt was used in the 
reaction. When the base was changed from Et3N to TMEDA, the selectivity dropped in each 
case from 2:1 to around 1:1 (Table 20). The dramatic change in diastereoselectivity from a 
syn-selective reaction to an anti-selective reaction was not seen in the catalytic process in 
sharp contrast to the observations in the stoichiometric reaction of imine 35 (Table 20 cf table 
19).  However,  this  reaction  was  not  tested  with  Cy-NH2  to  make  it  more  similar  to  the 
stoichiometric reactions reported by Nagao et al. 
 
Entry  MgX2  Et3N 
syn/anti (% yield) 
TMEDA 
syn/anti (% yield) 
1  Mg(OTf)2  67/33 (63)  50/50 (42) 
2  Mg(ClO4)2  67/33 (61)  60/40 (58) 
I 75 (10 mol %), DMSO, MgX2 (20 mol %), base (20 mol %), then aldehyde 65, then rt, 12 h.  
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2.1.7  Aza enolate heteroaromatic reactions 
We were interested in discovering whether the catalytic aza enolate reactions could also be 
applied to reactions of nitrogen heterocycles. Hamana and Sugasawa reported an aldol like 
reaction of nitrogen containing heteroaromatic compounds with benzaldehydes
136 (Scheme 
64). However, there are limitations with their work, as firstly, the use of 9-BBN-OTf leads to 
a lengthy work-up involving H2O2. Secondly, stoichiometric quantities of the reagents are 
used. 
 
I 9-BBN-OTf, 
iPr2NEt, CH2Cl2, −78 
oC, then rt, 17 h. 
136 
Scheme 64 – Literature example of heteroaromatic reactions 
 
A  plausible  mechanism  similar  to  an  aza  enolate  reaction  could  be  envisaged  where  the 
heteroaromatic compound 108 reacts with a base in the presence of a Lewis acid to form 
intermediate 109, which can then undergo an aldol reaction with 66 to produce the product 
110 (Scheme 65).  
 
Scheme 65 – Possible mechanism for heteroaromatic compound 108 
 
Initial attempts were made to test if a catalytic aza enolate aldol reaction could take place 
under our recently developed reaction conditions. Firstly, 2-picoline and pyrazine were tested 
under the catalytic aza enolate conditions (Scheme 66). Frustratingly, both attempts to form 
the alcohol product were unsuccessful, with no reaction occurring. Therefore, reactions with 
stoichiometric  quantities  of  reagents  were  investigated,  which  also  led  to  no  reaction 
occurring with complete recovery of starting materials even when carried out neat or in a 
variety of different solvents (DMSO, MeCN, Et2O, CH2Cl2, THF, CHCl3, and EtOAc). Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I 2-picoline or pyrazine (50 mol %), Mg(ClO4)2 (50 mol %), solvent, Et3N (50 mol %), then 66, then rt, 12 h. 
Scheme 66 – Attempted heteroaromatic reactions  
 
2.1.8  Reactions of aza enolates with other electrophiles 
Investigations  were  conducted  into  the  reaction  of  aza  enolates  with  nitroso  compounds 
(Scheme 67). The reaction of a range of ketones has been reported in the literature with the 
use of L-proline as a catalyst.
137 Preliminary reactions involved a number of different solvents 
(DMSO, MeCN, Et2O, CH2Cl2, CHCl3, THF, and EtOAc) with catalytic quantities of amine 
75, Mg(ClO4)2 and Et3N and 1 equiv. of ketone 94. Frustratingly, no isolatable products were 
observed in any of these reactions and it was found that the majority of the starting materials 
were still present even upon heating to 50 °C (Scheme 67). 
 
I 75 (10 mol %), 94, Nitrosobenzene, Mg(ClO4)2 (20 mol %), Et3N (20 mol %), DMSO, rt. 12 h.  
Scheme 67 – Attempted aza enolate reaction with nitrosobenzene 
 
An extension to this work was to use azodicarboxylates as  electrophiles to analyse if ʱ-
functionalisation  could  occur  in  the  presence  of  a  ketone  (Scheme  68)  using  the  same 
conditions  as  above.  Frustratingly,  no  ʱ-functionalisation  was  observed  in  any  of  these 
reactions and it was found that in all reactions the starting materials were still present. This 
could be due to the mild conditions used and possible heating and/or using a stronger base 
may produce the ʱ-functionalised product.  Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I Mg(ClO4)2 (20 mol %), solvent, Et3N (20 mol %), then rt, 12 h. 
Scheme 68 – Attempted aza enolate reaction with azodicarboxylates 
 
2.1.9  Alkylation reactions 
Nakamura et al.
69 (Section 1.2.4) had shown that alkylation reactions with pre formed imine 
derivatives can be achieved with the use of magnesium enamides bearing an internal nitrogen 
coordination  site  using  stoichiometric  conditions  (Scheme  69).  Interestingly,  under  these 
reaction  conditions  alkylation  products  could  be  formed  even  with  poorly  reactive  alkyl 
halides such as alkyl chlorides and fluorides.  
 
I MesMgBr, THF, rt, then, 80 °C, 1 h; 
II Chlorocycloheptane, THF, 45 °C, 24 h, then, 60 °C, 12 h, then H3O
+.
69 
Scheme 69 – Literature example of an alkylation reaction 
 
It was envisioned that this transformation might be possible with the catalytic aza enolate 
conditions (Scheme 70). Frustratingly, all reactions using cyclohexanone 94 and pentan-3-
one 111 failed at room temperature and when heated to 40 °C, with starting materials being 
observed.  Leaving  the  reaction  mixtures  at  40  °C  for  48  h  also  had  no  impact  on  the 
formation of the product 112 with only starting materials being observed. It seems that aza 
enolate  generation conditions  employed in  Nakamura’s original work  are critical  for this 
reaction to be effective.  Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I 94 or 111, Chlorocycloheptane, Mg(ClO4)2 (20 mol %), DMSO, Et3N (20 mol %), then rt, 12 h. 
Scheme 70 – Attempted alkylation reactions 
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2.2  Conclusions and future Work 
The investigations into a novel catalytic aza enolate aldol reaction have been troublesome in 
parts. However, the feasibility of a catalytic aza enolate aldol reaction was demonstrated and 
good yields of aldol products could be obtained in some cases. Particularly in expanding this 
work into a catalytic reaction, as it was discovered that the formation of imine 74 is not 
reversible (Scheme 71 – shown in red). This indicates that due to the formation of imine 74 
from  the  condensation  of  Cy-NH2  and  4-chlorobenzaldehyde  (66),  the  catalytic  cycle  is 
inhibited  as  the imine does  not  participate further in  the catalytic cycle and leads  to the 
primary amine being removed from the reaction, leading to lower conversions/yields being 
obtained (Scheme 71 – shown in red).  
 
 
I (Mg(ClO4)2 (50 mol %), DMSO:acetone (4:1), Et3N (50 mol %), then rt, 12 h. 
Scheme 71 – Catalytic cycle showing the irreversible formation of the aldehyde derived 
imine 
 
 Chapter 2 – Development of a catalytic aza enolate aldol reaction 
 
 
62 
 
Optimization,  did  lead  to  some  interesting  results,  by  adding  the  aldehyde  dropwise  the 
results were improved with good yields being obtained. In addition, 10 mol % of the primary 
amine  was  found to  be  the optimum  for achieving the highest  conversion  (Scheme 72  - 
selected examples of aldol products with the best yields).  
Scheme 72 – Summary of aldol products  
 
Alongside the development of catalytic aza enolate aldol reactions, a brief investigation of 
catalytic asymmetric aldol reactions was also carried out, which led to only low to moderate 
enantioselectivities with valinol 102 producing the best ee of 40% (Scheme 73).  
 
I 102 (10 mol %), Mg(ClO4)2 (20 mol %), DMSO:acetone, Et3N (20 mol %), then 66, then rt, 12 h. 
Scheme 73 – Summary of best chiral amine 
 
Considerable time was spent on attempting to improve the ee by various methods, resulting in 
no significant improvement. However, with the use of the racemic 84 and chiral sulfinamide 
106, isolated yields did improve and more interestingly, the reaction between 84 or 106 and 
the aldehyde 66 (Scheme 74) may now be reversible - a possible reason for the higher yields 
obtained.  Chapter 2 – Development of a catalytic aza enolate aldol reaction 
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I 84 or 106 (10 mol %), Mg(ClO4)2 (20 mol %), DMSO:acetone, Et3N (20 mol %), then 66, then rt, 12 h. 
Scheme 74 – Summary of chiral and racemic sulfinamide 
 
However, this work was discovered later in the project and therefore, an interesting area for 
future work on this would be to investigate the use of chiral sulfinamides further. As the 
chiral sulfinamide produced a moderate ee of 38%, changing the tert-butyl to a range of other 
groups may enhance enantioselectivity. The synthesis of the chiral iso-butylsulfinamide in 
optically  pure  form  has  been  carried  out  in  high  yields  and  enantioselectivities.  Some 
excellent reviews discussing chiral sulfinamide synthesis are available and the area is well 
studied.
138-145 Therefore, this would be an interesting avenue to investigate for future work. 
Possible chiral sulfinamides to synthesise are shown in scheme 75.  
 
Scheme 75 – Future chiral amines to be synthesised 
 
Another area to explore is to investigate if enolization is a significant problem when using 
enolisable aldehydes as the electrophile. A possible experiment to investigate this is to react 
the chiral aldehyde 123 under the developed aza enolate conditions. This would show how 
quickly aldehyde 123 racemizes and by how much (Scheme 76), thus showing if enolization 
of the electrophile is a significant problem.  
 
I 75 (10 mol %), Mg(ClO4)2 (20 mol %), DMSO:acetone, Et3N (20 mol %), then 123, then rt, 12 h. 
Scheme 76 – Future work to determine if enolisation is a problem 
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Finally, attempts were made at a heteroaromatic aldol reaction, reactions with nitroso and 
diazo electrophiles, and ʱ-alkylation reactions, all to no avail (Scheme 77). Nonetheless, a 
novel catalytic aza enolate reaction has been demonstrated.  
 
I 75 (10 mol %), 94, Nitrosobenzene, Mg(ClO4)2 (20 mol %), Et3N (20 mol %), DMSO, rt. 12 h.  
 
I Mg(ClO4)2 (20 mol %), solvent, Et3N (20 mol %), then rt, 12 h. 
 
I 94 or 111, Chlorocycloheptane, Mg(ClO4)2 (20 mol %), DMSO, Et3N (20 mol %), then rt, 12 h. 
Scheme 77 – Summary of other electrophiles that have been usedChapter 3 - Aza enolate reactions with more challenging electrophiles 
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Chapter 3 - Aza enolate reactions with more challenging electrophiles 
 
3.1  Introduction  
The reaction of ‘normal’ enolates with epoxides is more challenging due to the low reactivity 
of epoxides, though more reactive enolates such as amide/ester enolates can achieve this 
transformation, often with additional activation of the epoxide by a Lewis acid. Taylor et al. 
reported  the  reaction  of  Al-enolates  of  esters  with  various  epoxides.
146,147  This  involved 
treating 
tBu-ester 124 with LDA and the Lewis acid Et2AlCl to form the Al-enolate. This was 
reacted with the chosen epoxide to form the desired product 125 upon addition of acid (Table 
21).   
 
Entry  R1  R2  Yield  syn:anti 
1  H  Me  46%  - 
2  H  Et  52%  - 
3  Me  Me  56%  84:16 
4  Me  Et  43%  84:16 
5  Me 
iPr  56%  88:12 
I LDA, THF, 
nBuLi, −78 °C, 30 min, then Et2AlCl, 15 min. then epoxide, then 5 h at −45 °C. 
II p-TsOH. 
Table 21 – Ester enolates ring opening epoxides 
 
Crotti  et  al.  demonstrated  the  use  of  lithium  enolates  derived  from  pinacolone  and 
acetaphenone in the presence of LiClO4 to ring open a variety of epoxides to afford in good 
yields  the  corresponding  γ-hydroxy  ketones  (Table  22).
148  As  expected,  the  majority  of 
reactions all occur on the least hindered end of the epoxide (Table 22). Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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Entry  Epoxide  R1  R2  ʱ-attack (126)  β-attack (127)  Yield 
1 
   
tBu  Me  <1  >99  98% 
2 
 
Ph  Me  <1  >99  86% 
3 
 
tBu  c-C4H8  -  -  80% 
4 
 
tBu  PhOCH2  <1  >99  90% 
5 
 
tBu  Ph  9  91  95% 
I THF, LHMDS, ketone, 0 °C, 15 min 
II epoxide, THF, 30 min, then LiClO4, 24 h, 50 °C.   
Table 22 – Lithium enolates reacting with various epoxides 
 
In 1994, Hoye et al. demonstrated the use of enolates of esters and amides to react with the 
more reactive, cyclic sulfate 128, to give hydroxylated products 129 in good yields (72-92%) 
(Table 23 – selected examples).
149 
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I MeCN, −78 °C, 
nBuLi, 2 h, then 128 in THF, −78 °C, 1 h, then 14 h, rt. a isolated as a 2:1 mixture of 
diastereomers 
Table 23 – Lithium enolates reacting with cyclic sulfates 
 
Ring opening of epoxides has also been achieved with enamines, demonstrated by Britten et 
al.
150  Britten  described  the  reaction  of  enamine  130  with  an  epoxide  to  afford  1,4-
hydroxyketones 131 in moderate yields of 33-60% (Table 24). It is worth pointing out that 
the conditions used by Britten involve very high temperatures to make the reaction proceed 
(Table 24).  
 
 
 
 
 
Entry  Nucleophile  Product  Yield 
1   
 
73% 
2 
 
 
72%
a 
3 
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Entry  R1  Yield 
1  Ph  42% 
2  H  33% 
3  Me  60% 
4  Ph  50% 
5  Ph  56% 
I 130, DMF, 0 °C, epoxide, 24 h, then reflux, 30 min.  
Table 24 – Ring opening of epoxides with enamines 
 
The use of magnesium aza enolates to ring open epoxide 28 and oxetane 31 was reported by 
Tarbell et al.
87 and Hudrlik et al.
88 (Scheme 78). Firstly, Tarbell and Harvey
87 reported the 
deprotonation of imine 25 with EtMgBr and reaction with epoxide 28 to produce the product 
29 (Scheme 78). Reaction with a more challenging electrophile such as oxetane 31 has not 
been  achieved  with  simple  enolates.  However,  Hudrlik  et  al.
88  reported  the  use  of  aza 
enolates as nucleophiles for the ring opening of oxetane in good yields, using a Grignard 
reagent  as  the  base,  to  give  the  cyclised  product  32  (Scheme  78).  Hudrlik  et  al.
88  also 
reported the ring opening of epoxide 28 to give the product 29 in a greater yield of 75% 
compared to Tarbell and Harvey
87 (Scheme 78). Interestingly, Tarbell and Harvey reported 
that ring opening of epoxide 28 occurs regioselectivly and produces 29 exclusively. However, 
characterisation was achieved solely by boiling point and elemental analysis and no NMR 
data to validate the formation of the product 29 was provided. Hudrlik et al. also do not 
provide any NMR data and simply refer back to the work by Tarbell and Harvey. Therefore, 
it seems that with the work by Tarbell et al.
87 and Hudrlik et al.
88 there is some uncertainty 
that only one isomer of the ring opened product 29 was isolated. Therefore, it was decided to 
repeat these reactions to explore which product(s) are formed.   Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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I EtMgBr, THF, reflux, 2 h, then 0 °C then either 
II 31 or 
III 28, then rt, 25 h.
87,88,151 
Scheme 78 – Ring opening of oxetane and epoxides 
 
3.2  Results and discussion 
3.2.1  Stoichiometric reactions with epoxides 
Having developed a catalytic aza enolate aldol reaction (Chapter 2), the next step was to 
apply  this  methodology  to  more  challenging  electrophiles  such  as  epoxides.  At  first,  the 
stoichiometric literature procedure by Tarbell and Harvey
87 was repeated with the use of 
imine 25 and propylene oxide 28 (Scheme 79, step I). Interestingly, all possible regio- and 
stereo- isomers were produced in a combined 31% yield, in contrast to the literature report 
(vide supra). Due to the mixture of all possible regio- and stereo- isomers being produced, 
spectroscopic characterisation was extremely difficult. The cyclised lactol form that exists in 
equilibrium with the γ-hydroxycarbonyl products 132 and 134 is also present as a complex 
mixture  of  diastereomers  (Scheme  79).  To  overcome  the  difficulties  in  assigning  the 
1H 
NMR,  it  was  thought  that  oxidising  the  alcohols  to  the  corresponding  aldehydes/ketones 
could simplify the spectrum as only a maximum of two products would be seen (Scheme 79, 
136 and 137). A Swern-Moffatt oxidation was utilised to oxidise the mixture of 132-135 to 
136/137 (Scheme 79, step II). Pleasingly, upon purification, product 136 was isolated in a 
yield  of  42%.  However,  product  137  was  not  isolated  cleanly  due  to  the  small  amounts 
generated.  As  expected,  this  suggests  that  ring  opening  occurs  preferentially  at  the  least 
hindered end.  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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I THF, EtMgBr, reflux, 2 h then rt, 30 min, 0 
oC, 28. 
II SO3.Py, DMSO, −76 
oC, DCM; Et3N, rt, 5 h. 
Scheme 79 – Repeating literature example 
 
Expanding  on  this  result  (Scheme  79),  previously  prepared  imine  25  was  reacted  with 
epoxide 138 (Scheme 80). Epoxide 138 was chosen as this is likely to open regioselectively 
to give only products 139/140. This too exists as a mixture of the acyclic (139) and the cyclic 
(140)  lactol  forms;  however,  conversion  to  the  corresponding  oxime  (141)  prevents  the 
formation  of  the  cyclised  lactol  form  and  thus  made  spectroscopic  analysis  simpler. 
Pleasingly, this successfully led to the isolation of 141 as a mixture of geometric isomers with 
approximately 95% of E-141 compared to 5% of Z-141 in a modest yield of 32% over two 
steps (Scheme 80). When changing the epoxide to styrene oxide, no apparent conversion to 
the γ-hydroxycarbonyl products was observed.  
I EtMgBr, THF, reflux, then 0
 °C, epoxide 138; 
II NH2OH, pyridine, ethanol, reflux, 12 h. 
Scheme 80 – Ring opening of epoxide 138 
 
Changing the imine from 25 (Scheme 80) to the previously prepared chelating imine 56 and 
reacting  this  with  epoxides  28  and  138,  successfully  led  to  the  formation  of  the  desired 
products (Scheme 81). Using the chelating imine 56 with the more hindered epoxide 138 led 
to the isolation of the products 141 as a mixture of geometric isomers in a modest yield of 
36% (Scheme 81). Changing the epoxide from 138 to the less hindered epoxide 28 leads to a 
mixture of geometric isomers being obtained over two steps in a 24% isolated yield (Scheme 
81). The reason why there is more cis-isomer (Scheme 81 - Z-142) is presumably due to the Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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substituent being less bulky than that on Z-141. The use of the chelating imine 56 compared 
to the cyclohexyl-imine 25 with epoxide 138 gave a slight improvement in the yield of 36% 
compared to 32% with imine 25 (Scheme 80 compared to Scheme 81).  
I EtMgBr, THF, reflux, then 0
 °C, epoxide 28 or 138; 
II NH2OH, pyridine, ethanol, reflux, 12 h. 
Scheme 81 – Ring opening of different epoxides 
 
Having demonstrated the use of imines 25 and 56 in the ring opening of epoxides (Scheme 80 
and 81), the next step was to investigate if the mild aza enolate methodology developed 
earlier in the project (Chapter 2) could be applied to the ring opening of epoxides. This would 
involve the formation of the aza enolate using a Lewis acid and base (Mg(ClO4)2 and Et3N) 
under  the  mild  conditions  that  were  developed  earlier,  avoiding  the  use  of  the  harsh 
conditions previously reported in the literature, i.e. reflux and Grignard reagent (vide supra). 
Firstly, a proof of principle experiment was investigated using imine 25 directly with 2,2-
dimethyloxiran  (138)  with  stoichiometric  quantities  of  Mg(ClO4)2  and  Et3N,  affording  a 
mixture of the acyclic (139) and cyclic (140) lactol forms in a conversion yield of 24% and 
the successful formation of 141 in an isolated yield of 20% as a mixture of geometric isomers 
(Scheme 82). A test catalytic reaction using catalytic quantities of Mg(ClO4)2 (50 mol%) and 
Et3N (50 mol%) was also attempted. This led to the formation of the hydroxylketone/lactol 
139/140 in a 12% conversion by 
1H NMR spectrum; regrettably, the subsequent isolation of 
the oxime 141 was difficult due to the small quantities obtained.  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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I THF, 0 °C, Mg(ClO4)2, epoxide 138, Et3N, then rt, 12 h. 
II Hydroxylamine, pyridine, ethanol, reflux, 2 h.  
Scheme 82 – Ring opening of epoxide 138 using milder aza enolate conditions 
 
Having discovered that an aza enolate reaction with imine 25 and epoxide 138 takes place 
using the milder Lewis Acid conditions, the next step was to investigate if a reaction could be 
achieved  in  which  the  imine  was  generated  in  situ  (Scheme  83).  This  involved  using 
cyclohexanone  (94)  directly  with  epoxide  (138)  and  Cy-NH2  in  a  one-pot  procedure. 
Examination of the crude 
1H NMR indicated only a low conversion, 11%, to the acyclic (139) 
and  cyclic  (140)  lactol  forms.  Unfortunately,  attempted  isolation  of  the  oxime  141  was 
unsuccessful (Scheme 83).  
 
I Cy-NH2, THF, Mg(ClO4)2, 138, Et3N then rt, 12 h. 
II NH2OH, pyridine, ethanol, reflux, 2 h. 
Scheme 83 – In situ imine generation and reaction with epoxide 138 
 
Having learnt that reactions with epoxides using the mild aza enolate generation method do 
take place, albeit not very efficiently, the next step was to investigate a simpler more reactive 
electrophile. Cyclic sulfate 143 is an interesting electrophile to investigate as it is known to 
be  more  reactive  than  an  epoxide  and  also  gives  a  product  with  only  one  chiral  centre, 
meaning  interpretation  of  the 
1H  NMR  should  be  simpler.  The  high  reactivity  of  cyclic 
sulfates has been attributed to both ring strain and the good leaving group (ROSO3
- c.f. to 
epoxide  RO
-).
152  Therefore,  a  reaction  involving  imine  25  with  cyclic  sulfate  143  was 
investigated using stoichiometric quantities of base (Et3N or DIPEA) and MgX2 (Table 25). 
Changing the magnesium counterion from bromide (Table 25, entries 1 and 4) to triflate or 
perchlorate (Table 25, entries 2, 3, 5 and 6) had a significant impact on the conversion to the 
γ-hydroxycarbonyl  product  144,  with  magnesium  perchlorate  providing  the  highest 
conversion, 47%, and cleanest crude 
1H NMR spectrum when using Et3N as the base (Table Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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25, entry 6). Pleasingly, the products were isolated in low to moderate yields of 18 and 31% 
from these reactions (Table 25, entries 3 and 6). 
 
Entry  Base  MgX2 
X = 
Conversion
a  Yield 
1  DIPEA  Br  <5%  n.d. 
2  DIPEA  OTf  <5%  n.d. 
3  DIPEA  ClO4  30%  18% 
4  Et3N  Br  <5%  n.d. 
5  Et3N  OTf  40%  n.d. 
6  Et3N  ClO4  47%  31% 
I MeCN, MgX2 (1.2 equiv.), Base (2 equiv.), −76 
°C, then 143, then rt, 11 h. 
a % conversion determined by 
1H 
NMR (CDCl3). 
Table 25 – Ring opening of cyclic sulfate 143 using milder aza enolate conditions 
 
3.2.2  Catalytic reactions with epoxides 
Having shown that ring opening of epoxides using stoichiometric quantities of reagents could 
be achieved (Section 3.2.1), the next step was to investigate if a catalytic aza enolate reaction 
could work, with catalytic quantities of amine (10 mol %), Mg(ClO4)2 (20 mol %) and Et3N 
(20 mol %). Initially, a proof of principle experiment was investigated. This involved a small 
amine  screen  with  acetone  (71)  and  cyclic  sulfate  (143)  or  epoxide  (138)  in  a  one-pot 
procedure  (Table  26).  Pleasingly,  reactions  using  cyclic  sulfate  143  produced  moderate 
conversions by crude 
1H NMR (Table 26, entries 4-6), with the chelating amine producing 
the highest conversion of 35% and an isolated yield of 29% (Table 26, entry 4). Interestingly, 
on changing the epoxide from 143 to 138, no apparent conversion to the product 145 was 
seen  with  the  dehydrated  product  146  being  observed  (Table  26,  entries  1-3),  with 
approximately 35% conversion by 
1H NMR. The dehydrated product 146 was confirmed by 
comparing to the literature
153.  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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Entry  Amine 
 
Epoxide  Product (145)  By-product (146) 
Conversion
a  Yield  Conversion
a  Yield 
1 
 
138  <5%  n.d.  35%  n.d. 
2  Cy-NH2  138  <5%  n.d.  34%  n.d. 
3    138  <5%  n.d.  35%  n.d. 
4 
 
143  35%  29%  <5%  n.d. 
5  Cy-NH2  143  25%  n.d.  <5%  n.d. 
6    143  26%  21%  <5%  n.d. 
I Amine (10 mol %), Mg(ClO4)2 (20 mol %), DMSO:acetone, Et3N (20 mol %) then 138 or 143, then rt, 12 h. 
a % 
conversion determined by 
1H NMR (CDCl3). n.d. = not determined. 
Table 26 – Catalytic ring opening of epoxide 138 and cyclic sulfate 143 using ketone 71 
 
To test the scope of this reaction, the ketone was changed from acetone 71 to cyclohexanone 
94. Unfortunately, in the majority of these reactions when using epoxide 138, an intractable 
mixture was obtained and no apparent conversion to the desired product 147/148 was seen 
(Table 27, entries 1-3). However, again the by-product 149 was observed in one case, with a 
conversion of 10% by crude 
1H NMR (Table 27, entry 3). Upon changing the epoxide 138 to 
the cyclic sulfate 143, low conversions to the desired product 147/148 were observed by 
crude 
1H  NMR  analysis  (Table  27,  entries  4-6)  with  no  apparent  conversion  to  the  side 
product 149.  
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Entry  Amine 
 
Epoxide  Product (147)  By-product (149) 
Conversion
a  Yield  Conversion
a  Yield 
1 
 
138  <5%  n.d.  <5%  n.d. 
2  Cy-NH2  138  <5%  n.d.  <5%  n.d. 
3    138  <5%  n.d.  10%  n.d. 
4 
 
143  15%  n.d.  <5%  n.d. 
5  Cy-NH2  143  10%  n.d.  <5%  n.d. 
6    143  10%  n.d.  <5%  n.d. 
I Amine (10 mol %), Mg(ClO4)2 (20 mol %), DMSO, Et3N (20 mol %) then 138 or 143, then rt, 12 h. 
a % 
conversion determined by 
1H NMR (CDCl3). n.d. = not determined. 
Table 27 - Catalytic ring opening of epoxide 138 and cyclic sulfate 143 using ketone 94 
 
With these preliminary results (Tables 26 and 27), chelating amine (75) produced the best 
yield of 29% when using acetone as the ketone (Table 26, entry 4), and therefore, chelating 
amine 75 was selected for further examination. This involved using acetone 71 directly with 
styrene oxide (150) in a one-pot procedure using the same conditions as earlier (Scheme 84). 
Examination of the crude 
1H NMR spectrum indicated that starting material and imine 76 
were present. Varying the solvent had no significant outcome on the formation of 151/152, in 
addition, the crude NMR was difficult to interpret, and therefore it was decided to prepare an 
authentic sample of the product.  
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I Amine (10 mol %), Mg(ClO4)2 (20 mol %), Solvent:Acetone (4:1), Et3N (20 mol %) then 150, then rt, 12 h.  
Scheme 84 – Ring opening of styrene oxide 
 
Attention was focused on synthesising an authentic sample of 151. Dione 153 was reacted 
with 2-chloro-1-phenylethanone (154) in the presence of potassium carbonate to produce the 
ketone  (155)  in  an  acceptable  yield  of  21%  (Scheme  85,  step  I).  The  ketone  155  was 
subjected to selective reduction of the benzylic carbonyl via TiCl3 and aq. NH3 following a 
literature procedure
154 (Scheme 85, step II). However, on examination of the crude 
1H NMR, 
the ketone 155 had cyclised into pyrrole 156. 
I Potassium carbonate, ethanol, reflux, 12 h. 
II aq. NH3, TiCl3, MeOH, 0 
oC, 12 h. 
Scheme 85 – Attempted synthesis of authentic sample 151 
 
3.2.3  Stoichiometric reactions of aldehyde-derived imines with epoxides 
It was thought with the limited success of imines ring opening challenging substrates (vide 
supra) that it would be interesting to investigate the use of aldehyde-derived imines with 
epoxides to see if any ring opening occurs. The previously prepared imines 61 and 62 were 
reacted  with  epoxides  28  and  138  (Scheme  86).  Unfortunately,  all  attempts  resulted  in 
unreacted starting material remaining.  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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I Et3N, Mg(ClO4)2, aldehyde, MeCN, 12 h, rt. 
Scheme 86 – Attempted reactions of aldehyde-derived imines with epoxides 
 
3.2.4  Investigating intramolecular reactions  
Given  the  problems  and  low  conversions  that  were  obtained  in  these  reactions  with 
catalytic/stoichiometric quantities (Sections 3.2.1 - 3.2.3); intramolecular reactions were then 
investigated,  as  it  was  hoped  this  would  be  more  successful.  In  order  to  investigate 
intramolecular  reactions,  compounds  containing  both  a  carbonyl  and  an  epoxide  were 
required.  Possible  compounds  to  synthesise  are  outlined  in  scheme  87.  These  substrates 
would then undergo the aza enolate reactions as previously (Section 2.1). The formation of 
intramolecular  substrates  might  give  useful  information  regarding 
stereocontrol/regioselectivity and the geometry of the aza enolate intermediates. Furthermore, 
a  major advantage is  that intramolecular substrates could  be designed to  enable multiple 
stereocentres to be created in a single aza enolate reaction.  
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I Amine, Base, Lewis acid, DMSO, rt, 12 h.  
Scheme 87 – Possible compounds to synthesise 
 
Therefore, to form 157 diene 166 was selected and underwent a hydroboration to afford the 
alcohol 167 in 33% yield after oxidative work-up (Scheme 88, step I). Nooy et al.
155 reported 
that the use of m-CPBA in conjunction with TEMPO could lead to oxidation of the alkene 
and alcohol in a one-pot procedure. Therefore, attempts were made to use this procedure to 
generate the desired epoxy-aldehyde 157 (Scheme 88, step II), However, 
1H NMR analysis 
revealed that no reaction had taken place even when adding excess m-CPBA and TEMPO 
with starting materials being recovered.  
 
I BH3.THF, 0
oC, 1 h, then H2O2, NaOH, rt, 12 h. 
II m-CPBA, CH2Cl2, rt, then TEMPO, rt.12 h. 
Scheme 88 – Attempted synthesis of 157 
 
With the problems associated with the proposed synthesis of 160 and 161 (Scheme 86), it was 
decided that compound 158 should be synthesised instead (Scheme 89). This involved using 
hydrazone aza enolate methodology (See chapter 1) to alkylate 168 and form 169 (Scheme Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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89), which would then undergo epoxidation to form the epoxy-ketone 158. We could then 
explore using an aza enolate reaction for the formation of the bicyclic products 162 and/or 
163 (Scheme 89).   
Scheme 89 – Proposed synthesis of 158 
 
Hydrazones 168 and 170 were prepared using a literature procedure
156 from cyclohexanone 
(94) or cyclopentanone (171) and dimethylhydrazine 172 in quantitative yield (Scheme 90).
 
This was followed by alkylation to furnish ketones 173, 174 and 175 in reasonable yields of 
60 %, 59 % and 54 % respectively (Scheme 90). 
 
I 168 or 170, 80 °C, 14 h. 
II THF, 0 °C, 
nBuLi, 45 min, allyl bromide, then rt, 3 h.  
Scheme 90 – Synthesis of compounds 173, 174 and 175 
 
With sufficient  alkene compounds  173,  174 and 175 in  hand,  174 was epoxidised using 
commercially available m-CPBA (Scheme 91). Unfortunately, lactone 176 was isolated in a 
29% yield as the major product in place of the desired epoxy-ketone 177 (Scheme 91). To 
overcome  this  problem,  an  alternative  procedure  was  attempted  using  NaHCO3  as 
epoxidation of an alkene in the presence of a ketone has been shown to work with a similar Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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substrate.
157 Therefore, an attempt was made to use 174 in a 1:1 mixture of CH2Cl2:NaHCO3, 
unfortunately, again, the Baeyer–Villiger product 176 was observed.  
 
I 174, CH2Cl2, m-CPBA, 0
oC, 20 min, then rt, 12 h. 
II 174, CH2Cl2, 1M NaHCO3 m-CPBA, rt. 12 h. 
Scheme 91 – Attempted synthesis of 177 
 
To prevent the formation of undesired lactone 176, the carbonyl group of 174 was acetal 
protected  prior  to  m-CPBA  oxidation  to  give  178  in  a  quantitative  yield  (Scheme  90). 
However, upon addition of m-CPBA the acetal was hydrolysed and frustratingly again, the 
Baeyer–Villiger product 176 was observed in a 60% yield (Scheme 92).  
I trimethyl orthoformate,  amberlyst-15, petrol, rt. 1 h. 
II 178, m-CPBA, CH2Cl2, 0 °C. 
Scheme 92 – Synthesis of unwanted Baeyer–Villiger product 176 
 
To overcome these problems, other literature procedures that have been shown to epoxidise 
alkenes in the presence of ketones were investigated. Alkene 173 was reacted with a freshly 
prepared solution of potassium peroxomonosulfate (Oxone®) in water/EDTANa2 following a 
literature procedure
158 (Scheme 93). Unfortunately, upon examination of the crude 
1H NMR, 
no apparent conversion to the product  179 was observed, with starting material  173 still 
present.   
 
I Potassium peroxomonosulfate, acetone, 2 
oC. pH maintained at 7.5 by additions of 0.5M KOH. 
Scheme 93 – Attempted synthesis of 179 
 
With no reaction occurring with Oxone® (Scheme 93), Baertschi et al.
159,160 has reported that 
3,3-Dimethyldioxirane (DMDO) has been successful in epoxidising an alkene in the presence Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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of a ketone where other conventional methods such as m-CPBA and Oxone® had failed. 
Furthermore, the by-product of oxidation with DMDO is acetone, a fairly innocuous and 
volatile compound making purification of the products straightforward.
 Therefore, DMDO 
was synthesised using a literature procedure
161 and subsequently reacted with  alkene 173 
(Scheme 94). Examination of the crude 
1H NMR spectrum indicated a very low conversion, 
10%,  to  the  product  179.  Unfortunately,  due  to  this  low  conversion,  this  reaction  was 
abandoned.  
 
I DMDO, acetone, 0 °C, 1 h.  
Scheme 94 – Synthesis of 179 
 
From encountering numerous problems with the epoxidation of the alkene 173, it was thought 
that reducing the ketone 173 to the alcohol 180, followed by subsequent epoxidation would 
lead to the epoxy alcohol 181. Oxidation would give the desired product 179 and this route 
should avoid the formation of the undesired Baeyer-Villiger product 176 (Scheme 95).  
I MeOH/THF (1:1), NaBH4, 1 h, rt. 
II CH2Cl2, 0 °C, m-CPBA, 2 h. 
III Swern oxidation. 
Scheme 95 – Proposed synthesis of 179 which avoids the unwanted product 176 
 
Therefore, the ketone 173 was reduced with sodium borohydride to form the alcohol 180 in 
quantitative yield (Scheme 96, step I). However, subsequent epoxidation failed to produce 
181; instead, the cyclic ether 182 was formed in 85% yield (Scheme 96).   
 
I MeOH/THF (1:1), NaBH4, 1 h, rt. 
II CH2Cl2, 0 °C, m-CPBA, 2 h. 
Scheme 96 – Attempted synthesis of 181 
 Chapter 3 - Aza enolate reactions with more challenging electrophiles 
 
 
82 
 
Comparing with the literature data from Hartung et al.
162 and Gravel et al.
163, it appears that 
182 was formed as a mixture of three diastereomers (182a-182c) plus another unidentified 
product (Scheme 97).  
 
Scheme 97 – Diasteromers of 182 
 
Initially, upon examination of the crude 
1H NMR spectra it was thought that the desired 
epoxide 181 had been formed (Scheme 96). Therefore, subsequent oxidation was attempted 
to generate the ketone 179. Upon analysis of the NMR spectra and comparing to the literature 
data from Gravel et al.
163 it was clear that an aldehyde had been formed, and the cyclic ether 
183 was isolated in a 50% (Swern) or 30% (PCC) yield(s) as a mixture of three diastereomers 
and an unidentified product (Scheme 98). 
 
I oxalyl chloride, DMSO, −76 °C, CH2Cl2, Et3N, then, rt, 2 h or CH2Cl2 4 Å ms, PCC, 10 min, then rt, 12 h.  
Scheme 98 – Diasteromers of 183 
 
With the difficulties in synthesising the two original targets 157 and 158 (Scheme 87), efforts 
were then diverted to synthesising a substrate with an aromatic ring 159. Taber et al.
164 have 
achieved the formation of 159, directly from the commercially available alcohol 184. This 
involved using 1-phenylethanol 184 directly with allyl chloride 185 in an ortho-allylation 
reaction (Scheme 99). Unfortunately, the formation of the product 186 was not observed with 
numerous attempts and in all cases unreacted starting material remained.  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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I TMEDA (4 equiv.), Et2O, 0 °C, 
nBuLi, 5 min, then reflux, 1 h, then rt, −5 °C, CuCN, 30 min, allyl chloride, 10 
min, rt, 30 min. 
Scheme 99 – Attempted ortho-allylation reaction 
 
Sälinger and Brückner
165 recently reported that the use of bromo-alcohol 187 in a lithiation 
with a catalytic amount of CuCN·2LiCl and allyl bromide 188 could lead to the formation of 
the desired product 186 (Scheme 100).  
 
I 
iPr2Mg, Et2O, TMEDA, then 187, −40 °C, 10 min, then rt, 30 min, 188, CuCN·2LiCl, 1.5 h.
165 
Scheme 100 – Literature example of formation of 186 
 
Therefore, 187 was synthesised in a quantitative yield from the commercially available 189 
via  a  NaBH4  reduction.  The  alcohol  was  then  reacted  with  allyl  bromide  188  using  the 
Sälinger and Brückner
165 procedure. Frustratingly, product 186 was not observed in crude 
1H 
NMR with starting material and an intractable mixture being obtained (Scheme 101). 
 
I MeOH/THF (1:1), NaBH4, 1 h, rt. 
II 
iPr2Mg, Et2O, TMEDA, then 187, −40 °C, 10 min, then rt, 30 min, 188, 
CuCN·2LiCl, 1.5 h. 
Scheme 101 – Attempted synthesis of 186 
 
3.2.5  Formation of Oxazolidines 
After encountering all of these problems  in  forming the desired  epoxide substrate in  the 
presence of a ketone, it was decided to consider another strategy. Although ketone enolates 
do  no  normally  react  with  epoxides,  it  was  thought  that  using  the  more  reactive  epi-
halohydrin  reagents  could  overcome  this  obstacle.  It  was  envisioned  that  by  reacting  an Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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enolate with an epi-halohydrin it may be possible to produce the desired epoxy-ketone 179 
(Scheme 100, step a). However, the enolate could ring open the epoxide as the epoxide is 
now more reactive with a halogen group pulling electron density away from the ring making 
the  less  substituted  carbon  more  ʴ
+  electron  deficient,  leading  to  190.  This  could  then 
undergo an ‘SN2’-like reaction and lead to the product 179 (Scheme 102, step b).  
Scheme 102 – Proposed mechanisms for formation of 179 
 
With this plan (Scheme 102), cyclohexanone 94 was deprotonated with LDA to form the 
enolate,  which  was  reacted  with  epi-chlorohydrin  191  (Scheme  103);  unfortunately,  the 
desired product (179) was not formed with starting materials being recovered.  
 
I THF, -76 °C, LDA, 30 min, then rt, 1.5 h.  
Scheme 103 – Attempted synthesis of 179 
 
It  was  thought  that  the  enolate  might  not  have  been  reactive  enough.  Therefore,  it  was 
thought  that the use of  an aza  enolate could  possibly overcome this  problem as we had 
already  demonstrated  that  aza  enolates  could  ring  open  epoxides  (Section  3.2.1).  Hence, 
imine  25  was  reacted  with  epi-chloro  and  bromohydrin  (191  and  192)  using  a  Grignard 
reagent to generate the aza enolate (Scheme 104). Unfortunately, the epoxide 179 failed to 
form. However, interestingly, oxazolidines were formed in excellent yields [85% when X = 
Cl (193) and 89% when X = Br (194)] and there appear to be no products formed by the 
attack of the aza enolate carbon on the epoxide possibly due the change in reactivity of the 
epoxide equivalent compared to earlier work (Section 3.2.1) (Scheme 104).  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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I 3M EtMgBr (1.15 equiv.), THF, reflux, 2 h, then 0 °C, epi-chloro or bromohydrin, 1 h, then rt, 12 h. 
Scheme 104 – Formation of oxazolidines 193 and 194 
 
A possible mechanism involves deprotonating imine 25 with the Grignard reagent to form the 
aza enolate (195), this could then ring open the epoxide by attack of the nitrogen to give 196, 
which cyclises upon work-up to form the oxazolidine (Scheme 105).  
 
Scheme 105 – Proposed mechanism of oxazolidine formation 
 
Given the high yields obtained, this might offer a useful way of making 1,3-oxozolidines, 
therefore, a brief literature search was carried out to see if any similar reactions had been 
previously reported. It was found that generally the synthesis of 1,3-oxozolidines is normally 
achieved  by  the  condensation  of  1,2-amino  alcohols  with  carbonyl  compounds  in  the 
presence  of  acid  catalysts
166,167.  In  recent  years,  several  so-called  [3+2]  cycloaddition 
reactions have been reported to produce 1,3-oxazolidines,
168,169 particularly, by the groups of 
Nishitani and Su. Nishitani et al.
170 demonstrated that a variety of 1,3-oxazolidines can be 
synthesised by reacting imines and epoxides with the use of samarium iodide (Table 28, 
selected examples).  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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Entry  Imine (197)  Epoxide (198)  Oxazolidine (199) % yield 
1 
 
 
93 
2 
 
 
83 
3 
 
 
81 
4 
   
6 
5 
 
 
82 
6 
 
 
85 
I Imine, epoxide, SmI2 (5 mol%), THF, rt, Ar atmosphere, 5 h.
170 
Table 28 – Literature examples of oxazolidine formation using different epoxides 
 
Su et al.
171 has demonstrated that N-arylimines can react with epoxides under mild conditions 
in  the  presence  of  a  catalytic  amount  of  Yb(OTf)3  (5  mol  %)  to  give  1,3-oxazolidine 
derivatives in good yields (Table 29 – selected examples). Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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. 
Entry  R1  R2  R3  R4  Yield 
(%) 
1  H  C6H5  C6H5  CH2Cl  85 
2  H  p-NO2-C6H4  C6H5  CH2Cl  89 
3  H  p-MeO-C6H4  C6H5  CH2Cl  77 
4  C6H5  C6H5  C6H5  CH2Cl  95 
5  C6H5  C6H5  C6H5  CH2OCH2Ph  83 
6  C6H5  C6H5  p-Cl-C6H4  CH2OCH2Ph  90 
I CH2Cl2, Yb(OTf)3 (5 mol %), 40 °C, 2 h.
171 
Table 29 – Literature example of different oxazolidine derivatives 
 
Another recent example is from Jarvo et al.
172 who reported the use of a rhodium, palladium 
or nickel catalyst in the formation of 1,3-oxazolidines (Scheme 106). This involved using 
either  imine  200  or  201  with  epoxide  202  (enantiopure)  or  203  (racemic)  to  form  the 
corresponding 1,3-oxazolidines 204 (Scheme 106). 
 
Scheme 106 – Literature example of enanatiopure oxazolidines 
 
All  of  these  examples  have  advantages  in  that  good  yields  are  obtained  and  catalytic 
quantities  of metal  salt  are used. However, there are some disadvantages;  in  the case of 
Nishitani  et  al.  SmI2  has  to  be  used,  which  is  difficult  to  prepare,  is  air  sensitive  and 
expensive. The majority of reactions that Su et al. reports involve epi-chlorohydrin, aromatic 
substituents on the imine (no enolizable ketones/aldehydes), heat at 40 °C and only a small 
number of epoxides were investigated. With Jarvo et al. protecting groups have to be used on 
the nitrogen and only one epoxide is utilised in this chemistry as the unsaturated epoxide is 
necessary for the catalytic reaction to work. In addition, in all cases pre-formed imines are 
employed,  therefore,  these  imines  have  to  be  synthesised  before  being  used.  With  these 
disadvantages, it was thought if a magnesium aza enolate method could be developed with in-Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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situ formation of the imine and subsequent reaction with an epoxide it would be a more 
effective  method  of  preparing  oxazolidines.  This  would  involve  the  use  of  the  earlier 
developed aza enolate methodology. A proof of principle experiment was carried out, which 
involved  the  use  of  cyclohexanone  94  with  chelating  amine  75  or  Cy-NH2  and  epi-
chlorohydrin 191 (Scheme 107). Oxazolidine product(s) 193/205 were isolated in a 47 and 
20% yield respectively (Scheme 107).  
 
I Amine 75 or Cy-NH2, 94, THF, Mg(ClO4)2, chloromethyloxirane 191, Et3N, rt, 12 h.  
Scheme 107 – Synthesis of oxazolidines 193 and 205 
 
With these promising results (Scheme 107), a small solvent screen was attempted using the 
same conditions with cyclohexanone 94 and the chelating amine 75 (Table 30). With the use 
of DMSO (Table 30, entry 1), no apparent conversion by 
1H NMR was observed, however, 
the use of CH2Cl2, MeCN and THF (Table 30, entries 2-4) all produced conversions varying 
from 30-66%. Isolated yields were obtained with MeCN and THF (Table 30, entries 3-4) of 
31% and 50% respectively. Evidence for an aza enolate intermediate was provided by control 
reactions, which excluded one of the two key reagents from the reaction mixture: magnesium 
salt and triethylamine (Table 30, entries 5-6). No apparent conversion to the oxazolidine 
product 205 was observed in each case, clearly suggesting a synergistic operation of the 
primary amine, magnesium salt and triethylamine in the reaction mechanism.  
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Entry  Ketone (94) 
equiv. 
Amine (75) 
equiv. 
Epoxide (191) 
equiv. 
Solvent  Conversion*  Yield 
(205) 
1  1  1  1  DMSO  <5%  n.d. 
2  1  1  1  CH2Cl2   30%  n.d. 
3  1  1  1  MeCN  45%  31 
4  1  1  1  THF  66%  50 
5
a  1  1  1  THF  <5%  n.d. 
6
b  1  1  1  THF  <5%  n.d. 
I Solvent, Mg(ClO4)2, chloromethyloxirane, Et3N, rt, 12 h. * % conversion determined by 
1H NMR (CDCl3). 
a No 
Et3N. 
b No Mg(ClO4)2. 
Table 30 - Evidence for an aza enolate intermediate was provided by control reactions 
 
With these promising results, the next step was to investigate different epoxide substrates. 
Therefore, epoxide 28 was reacted with ketone 94 and chelating amine 75 (Scheme 108). 
With changing the epoxide from  191 to  28, it  was  discovered that the product  206 was 
degrading on silica and produced a low yield of 20%. Therefore, it was thought that reducing 
the C-O bond of product 206 with NaBH4 to give the corresponding alcohol product 207 
might lead to a product that is easier to purify. Therefore, a reduction was attempted and 
pleasingly, the alcohol product was isolated in 50% over the two steps. However, it was 
discovered that the undesirable product 208 was also isolated in a 37% yield (Scheme 108). 
When comparing the 
1H NMR spectra of the oxazolidine product 206 (Scheme 107) with the 
earlier reactions 139 and 140 involving epoxide ring opening via aza enolates (Section 3.2.1), 
there appears to be some peaks in the earlier reactions with 139 and 140 (Scheme 82) which 
correspond to the oxazolidine products and could explain why the yields for those reactions 
(139 and 140, Scheme 82) were low. However, there is a slight change in reaction conditions, 
the earlier reactions were done at 0 °C and then warmed to room temperature compared to 
these reaction conditions which were done at room temperature with no cooling.  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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I THF, 94, 75, Mg(ClO4)2, 28, Et3N, rt, 12 h; 
II NaBH4, MeOH:THF (1:1), rt, 2 h.  
Scheme 108 – Formation of 207 
 
With this promising result (Scheme 108), the next step was to test if a different epoxide could 
be  utilized  in  this  methodology.  Earlier,  Nishitani  et  al.
170  described  that  the  reaction  of 
cyclohexene oxide 209 gave only a very low yield of 6% of the corresponding oxazolidine 
(Table 25). Therefore, it was believed that the use of cyclohexene oxide 209 would be an 
interesting epoxide to test under our conditions. In addition, they also use styrene oxide 210 
and  produce  a  good  yield  of  81%  of  the  corresponding  oxozolidine  (Table  25)  Thus, 
cyclohexanone 94 was reacted with the chelating amine 75 and cyclohexene oxide 209 or 
styrene oxide 210 (Scheme 109). Pleasingly, with cyclohexene oxide 209 the oxazolidine 
derived product 211 was isolated as a mixture of diastereomers (2:1) in a modest yield of 
48%. Unfortunately, with the use of epoxide 210 the major isolated product was that of the 
reduced imine 213 in a yield of 69% and not the desired product 212 (Scheme 109). 
 
I THF, Mg(ClO4)2, Et3N, rt, 12 h; 
II NaBH4, MeOH:THF (1:1), rt, 2 h.  
Scheme 109 – Formation of 211 and by-product 213 
 
To expand the scope of this reaction, a small ketone screen was carried out. This involved 
using linear ketone 214 and cyclopentanone 171 with the chelating amine 75 and epoxide 28 Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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(Scheme 110). Unfortunately, in both cases the major product isolated was the reduced imine. 
Amines 215 and 216 were obtained in 65 and 63% yields respectively.   
 
I THF, Mg(ClO4)2, Et3N, rt, 12 h; 
II NaBH4, MeOH:THF (1:1), rt, 2 h.  
Scheme 110 – Formation of by-products 215 and 216 
 
Moving on from these results (Scheme 110), it was thought that the use of a simple amine 
and a simple ketone might lead to easier interpretation of the data. Therefore, n-butylamine 
was selected and reacted with epoxides 28 and 210 using acetone 71 as the ketone (Scheme 
111). Unfortunately, in both reactions the desired products 217 and 218 were not observed, 
with the undesired products  219 and 220 being isolated in  yields of 50% and 51% as  a 
mixture of diastereomers (Scheme 111). A possible reason for these reactions not to have 
formed the desired products is that the volatile acetone 71 may be evaporating. Therefore, it 
was decided for subsequent reactions to revert to cyclohexanone 94 as it has already proven 
to work.  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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a 
I THF, Mg(ClO4)2, n-butylamine, Et3N, rt, 12 h, then NaBH4, MeOH:THF (1:1), rt, 2 h. 
Scheme 111 – Attempted formation of 217 and 218 
 
Lastly, a small amine study was investigated with cyclohexanone 94 and epoxide 28 (Scheme 
112). Both n-butylamine and chiral amine 63 produced the corresponding product 221 and 
222 (mixture of diastereomers, 1:1) after reduction via NaBH4 in moderate yield (43% and 
49% yield respectively). However, the use of the more hindered amine 223, led to undesired 
product 224 being produced in a 53% yield via the amine ring opening the epoxide (Scheme 
112).  
 
I THF, Mg(ClO4)2, amine, Et3N, rt, 12 h, then NaBH4, MeOH:THF (1:1), rt, 2 h. 
Scheme 112 – Synthesis of different alcohols  
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3.2.6  C-H activation  
The use of cyclo-palladated imines with various electrophiles has not been widely explored 
with regard to C-H activation; however, it has been explored with other very similar systems 
such as oximes
173,174 (Scheme 113) and pyridines
175 (Scheme 114).  
 
I Pd(OAc)2 (5 mol %), TBHP (2 equiv.), AcOH (0.5 equiv.), Tol, 100 °C, 2 h.
173 
Scheme 113 - Literature example of C-H activation using oximes 
 
I Ni(cod)2 (3 mol %), P(
iPr)3 (12 mol %), ZnMe2 (6 mol %), Tol, 50 °C, 24 h.
175 
Scheme 114 – Literature example of C-H activation using pyridines 
 
Therefore, it was envisioned that the use of a pre-formed imine with a palladium source could 
produce  an  imine-palladium  complex,  which  could  then  be  used  for  ortho-halogenation 
(Scheme 115 – example of palladium(II) catalysis). 
 
Scheme 115 - Example of palladium(II) catalysis Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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Firstly, imines 225 and 226 were chosen as they offer another coordination site from the lone 
pair of the oxygen atom (or the sulphur atom in the case of 225). Imines 225 and 226 were 
prepared using literature procedures
176,177 (Table 31). 
 
Entry  Amine  Aldehyde  Imine  Procedure 
1 
 
 
 
I 
2 
   
 
II 
I CH2Cl2, PPTS, MgSO4, rt., 24 h. 
II Tol, 4 Å molecular sieves, reflux, 16 h.   
Table 31 – Synthesis of imines 225 and 226 
 
With these substrates in hand, imine 225 was subjected to a literature palladation procedure
178 
to see if the imine-palladium complex 227 could be produced (Scheme 116), which could 
then be used for ortho-halogenation. This involved using Pd(OAc)2, AcOH at 100 °C for 1 h 
(Scheme 116), however, the desired product was not isolated with an intractable mixture 
being obtained. It was thought that the conditions used were too harsh, therefore, milder 
conditions were utilised with imine 225 dissolved in deuterated MeOH with Pd(OAc)2 for 6 h 
(Scheme 116). This also did not produce the imine-palladium complex 227 with only starting 
material being observed. It was then thought that use of a different palladium species could 
overcome this problem, therefore, imine 225 was subjected to another literature procedure
179 
which  involved  using  imine  225  with  Na2PdCl4,  NaOAc  and  AcOH  for  24  h  at  room 
temperature (Scheme 116). Unfortunately, this also led to no reaction being observed with a 
mixture of starting material and an intractable mixture being obtained.  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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I Imine 224, Pd(OAc)2, AcOH, 100 °C, 1 h. 
II Imine 224, Pd(OAc)2, CD3OD, 6 h, rt. 
III Imine 224, Na2PdCl4, 
NaOAc, AcOH, 24 h, rt.  
Scheme 116 – Attempted synthesis of imine 227 
 
Having difficulties in obtaining the desired product (Scheme 116), we then explored whether 
direct halogenation could occur with in-situ formation of the imine-palladium complex (one-
pot). Therefore, following a literature procedure
180 imines 225 and 226 were examined in a 
halogenation reaction. Unfortunately, in both cases no reaction had taken place with starting 
material imine 225 or imine 226 being observed (Scheme 117). 
 
 
I Imine 113 or 114, Cu(OAc)2, CuCl2, Pd(OAc)2, 120 °C, 2 h. 
Scheme 117 – Attempted synthesis of imines 228 and 229 Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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3.3 Conclusions and Future Work 
 
The  investigation  into  using  the  developed  aza  enolate  chemistry  with  more  challenging 
electrophiles  has  been  troublesome  in  parts.  Firstly,  stoichiometric  reactions  were 
investigated.  Tarbell  and  Harvey  reported  that  the  ring  opening  of  epoxide  28  occurs 
regioselectively and produces 132 exclusively (Scheme 118). However, characterisation was 
achieved solely by boiling point and elemental analysis and no NMR data to validate the 
formation  of  the  product  132  was  provided  (Scheme  118).  When  this  reaction  was 
investigated, all possible regio- and stereo- isomers were produced in a combined 31% yield 
which was in contrast to the reported literature by Tarbell and Harvey (Scheme 118). With 
the difficulties in assigning the 
1H NMR, the alcohols were oxidised to the corresponding 
aldehyde/ketone (136/137), with product 136 being isolated in a yield of 42% (Scheme 118).  
I THF, EtMgBr, reflux, 2 h then rt, 30 min, 0 
oC, 28. 
II SO3.Py, DMSO, −76 
oC, DCM; Et3N, rt, 5 h. 
Scheme 118 – Summary of ring opening of epoxide 28 
 
When expanding on this result with epoxide 138, which was selected due to its likelihood to 
open regioselectively, there were still problems due to the mixture of the acyclic (139) and 
the  cyclic  (140)  lactol  forms  which  made  characterisation  difficult.  Pleasingly  this  was 
overcome with the use of oxime formation and led to the successful isolation of the desired 
products in a 32% yield over two steps (Scheme 119).  
I EtMgBr, THF, reflux, then 0
 °C, epoxide 138; 
II NH2OH, pyridine, ethanol, reflux, 12 h. 
Scheme 119 – Summary of ring opening of epoxide 138 Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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Secondly, the use of the earlier developed aza enolate methodology using a Lewis acid and 
base was applied to epoxides and led to the successful formation of the desired products, 
albeit in low yield of 20% over two steps (Scheme 120). Nonetheless, a novel method to ring 
open  an  epoxide  using  the  mild  aza  enolate  generation  method  developed  earlier  was 
demonstrated.  
I THF, 0 °C, Mg(ClO4)2, epoxide 138, Et3N, then rt, 12 h. 
II Hydroxylamine, pyridine, ethanol, reflux, 2 h.  
Scheme 120 – Summary of ring opening of 138 using the milder aza enolate chemistry 
 
From  demonstrating  that  reactions  with  epoxides  using  the  mild  aza  enolate  generation 
method  do  take  place,  investigations  into  a  simpler  more  reactive  electrophile  the  cyclic 
sulfate  143  were  undertaken.  It  was  discovered  that  the  use  of  magnesium  perchlorate 
provided the highest conversion, 47%, and cleanest crude 
1H NMR when using Et3N as the 
base. The product 144 was isolated in a yield of 31% (Scheme 121).  
 
I MeCN, MgX2 (1.2 equiv.), Base (2 equiv.), −76 
°C, then 143, then rt, 11 h. 
Scheme 121 – Summary of ring opening of cyclic sulfate 143 
 
Catalytic reactions using epoxides and their derivatives were also investigated, unfortunately, 
low conversions were obtained, and characterisation was difficult. This led to investigations 
into intramolecular substrates that would include an epoxide in the presence of a ketone, 
which was hoped to be more successful (Scheme 122). Unfortunately, all attempts to form the 
desired targets have thus far proved unsuccessful.  
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I Amine, Base, Lewis acid, DMSO, rt, 12 h.  
Scheme 122 – Summary of attempted synthesis of target products 
 
Lastly, the use of different epoxides led to the serendipitous discovery of a method for the 
formation of oxazolidines using aza enolate chemistry. Pleasingly this led to good yields 
being obtained with a variety of electrophiles (Scheme 123), with some associated problems 
as described.  
 
Scheme 123 – Summary of different oxazolidine/alcohol products 
 
Future work on this project will focus on two areas. The first being, to explore the catalytic 
reactions further, particularly, the formation of the undesired by product 146 and improve on 
the yields of the product 145 (Table 32).  Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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Entry  Amine 
 
Epoxide  Product (145)  By-product (146) 
Conversion
a  Yield  Conversion
a  Yield 
1 
 
138  <5%  n.d.  35%  n.d. 
2  Cy-NH2  138  <5%  n.d.  34%  n.d. 
3    138  <5%  n.d.  35%  n.d. 
4 
 
143  35%  29%  <5%  n.d. 
5  Cy-NH2  143  25%  n.d.  <5%  n.d. 
6    143  26%  21%  <5%  n.d. 
I Amine (10 mol %), Mg(ClO4)2 (20 mol %), DMSO:acetone, Et3N (20 mol %) then 138 or 143, then rt, 12 h. 
a % 
conversion determined by 
1H NMR (CDCl3). n.d. = not determined. 
Table 32 – Summary of catalytic ring opening reactions 
 
Secondly, the optimisation of the oxazolidine reaction to improve the yields, as well as the 
synthesis of a more diverse range of amines, ketones and epoxides (Scheme 124). A catalytic 
version of the oxazolidine formation could also be attempted with catalytic quantities of base 
and Lewis acid. 
 
Scheme 124 – Potential substrates to use 
 
Finally,  a  more  in  depth  study  in  asymmetry  could  be  investigated  with  the  oxazolidine 
reactions  using  chiral  epoxides  (Scheme  125).  In  addition,  as  molecules  containing 
oxazolidine  ring  systems  exhibit  many  activities  such  as  antibacterial  activity  and  anti-Chapter 3 - Aza enolate reactions with more challenging electrophiles 
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tuberculosis  activity,
181  efforts  may  be  concentrated  on  forming  a  variety  of  different 
oxazolidine structures and testing their biological activity.  
 
Scheme 125 – Potential chiral substrates to use 
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Chapter 4 - Experimental Section 
 
4.1  General Methods 
All  the  reagents  and  solvents  were  used  as  received  without  further  purification,  unless 
otherwise stated. Where necessary, reactions were carried out under argon unless otherwise 
stated, and laboratory reagent grade solvents were used unless otherwise stated. Petroleum 
ether  40-60  °C  is  reported  as  petrol  and  was  purchased  from  Fisher.  Reactions  were 
monitored by TLC on SIL G/UV254 silica plates purchased from VWR, and were visualized 
under  UV  lamp  operating  at  short  and  long  wavelength  ranges  with  alkaline  potassium 
permanganate solution or phosphomolybdic acid (PMA). Flash column chromatography was 
carried out with Kieselgel 60M 0.04/0.063nm (230-240 mesh) silica gel. All yields quoted are 
isolated yields, and when multiple products are obtained, data are presented in terms of the 
order of compounds isolated. 
 
1H NMR spectra were recorded at 300 MHz, 400 MHz, 500 MHz or 600 MHz on a Bruker 
AMX300,  Bruker  AMX400,  Bruker  AMX500,  or  Bruker  AMX600  MHz  spectrometer 
operating  at  ambient  temperature  using  an  internal  deuterium  lock.  Chemical  shifts  are 
reported in parts per million using the following abbreviations: s singlet, d doublet, t triplet, q 
quartet, qn quintet, sx sextet, sept septet, m multiplet, br broad; or a combination thereof. 
Coupling constants (J) are reported in Hertz (Hz). 
13C NMR spectra were recorded at 75 MHz 
on  a  Bruker  AMX300,  100  MHz  on  a  Bruker  AMX400  MHz,  125  MHz  on  a  Bruker 
AMX500 MHz and 150 MHz on a Bruker AMX600 MHz spectrometer and are reported in 
ppm using CDCl3 or DMSO-d6 as an internal standard. Mass spectra (EI, CI and ES) were 
obtained from VG70-SE or a MAT 900 XP spectrometer by Dr. Lisa Haigh (UCL Chemistry 
Department). Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum 100 operating 
in ATR mode and are quoted in cm
–1. Optical rotations were determined from an average of 
five measurements at ambient temperature using a 1 mL, 1 dm cell and were measured using 
Perkin–Elmer 343 polarimeter (sodium D-line, 529 nm). [ʱ]D values are reported in 10
–1 deg 
cm
2  g
–1,  c  is  concentration  (g/100  mL).  The  following  chiral  column  was  used: 
CHIRALPAK® AD column (0.46cm × 25cm) purchased from Daicel Chemical Industries, 
Ltd.  
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4.2  Experimental procedures 
 
N-Cyclohexylidenecyclohexanamine
182,183 (25)  
 
Cyclohexylamine (23.30 mL, 204 mmol) was added to a stirred solution of cyclohexanone 
(21.10 mL, 204 mmol) in dry Et2O (150 mL) containing 4 Å molecular sieves for 10 min. 
The solution was left to stand for 14 h at room temperature. The solvent was removed under 
reduced pressure to obtain the crude product as pale orange liquid. Purification by vacuum 
distillation gave the title compound as a colourless oil (20.6 g, 97%).  
 
bp 110-116 °C, 1 Torr (Lit. bp 111-115 °C, 8 Torr
182): 
1H NMR (300 MHz, CDCl3): ʴppm 
3.14 (1H, m, 1-H), 2.46-2.07 (4H, m, 6-H), 1.59-1.41 (16H, m, cyclohexyl); 
13C NMR (75 
MHz, CDCl3): ʴppm 170.6 (C-5), 57.8 (C-1), 36.6 (C-6), 33.8 (C-2), 29.0 (C-8), 27.5 (C-7), 
26.1 (C-4), 24.9 (C-3); LRMS (ES
+): 180 (100%, [M+H]
+), 83 (75); υmax (film/cm
-1) 2984 (C-
H), 1660 (C=N), 1448 (CH2).
 
 
N
1-Cyclohexylidene-N
2,N
2-diethylethane-1,2-diamine
69 (56)  
 
 
N,N-Diethylethylenediamine  (80  mL,  100  mmol)  was  added  to  cyclohexanone  (70  mL,      
100 mmol) containing 4 Å molecular sieves. The solution was heated to 80 °C for 18 h. The 
reaction mixture was filtered through a pad of Celite® and washed with Et2O (5 × 30 mL). 
The solvent was removed under reduced pressure to obtain the title compound as a pale 
brown oil (9.5 g, 95%). 
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1H NMR (500 MHz, CDCl3): ʴppm 3.33 (2H, t, J = 7.2 Hz, 5-H), 2.57 (2H, t, J = 7.2, 6-H), 
2.45 (4H, q, J = 7.2 Hz, CH2CH3), 2.24-2.34 (4H, m, 3-H), 1.60-1.75 (6H, m, 2-H and 4-H), 
1.04 (6H, t, J = 7.2 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3): ʴppm 173.6 (C-1), 53.9 (C-6), 
48.7 (CH2CH3), 39.9 (C-5), 29.0 (C-2), 27.6 (C-2), 26.9 (C-3), 26.0 (C-4), 11.8 (CH2CH3); 
LRMS (ES
+): 197 (100%, [M+H]
+); υmax (film/cm
-1) 2928 (C-H), 1661 (C=N).  
 
N-(2-Methylpropylidene)cyclohexanamine
127,184 (59)
  
 
Butanal (25.30 mL, 201 mmol) was added drop-wise to cyclohexylamine (23.10 mL, 201 
mmol) at −5 °C in an ice-salt bath. The mixture was stirred for 30 min, and then allowed to 
warm to room temperature. The water layer was removed and the organic extract was left to 
stand for 24 h in the presence of KOH pellets. This mixture was filtered and concentrated 
under reduced pressure to obtain the title compound as a light orange oil (19 g, 95%). 
 
1H NMR (300 MHz, CDCl3): ʴppm 7.35 (1H, d, J = 5.8 Hz, 5-H), 2.75-2.68 (1H, m, 1-H), 
2.28-2.19 (1H, m, 6-H), 1.58-1.28 (10H, m, 2-H, 3-H and 4-H), 0.90-0.87 (6H, m, 7-H); 
13C 
NMR (75 MHz, CDCl3): ʴppm 167.4 (C-5), 69.3 (C-1), 34.3 (C-6), 33.8 (C-2), 25.5 (C-4), 
24.8 (C-3), 19.5 (C-7); LRMS (CI): 154 (100%, [M+H]
+); HRMS (CI) observed [M+H]
+: 
154.15914; C10H20N requires 154.15957; υmax (film/cm
-1) 2927 (C-H), 1668 (C=N). 
 
2-Methyl-N-propylidenepropan-2-amine
128,185 (60)  
 
2-Methylpropan-2-amine (10.90 mL, 103 mmol) was added to a stirred solution of propanal 
(6.20  mL,  86  mmol)  in  CH2Cl2  (15  mL)  containing  MgSO4  (1.50  g).  The  solution  was 
refluxed for 12 h. The reaction mixture was filtered and the solvent was removed under 
reduced pressure to  obtain  the crude product  as  a  yellow liquid.  Purification by vacuum 
distillation produced the title compound as a pale yellow oil (5.50 mL, 90%). Chapter 4 - Experimental section 
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bp 100-103 °C, 1 Torr (Lit. bp 99-100 °C, 1 Torr
128): 
1H NMR (500 MHz, CDCl3): ʴppm 7.70 
(1H, t, J = 4.9 Hz, 3-H), 2.12 (2H, qd, J = 7.7, 4.9 Hz, 2-H), 1.11 (9H, s, 5-H), 0.91 (3H, t, J 
= 7.7 Hz, 1-H); 
13C NMR (125 MHz, CDCl3): ʴppm 159.8 (C-3), 56.5 (C-4), 32.5 (C-5), 29.5 
(C-2), 10.7 (C-1); LRMS (EI): 113 (100%, [M]
+•); υmax (film/cm
-1) 2970 (C-H), 1628 (C=N). 
 
 
2-Methyl-N-propylidenepropane-2-sulfinamide
129,186  (61)  
 
2-Methylpropane-2-sulfinamide (1.00 g, 8.26 mmol) was added to a stirred solution of PPTS   
(0.10 g, 0.41 mmol) in CH2Cl2 (13.8 mL) containing MgSO4 (5.00 g, 41.30 mmol). Propanal       
(1.20 mL, 16.50 mmol) was added to the stirred solution. The solution was stirred for 14 h at 
room  temperature.  The  reaction  mixture  was  filtered  through  Celite©  and  washed  with 
CH2Cl2 (2 × 15 mL). The solvent was removed under reduced pressure to obtain the crude 
product. Purification by column chromatography eluting with CH2Cl2:petrol (5:1) gave the 
title compound as a colourless oil (0.95 g, 95%).    
 
1H NMR (500 MHz, CDCl3): ʴppm 7.70 (1H, t, J = 4.9 Hz, 1-H), 2.12 (2H, qd, J = 7.7, 4.9 Hz, 
2-H), 1.11 (9H, s, 5-H), 0.91 (3H, t, J = 7.7 Hz, 3-H); 
13C NMR (125 MHz, CDCl3): ʴppm 
159.8  (C-1),  56.5  (C-4),  32.5  (C-5),  29.5  (C-2),  10.7  (C-3);  LRMS  (CI):  162  (100%, 
[M+H]
+); HRMS (CI) observed ([M+H]
+): 162.09571; C7H16ONS requires 162.09526.
 
 
2-Methyl-N-(2-methylpropylidene)propane-2-sulfinamide
130,187 (62)  
 
2-Methylpropane-2-sulfinamide (1.00 g, 8.26 mmol) was added to a stirred solution of PPTS   
(0.10  g,  0.41  mmol)  in  CH2Cl2  (13.80  mL)  containing  MgSO4  (5.00  g,  41.30  mmol).                       
2-Methylpropanal (2.30 mL, 24.80 mmol) was added to the stirred solution. The solution was 
stirred for 14 h at room temperature. The reaction mixture was filtered through Celite© and 
washed with CH2Cl2 (2 × 15 mL). The solvent was removed under reduced pressure to obtain 
the title compound as a colourless oil (930 mg, 93%). Chapter 4 - Experimental section 
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1H NMR (500 MHz, CDCl3): ʴppm 7.96 (1H, d, J = 4.4 Hz, 1-H), 2.74-2.65 (1H, m, 3-H), 1.16 
(9H, s, 5-H), 1.14 (3H, d, J = 3.1 Hz, 2-H), 1.13 (3H, d, J = 3.1 Hz, 2-H); 
13C NMR (125 
MHz, CDCl3): ʴppm 173.8 (C-1), 56.5 (C-4), 34.9 (C-3), 22.3 (C-5), 18.9 (C-2); LRMS (CI): 
176  (100%,  [M+H]
+);  HRMS  (CI)  observed  ([M+H]
+):  176.11030;  C8H18ONS  requires 
176.11091.
 
 
(R)-N-Cyclohexylidene-1-phenylethanamine (64)  
 
(R)-1-Phenylethylamine  (0.60  mL,  4.5  mmol)  was  added  to  a  stirred  solution  of 
cyclohexanone (0.50 mL, 5.1 mmol) in CH2Cl2 (5 mL) containing MgSO4 (0.20 g). The 
solution was stirred for 14 h at room temperature. The reaction mixture was filtered and the 
solvent was removed under reduced pressure to obtain the title compound as a green oil (470 
mg, 94%). 
 
Data in agreement with the literature
188,189 
Green oil; 
1H NMR (500 MHz, CDCl3): ʴppm 7.56-7.33 (2H, m, 9-H), 7.28-7.25 (3H, m, 8-H 
and 10-H), 4.68 (1H, q, J = 6.5 Hz, 5-H), 2.31 (4H, m, 2-H), 1.81 (3H, d, J = 6.5 Hz, 6-H), 
1.73-1.47 (4H, m, 3-H), 1.46-1.44 (2H, m, 4-H); 
13C NMR (125 MHz, CDCl3): ʴppm 172.2 
(C-1), 146.3 (C-7), 128.4 (C-9), 126.6 (C-8), 126.2 (C-10), 57.8 (C-5), 40.3 (C-2), 29.6 (C-2 
or C-3), 28.0 (C-2 or C-3), 26.2 (C-3), 25.2 (C-4); LRMS (EI): 201 (100%, [M]
+•), 186 (48%, 
[M
+•-Me]),  105  (21%  [M
+•-C6H10N]);  HRMS  (EI)  observed  ([M]
+•):  201.15069;  C14H19N 
requires 201.15120; υmax (film/cm
-1) 1670 (C=N); [ʱ]
22
D = +17.6° (c = 1, CHCl3).  
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(R)-N-(2-Methylpropylidene)-1-phenylethanamine
131,190 (65)  
 
(R)-1-Phenylethylamine  (1.30  mL,  9.90  mmol)  was  added  to  a  stirred  solution  of 
isobutyraldehyde (0.80 mL, 9 mmol) in CH2Cl2 (5 mL) containing MgSO4 (0.30 g). The 
solution was stirred for 14 h at room temperature. The reaction mixture was filtered and the 
solvent was removed under reduced pressure to obtain the title compound as a yellow oil 
(460 mg, 92%). 
 
1H NMR (500 MHz, CDCl3): ʴppm 7.63 (1H, d, J = 5.4 Hz, 1-H), 7.40-7.32 (5H, m, 7-H, 8-H 
and 9-H), 4.30 (1H, q, J = 6.8 Hz, 4-H), 2.52 (1H, m, 2-H), 1.52 (3H, d, J = 6.8 Hz, 5-H), 
1.12 (6H, t, J = 7.5 Hz, 3-H); 
13C NMR (75 MHz, CDCl3): ʴppm 168.4 (C-1), 145.3 (C-6), 
128.4 (C-8), 126.7 (C-7), 126.5 (C-9), 69.4 (C-4), 34.1 (C-2), 24.9 (C-5), 19.5 (C-3); LRMS 
(CI): 176 (100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 176.14426; C12H17N requires 
176.14338; υmax (film/cm
-1) 1665 (C=N); [ʱ]
22
D = +48.5° (c = 1, CHCl3), Lit. [ʱ]
22
D = +82.3° 
(c = 1, CHCl3)
131. 
 
2-Cyclohexylidene-1,1-dimethylhydrazine
191 (168)  
 
Cyclohexanone (42.50 mL, 408 mmol), was added to hydrazine (34.10 mL, 448 mmol) and 
heated together at 80 °C for 12 h. Upon cooling to room temperature, solid NaOH pellets   
(12 g) was added and the mixture was stirred for 30 min. The reaction mixture was extracted 
with ether (3 × 50 mL) and the combined organic extracts were washed with saturated NaCl 
solution (60 mL), dried over MgSO4 and filtered. The solvent was removed under reduced 
pressure to obtain the title compound as a brown oil (40 g, quantitative).  
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1H NMR (500 MHz, CDCl3): ʴppm 2.26-2.17 (2H, m, H-2), 2.17-2.07 (6H, m, H-5), 1.98-1.90 
(2H, m, H-2), 1.45-1.28 (6H, m, H-3 and H-4); 
13C NMR (125 MHz, CDCl3): ʴppm; 170.1 (C-
1),  47.5  (C-5),  35.9  (C-2),  28.5  (C-2),  27.4  (C-3),  25.9  (C-4);  LRMS  (CI):  141  (100%, 
[M+H]
+), 96 (7); HRMS (CI) observed ([M+H]
+): 141.13980; C8H17N2 requires 141.13917; 
υmax (film/cm
-1) 2920 (C-H), 2840 (N-CH3), 1665 (C=N). 
 
2-Cyclopentylidene-1,1-dimethylhydrazine
191 (170)  
 
Cyclopentanone (28.40 mL, 297 mmol), was added to hydrazine (31 mL, 386 mmol) and 
heated together at 80
 °C for 12 h. Upon cooling to room temperature, solid NaOH pellets     
(8 g) was added and the mixture was stirred for 30 min. The reaction mixture was extracted 
with ether (3 × 45 mL) and the combined organic extracts were washed with saturated NaCl 
solution (60 mL), dried over MgSO4 and filtered. The solvent was removed under reduced 
pressure to obtain the title compound as a brown oil (27 g, quantitative).  
 
1H NMR (500 MHz, CDCl3): ʴppm 2.53 (6H, s, 4-H), 2.45 (2H, m, 2-H), 2.37 (2H, m, 2-H), 
1.70-1.81 (4H, complex m, 3-H); 
13C NMR (125 MHz, CDCl3): ʴppm; 177.5 (C-1), 47.9 (C-4), 
33.4 (C-2), 29.5 (C-2), 24.8 (C-3); LRMS (CI): 127 (100%, [M+H]
+), 96 (1); HRMS (CI) 
observed ([M+H]
+): 127.12412; C7H15N2 requires 127.12352; υmax (film/cm
-1) 2970 (C-H), 
1660 (C=N). 
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N-(4-Chlorobenzylidene)-2-methylpropane-2-sulfinamide
176 (225)  
 
(±)
tButyl  sulfinamide  (0.50  g,  4.1  mmol)  was  added  to  CH2Cl2  (5  mL),  followed  by 
pyridinium p-toluenesulfonate (PPTS) (104 mg, 4.1 mmol), MgSO4 (5.00 g, 41.3 mmol) and  
4-chlorobenzaldehyde (0.90 g, 6.2 mmol). The mixture was stirred at room temperature for 
12 h. The reaction mixture was filtered through a pad of Celite® and the filter cake was 
washed  with  CH2Cl2  (4  ×  10  mL).  Purification  by  column  chromatography  eluting  with 
petrol:EtOAc (2:1) gave the title compound as a white solid (0.49 g, 97%).  
 
mp = 39–41 °C. 
1H NMR (300 MHz, CDCl3): ʴppm 8.37 (1H, s, 5-H), 7.60 (2H, m, 3-H), 7.20 
(2H, m, 2-H), 1.08 (9H, s, 7-H); 
13C NMR (75 MHz, CDCl3): ʴppm 181.4 (C-5), 138.5 (C-1), 
132.5  (C-4),  130.5  (C-3),  129.2  (C-2),  57.7  (C-6),  22.5  (C-7);  LRMS  (CI):  244  (100%, 
[M+H]
+); HRMS (CI) observed ([M+H]
+): 244.05580;  C11H15ClNOS  requires  244.05628; 
υmax (film/cm
-1) 1740 (C=N), 1090 (S=O).  
 
N-(4-Chlorobenzylidene)-4-methylbenzenesulfonamide
177 (226) 
 
4-Methylbenzenesulfonamide (1.30 g, 7.8 mmol) was added to toluene (10 mL), followed by 
4-chlorobenzaldehyde  (1.00  g,  7.1  mmol).  The  mixture  was  heated  with  a  Dean–Stark 
apparatus  in  the  presence  of  activated  molecular  sieve  4  Å  and  a  catalytic  amount  of 
amberlyst®-15  for  16  h.  The  mixture  was  cooled  to  room  temperature  without  stirring, 
filtered, washed with toluene (2 × 25 mL) and the filtrate was concentrated under reduced 
pressure.  The  solid  obtained  was  then  triturated  in  pentane  to  give  the  crude  product. 
Purification  by  column  chromatography  eluting  with  petrol:EtOAc  (8:1)  gave  the  title 
compound as a white solid (0.95 g, 95%).  
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mp = 170-173 °C. 
1H NMR (500 MHz, CDCl3): ʴppm 9.15 (1H, s, 5-H), 8.04 (2H, d, J = 8.5 
Hz, 2-H), 7.93 (2H, d, J = 8.5 Hz, 3-H), 7.84 (2H, d, J = 8.2 Hz, 8-H), 7.70 (2H, d, J = 8.2 
Hz, 7-H), 3.37 (3H, s, 10-H); 
13C NMR (125 MHz, CDCl3): ʴppm 170.5 (C-5), 144.8 (C-6), 
141.9 (C-9), 141.4 (C-4), 140.0 (C-1), 134.7 (C-2), 132.9 (C-3), 131.2 (C-7), 130.1 (C-8), 
20.8 (C-10); LRMS (CI): 294 (100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 294.03571; 
C14H13O2NSCl requires 294.03500; υmax (film/cm
-1) 1738 (C=N), 1366 (S=O)2).  
 
2-((4-Chlorophenyl)(hydroxy)methyl)cyclohexanone (67)  
 
Representative procedure using N-cyclohexylidenecyclohexanamine as amine 
N-Cyclohexylidenecyclohexanamine (25) (1 eq.) was added to MeCN (6 mL). The mixture 
was stirred for 5 min and sequentially a suspension of MgBr2 (1.2 eq.) in MeCN (6 mL) was 
added, followed by Et3N (2.5 eq.) at −45
 °C. The solution was stirred for 1 h at −45 °C. A 
solution of 4-chlorobenzaldehyde (1 eq.) in MeCN (3 mL) was added and the mixture was 
stirred for 1 h at −45 °C. The mixture was then stirred for 12 h at room temperature. The 
reaction  mixture  was  treated  with  1M  AcOH  (10  mL)  and  stirred  for  1.5  h  at  room 
temperature. The reaction mixture was quenched with water (10 mL) and then extracted with 
Et2O (2 × 10 mL). The combined organic extracts were washed with saturated NaCl solution 
(10 mL), dried over MgSO4 and filtered. The solvent was removed under reduced pressure to 
obtain the crude product as a brown oil. Purification by column chromatography eluting with 
petrol:Et2O (4:1), gave the title compound as a brown oil (14%) and as a mixture of syn:anti 
(1:1). 
 
Representative procedure using N,N-diethylethylenediamine as amine 
N,N-Diethylethylenediamine (0.1 eq.), was added to a stirred solution of cyclohexanone (1 
eq.) in DMSO (2.50 mL) followed by Mg(ClO4)2 (0.2 eq.), and Et3N (0.10 mL, 0.2 eq.). 4-
Chlorobenzaldehyde (1 eq.) was added to DMSO and this mixture was added dropwise to the 
stirred mixture via a syringe pump (1.59 cc/hr). The mixture was stirred for 12 h at room 
temperature under argon. The reaction mixture was quenched with water (30 mL) and then 
extracted with Et2O (2 × 35 mL). The combined organic extracts were washed with saturated 
NaCl solution (30 mL), dried over MgSO4 and filtered. The solvent was removed under Chapter 4 - Experimental section 
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reduced  pressure  to  obtain  the  crude  product  as  a  colourless  oil.  Purification  by  column 
chromatography eluting with petrol:Et2O (3:1) gave the title compound as a colourless oil 
(69%) and as a mixture of syn:anti (67:33). 
 
 
Data in agreement with the literature
192,193 
Anti-diastereomer: 
1H NMR (500 MHz, CDCl3): ʴppm 7.32 (2H, d, J = 8.6 Hz, 10-H), 7.27 
(2H, d, J = 8.6 Hz, 9-H), 4.76 (1H, d, J = 8.7 Hz, 7-H), 3.98 (1H, s, O-H), 2.57 (1H, dddd, J = 
13.7, 9.8, 5.8, 4.2 Hz, 5-HH), 2.48 (1H, dddd, J = 13.7, 8.7, 5.8, 4.4 Hz, 5-HH), 2.35 (1H, td, 
J = 8.7, 5.8 Hz, 6-H), 2.09 (1H, dt, J = 11.9, 6.2 Hz, 2-HH), 1.80 (1H, ddd, J = 11.9, 8.7, 5.1 
Hz, 2-HH), 1.70-1.26 (4H, m, 3-H and 4-H); 
13C NMR (100 MHz, CDCl3): ʴppm 215.6 (C-1), 
140.5 (C-8), 140.0 (C-11), 128.9 (C-10), 128.8 (C-10), 74.5 (C-7), 57.8 (C-6), 43.0 (C-2), 
31.1 (C-3), 28.1 (C-4), 25.1 (C-5); Syn-diasteromer: 
1H NMR (300 MHz, CDCl3): ʴppm 7.30 
(2H, d, J = 8.6 Hz, H-10), 7.26 (2H, d, J = 8.6 Hz, H-9), 5.37 (1H, d, J = 2.4 Hz, H-7), 3.00 
(1H, s, O-H), 2.70-2.60 (2H, m, H-2), 1.86-1.75 (5H, m H-4, H-5 and H-6), 1.65-1.55 (2H, 
m, H-3); 
13C NMR (125 MHz, CDCl3): ʴppm 212.6 (C-1), 139.9 (C-8), 131.3 (C-11), 128.7 
(C-10), 127.6 (C-9), 70.5 (C-7), 57.4 (C-6), 42.4 (C-2), 28.2 (C-3), 27.4 (C-4), 25.4 (C-5); 
LRMS  (EI):  238  (100%,  [M]
+•),  141  (66%,  [M]
+•-Aryl-CHOCl);  HRMS  (EI)  observed 
([M]
+•):  238.07639;  C13H15O2Cl  requires  238.07551;  υmax  (film/cm
-1)  3440  (O-H),  1695 
(C=O).  
 
3-(4-Chlorophenyl)-3-hydroxy-2,2-dimethylpropanal (68)  
 
Procedure 1 
N-(2-Methylpropylidene)cyclohexanamine  (59)  (0.20  g,  1.1  mmol)  was  added  to  MeCN       
(6 mL). The mixture was stirred for 5 min and sequentially a suspension of MgBr2 (0.20 g, 
1.3 mmol) in MeCN (6 mL) was added, followed by Et3N (0.40 mL, 2.8 mmol) at −45
 °C. 
The solution was stirred for 1 h at −45 °C. A solution of 4-chlorobenzaldehyde (0.15 g,    1.1 Chapter 4 - Experimental section 
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mmol) in MeCN (3 mL) was added and the mixture was stirred for 1 h at  −45 °C. The 
mixture was then stirred for 12 h at room temperature. The reaction mixture was treated with 
1M AcOH (10 mL) and stirred for 1.5 h. The reaction mixture was quenched with water (10 
mL) and then extracted with Et2O (2 × 10 mL). The combined organic extracts were washed 
with  saturated  NaCl  solution  (10  mL),  dried  over  MgSO4  and  filtered.  The  solvent  was 
removed under reduced pressure to obtain the crude product as a brown oil. Purification by 
column  chromatography  eluting  with  petrol:Et2O  (4:1)  gave  the  title  compound  as  a 
colourless oil (40 mg, 20%). 
 
Procedure 2 
2-Methylpropanal (0.10 mL, 1.1 mmol) was added to a solution containing cyclohexylamine 
(0.13 mL, 1.1 mmol) MeCN (4 mL). The mixture was stirred for 5 min and sequentially a 
suspension of Mg(ClO4)2 (0.25 g, 1.1 mmol) in MeCN (3 mL) was added, followed by Et3N 
(0.15 mL, 1.1 mmol) at −45
 °C. The solution was stirred for 1 h at −45 °C. A solution of    4-
chlorobenzaldehyde (0.15 g, 1.1 mmol) in MeCN (3 mL) was added and the mixture was 
stirred for 1 h at −45 °C. The mixture was then stirred for 12 h at room temperature. The 
reaction  mixture  was  treated  with  1M  AcOH  (10  mL)  and  stirred  for  1.5  h  at  room 
temperature. The reaction mixture was quenched with water (10 mL) and then extracted with 
Et2O (2 × 10 mL). The combined organic extracts were washed with saturated NaCl solution 
(10 mL), dried over MgSO4 and filtered. The solvent was removed under reduced pressure to 
obtain  the  crude  product  as  a  brown  oil.  The  crude  product  was  purified  by  column 
chromatography eluted with 4:1 petrol:Et2O, to obtain the title compound as a colourless oil 
(30 mg, 20%). 
 
Data in agreement with the literature
194 
OH peak not seen in 
1H NMR 
1H NMR (500 MHz, CDCl3): ʴppm 9.91 (1H, s, 1-H), 7.65 (2H, d, J = 8.2 Hz, 8-H), 7.47 (2H, 
d, J = 8.2 Hz, 7-H), 4.87 (1H, s, 5-H), 1.01 (3H, s, 4-H), 0.91 (3H, s, 4-H). 
13C NMR (75 
MHz, CDCl3): ʴppm 206.4 (C-2), 138.2 (C-6), 131.6 (C-9), 128.9 (C-7 or C-8), 128.2 (C-7 or 
C-8), 76.7 (C-5), 50.9 (C-3), 20.0 (C-4), 18.3 (C-4); LRMS (EI): 195 (100%, [M-OH]
+•); 
HRMS (EI) observed ([M-OH]
+•): 195.05810; C11H12OCl requires 195.05712; υmax (film/cm
-
1) 3458 (O-H), 1728 (C=O)-H).  
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4-(4-Chlorophenyl)-4-hydroxybutan-2-one (72)  
 
Authentic sample procedure
132 
L-proline (0.30 g, 2.1 mmol) was added to a stirred solution of acetone (0.10 mL, 1.4 mmol) 
in DMSO:acetone (4:1, 5 mL). 4-Chlorobenzaldehyde (1.00 g, 7.1 mmol) was added to the 
stirred mixture. The mixture was stirred for 12 h at room temperature. The reaction mixture 
was quenched with NH4Cl (20 mL) and then extracted with Et2O (2 × 15 mL). The combined 
organic extracts were washed with saturated NaCl solution (25 mL), dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to obtain the crude product as pale 
yellow oil. Purification by column chromatography eluting with petrol:Et2O (2:1) gave the 
title compound as a colourless oil (420 mg, 42%, 70% ee, major isomer R). HPLC (Daicel 
Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 17.6 min (R 
major), tR = 21.2 min (S minor). [ʱ]
22
D = +38.5° (c = 1, CHCl3), Lit. [ʱ]
22
D = +51.0° (c = 1, 
CHCl3)
132. 
 
Unoptimised procedure 
4-Chlorobenzaldehyde (1 eq.) was added to a stirred solution of DMSO (4 mL), followed by; 
Cyclohexylamine (0.5 eq.), acetone (10 eq.), Mg(ClO4)2 (0.5 eq.), and Et3N (0.5 eq.). The 
mixture was stirred for 12 h at room temperature. The reaction mixture was quenched with 
water (10 mL) and then extracted with Et2O (2 × 10 mL). The combined organic extracts 
were washed with saturated NaCl solution (15 mL), dried over MgSO4 and filtered. The 
solvent was removed under reduced pressure to obtain the crude product as a yellow oil. 
Purification  by  column  chromatography  eluting  with  petrol:Et2O  (3:1)  gave  the  title 
compound as a colourless oil.  
 
Optimised procedure 
Primary  amine  (0.1  equiv.)  was  added  to  a  stirred  solution  of  acetone  (10  equiv.)  in 
DMSO:acetone  (4:1,  2.5  mL)  followed  by;  Mg(ClO4)2  (0.2  eq.),  and  Et3N  (0.2  eq.).              
4-Chlorobenzaldehyde  (1  eq.)  was  added  to  a  solution  mixture  of  DMSO:acetone  (4:1,       
2.5 mL) and added dropwise via a syringe pump (1.59 cc/hr) to the stirred mixture. The 
mixture was stirred for 12 h at room temperature under argon. The reaction mixture was Chapter 4 - Experimental section 
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quenched with water (10 mL) and then extracted with Et2O (2 × 10 mL). The combined 
organic extracts were washed with saturated NaCl solution (10 mL), dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to obtain the crude product as pale 
yellow oil. Purification by column chromatography eluting with petrol:Et2O (3:1) gave the 
title compound as a colourless oil.  
Primary amine  Yield 
(%)/ee (%) 
Major isomer R 
or S 
N,N-Diethylethylenediamine (75)  60%   
2-Methoxyphenyl)methanamine (79)  14%   
(1R,2R)-Cyclohexane-1,2-diamine (78)  48%   
2-Methylpropane-2-sulfinamide (84)  78%   
4-(Methoxyphenyl)methanamine (79)  18%   
Butylamine (82)  40%   
(R)-1-Phenylethanamine (62)  38%/8%  R 
(1R,2S)-2-Amino-1,2-diphenylethanol (103)  60%/10%  R 
(R)-2-Amino-4-methylpentan-1-ol (104)  40%/6%  R 
(R)-2-Amino-3,3-dimethylbutan-1-ol (105)  34%/6%  R 
9-Amino(9-deoxy)epihydroquinine (96)  46%/8%  S 
(R)-1-Methoxy-3-phenylpropan-2-amine (101)  65%/23%  R 
(R)-2-Amino-3-phenylpropan-1-ol (100)  42%/16%  R 
(R)-2-Amino-3-methylbutan-1-ol (102)  41%/40%  R 
(R)-2-Methylpropane-2-sulfinamide (106)  81%/38%  R 
(1R,2R)-N
1-(4-Chlorobenzyl)cyclohexane-1,2-diamine (99)  64%/4%   
(2S,3S)-2-Amino-3-methylpentan-1-ol (107)  39%/2%   
 
 
Data in agreement with the literature
195,196 
1H NMR (500 MHz, CDCl3): ʴppm 7.36-7.32 (4H, m, 6-H and 7-H), 5.08 (1H, d, J = 4.4 Hz, 
4-H), 3.57 (1H, s, OH), 3.00 (1H, d, J = 5.5 Hz, 3-HH), 2.70 (1H, dd, J = 5.5, 4.4 Hz, 3-HH), 
2.15 (3H, s, 1-H); 
13C NMR (125 MHz, CDCl3): ʴppm 208.9 (C-2), 141.5 (C-5), 131.9 (C-6 
and C-8), 129.0 (C-7), 69.2 (C-4), 51.9 (C-3), 30.8 (C-1); LRMS (ES
+): 200 (
37Cl, 14%, Chapter 4 - Experimental section 
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[M]
+), 198 (
35Cl, 43%, [M]
+), 181 (95%, [M]
+-OH), 141 (100%, [M]
+-C3H5O); υmax/cm
-1 
3407 (O-H), 1703 (C=O).  
 
4-Cyclopropyl-4-hydroxybutan-2-one (85) 
 
N,N-Diethylethylenediamine  (0.20  mL,  1.4  mmol)  was  added  to  a  solvent  mixture  of 
DMSO:acetone  (4:1, 5  mL)  and stirred  followed by the addition  of;  acetone (10.50 mL,       
143  mmol),  Mg(ClO4)2  (0.60  g,  2.9  mmol),  and  Et3N  (0.40  mL,  2.85  mmol). 
Cyclopropanecarboxaldehyde  (1.10  mL,  14.3  mmol)  was  added  to  a  solvent  mixture  of 
DMSO:acetone (4:1, 5 mL) and added dropwise to the stirred mixture via a syringe pump 
(1.59 cc/hr). The mixture was stirred for 12 h at room temperature under argon, quenched 
with  water  (25  mL),  and  then  extracted  with  Et2O  (2  ×  30  mL).  The  combined  organic 
extracts were washed with saturated NaCl solution (35 mL), dried over MgSO4 and filtered. 
The solvent was removed under reduced pressure to obtain the crude product as a colourless 
oil. Purification by column chromatography eluting with petrol:EtOAc (3:1) gave the title 
compound as a colourless oil (140 mg, 14%). 
  
Data in agreement with the literature
197 
1H NMR (500 MHz, CDCl3): ʴppm 3.27 (1H, ddd, J = 11.2, 7.1, 4.9 Hz, 4-H), 3.01 (1H, s, 
OH), 2.68 (2H, m, 3-H), 2.13 (3H, s, 1-H), 0.86 (1H, qt, J = 7.1, 5.0 Hz, 5-H), 0.31 (1H, td, J 
= 9.7, 5.0 Hz, 6-H), 0.12 (1H, td, J = 9.4, 4.9 Hz, 7-H); 
13C NMR (125 MHz, CDCl3): ʴppm 
209.9 (C-2), 72.6 (C-4), 50.3 (C-3), 31.1 (C-1), 17.2 (C-5), 3.6 (C-6), 2.5 (C-7); LRMS (EI): 
127  (100%,  [M-H]
+•);  HRMS  (EI)  observed  (M
+•-H):  127.07581;  C7H11O2  requires 
127.07536; υmax (film/cm
-1) 3457 (O-H), 3016 (C-H), 1740 (C=O).  
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4-Hydroxy-6-methylheptan-2-one (86) 
 
N,N-Diethylethylenediamine  (0.20  mL,  1.2  mmol)  was  added  to  a  solvent  mixture  of 
DMSO:acetone  (4:1,  5  mL)  and  stirred  followed  by  the  addition  of;  acetone  (8.50  mL,         
116 mmol), Mg(ClO4)2 (0.50 g, 2.3 mmol), and Et3N (0.30 mL, 2.3 mmol). 3-methylbutanal 
(1.30 mL, 11.6 mmol) was added to a solvent mixture of DMSO:acetone (4:1, 5 mL) and 
added dropwise to the stirred mixture  via a syringe pump (1.59 cc/hr). The mixture was 
stirred for 12 h at room temperature under argon, quenched with water (25 mL), and then 
extracted with Et2O (2 × 30 mL). The combined organic extracts were washed with saturated 
NaCl solution (35 mL), dried over MgSO4 and filtered. The solvent was removed under 
reduced  pressure  to  obtain  the  crude  product  as  a  colourless  oil.  Purification  by  column 
chromatography eluting with petrol:EtOAc (3:1) gave the title compound as a colourless oil 
(170 mg, 17%).  
 
Data in agreement with the literature
198,199 
1H NMR (500 MHz, CDCl3): ʴppm 4.11 (1H, m, 4-H), 3.03 (1H, s, OH), 2.59 (1H, dd, J = 9.9, 
3.6 Hz, 3-HH), 2.52 (1H, dd, J = 8.7, 3.6 Hz, 3-HH), 2.17 (3H, s, 1-H), 1.71-1.78 (1H, m, 6-
H), 1.45 (1H, ddd, J = 12.5, 8.9, 5.3 Hz, 5-HH), 1.12 (1H, ddd, J = 11.5, 8.9, 5.3 Hz, 5-HH), 
0.90 (6H, dd, J = 7.6, 6.6 Hz, 7-H); 
13C NMR (125 MHz, CDCl3): ʴppm 210.3 (C-2), 65.7 (C-
4), 50.5 (C-3), 44.9 (C-5), 30.8 (C-1), 24.4 (C-6), 23.3 (C-7), 22.0 (C-7); LRMS (CI): 145 
(100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 145.12326; C8H17O2 requires 145.12285; 
υmax (film/cm
-1) 3448 (O-H), 2957 (C-H), 1730 (C=O).  
 
4-(Cyclohex-3-enyl)-4-hydroxybutan-2-one (87) 
 
N,N–Diethylethylenediamine  (0.10  mL,  0.9  mmol)  was  added  to  a  solvent  mixture  of 
DMSO/acetone  (4:1,  5  mL)  and  stirred  followed  by  the  addition  of;  acetone  (6.70  mL,        
90.8 mmol), Mg(ClO4)2 (0.40 g, 1.8 mmol), and Et3N (0.30 mL, 1.8 mmol). Cyclohex-3-
enecarbaldehyde (1.00 mL, 9.1 mmol) was added to a solvent mixture of DMSO/acetone Chapter 4 - Experimental section 
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(4:1, 5 mL) and added dropwise to the stirred mixture via a syringe pump (1.59 cc/hr). The 
mixture was stirred for 12 h at room temperature under argon. The reaction mixture was 
quenched with water (25 mL) and then extracted with Et2O (2 × 20 mL). The combined 
organic extracts were washed with saturated NaCl solution (35 mL), dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to obtain the crude product as a 
pale yellow oil. Purification by column chromatography eluting with petrol:EtOAc (3:1) gave 
the  title  compound  as  a  colourless  oil  and  as  a  mixture  of  diastereomers  syn:anti  (1:1)       
(130 mg, 13%). 
 
1H NMR (500 MHz, CDCl3): ʴppm 5.66-5.62 (2H, m, 7-H and 8-H), 3.92 (0.5H, ddd, J = 9.0, 
5.9, 2.6 Hz, 4-H), 3.83 (0.5H, ddd, J = 9.8, 6.9, 2.6 Hz, 4-H), 3.00 (0.5H, s, OH), 2.98 (0.5H, 
s, OH), 2.66 (1H, dd, J = 5.9, 4.3 Hz, 3-H), 2.63 (1H, dd, J = 6.9, 4.3 Hz, 3-H), 2.58 (0.5H, 
dd, J = 9.0, 4.7 Hz, 5-H), 2.54 (0.5H, dd, J = 9.8, 4.7 Hz, 5-H), 2.12 (3H, s, 1-H), 2.10-1.40 
(6H, m, 6-H and 9-H); 
13C NMR (125 MHz, CDCl3): ʴppm 210.4 (C-2), 210.3 (C-2), 127.4 (C-
7 or C-8), 126.9 (C-7 or C-8), 126.4 (C-7 or C-8), 125.7 (C-7 or C-8), 71.5 (C-4), 71.0 (C-4), 
47.7 (C-3), 47.6 (C-3), 39.3 (C-5), 39.3 (C-5), 30.9 (C-6) 30.9 (C-6), 28.4 (C-1), 27.8 (C-1), 
25.2 (C-9), 25.1 (C-9); LRMS (CI): 169 (100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 
169.12353; C10H17O2 requires 169.12285; υmax (film/cm
-1) 3424 (O-H), 1708 (C=O), 1365 
(C=C). 
 
4-Hydroxyheptan-2-one (88)  
 
N,N-Diethylethylenediamine  (0.10  mL,  0.7  mmol)  was  added  to  a  solvent  mixture  of 
DMSO:acetone (4:1, 2.5 mL) and stirred followed by the addition of; acetone (4.0 mL, 69.3 
mmol), Mg(ClO4)2 (0.30 g, 1.4 mmol), and Et3N (0.10 mL, 1.4 mmol). Butanal (0.50 g,            
7.0  mmol)  was  added  to  a  solvent  mixture  of  DMSO:acetone  (4:1,  2.5  mL)  and  added 
dropwise to the stirred mixture via a syringe pump (1.59 cc/hr). The mixture was stirred for 
12  h  at  room  temperature  under  argon.  The  reaction  mixture  was  quenched  with  water            
(25 mL) and then extracted with Et2O (2 × 20 mL). The combined organic extracts were 
washed with saturated NaCl solution (35 mL), dried over MgSO4 and filtered. The solvent 
was removed under reduced pressure to obtain the crude product as yellow oil. Purification Chapter 4 - Experimental section 
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by  column  chromatography  eluting  with  petrol:Et2O  (2:1)  gave  the  title  compound  as  a 
colourless oil (0.14 g, 16%).  
 
Data in agreement with the literature
200 
1H NMR (500 MHz, CDCl3): ʴppm 4.10-4.07 (1H, m, 4-H), 2.97 (1H, s, OH), 2.63 (2H, m, 3-
H), 2.11 (3H, s, 1-H), 1.51-1.34 (4H, m, 5-H and 6-H), 0.93 (3H, s, 7-H); 
13C NMR (125 
MHz, CDCl3): ʴppm 207.7 (C-2), 67.1 (C-4), 52.6 (C-3), 39.5 (C-5), 30.1 (C-1), 18.5 (C-6), 
14.4 (C-7); υmax (film/cm
-1) 3405 (O-H), 1743 (C=O).  
 
4-Hydroxy-4-(4-nitrophenyl)butan-2-one
201,202 (90) 
 
N,N-Diethylethylenediamine  (60  µL,  0.3  mmol)  was  added  to  a  solvent  mixture  of 
DMSO:acetone (4:1, 5 mL) followed by; acetone (2.40 mL, 31.0 mmol), Mg(ClO4)2 (150 mg, 
0.7 mmol), Et3N (92 µL, 0.7 mmol). 4-Nitrobenzaldehyde (0.50 g, 3.3 mmol) was added to a 
solvent mixture of DMSO:acetone (4:1, 5 mL) and added dropwise to the stirred mixture via 
a syringe pump (1.59 cc/hr). The mixture was stirred for 12 h at room temperature under 
argon,  quenched  with  water  (15  mL),  and  then  extracted  with  Et2O  (2  ×  20  mL).  The 
combined organic extracts were washed with saturated NaCl solution (25 mL), dried over 
MgSO4 and filtered. The solvent was removed under reduced pressure to obtain the crude 
product  as  a  colourless  oil.  Purification  by  column  chromatography  eluting  with 
petrol:EtOAc (3:1) gave the title compound as a colourless oil (0.34 g, 68%).  
 
1H NMR (500 MHz, CDCl3): ʴppm 8.20 (2H, d, J = 8.8 Hz, 7-H), 7.54 (2H, d, J = 8.8 Hz, 6-
H), 5.26 (1H, dd, J = 8.4, 4.6 Hz, 4-H), 3.60 (1H, d, J = 2.4 Hz, OH), 2.85 (1H, dd, J = 8.4, 
3.9 Hz, 3-H), 2.82 (1H, dd, J = 4.6, 3.9 Hz, 3-H), 2.22 (3H, s, 1-H); 
13C NMR (125 MHz, 
CDCl3): ʴppm 208.8 (C-2), 150.0 (C-5), 145.0 (C-8), 126.5 (C-6), 123.9 (C-7), 69.0 (C-4), 
51.6 (C-3), 30.8 (C-1); LRMS (EI): 209 (100%, [M]
+•); HRMS (EI) observed ([M+Na]
+•): 
232.05770; C10H11NO4 requires 223.05800; υmax (film/cm
-1) 3449 (O-H), 3118 (C-H), 1713 
(C=O). 
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4-Hydroxy-4-(4-methoxyphenyl)butan-2-one (91) 
 
N,N–Diethylethylenediamine  (0.10  mL,  0.7  mmol)  was  added  to  a  solvent  mixture  of 
DMSO/acetone (4:1, 5 mL) and stirred followed by the addition of; acetone (5.40 mL, 73.5 
mmol),  Mg(ClO4)2  (0.30  g,  1.5  mmol),  and  Et3N  (0.20  mL,  1.47  mmol).                                  
4-Methoxybenzaldehyde  (0.90  mL,  7.4  mmol)  was  added  to  a  solvent  mixture  of 
DMSO/acetone (4:1, 5 mL) and added dropwise to the stirred mixture via a syringe pump 
(1.59 cc/hr). The mixture was stirred for 12 h at room temperature under argon. The reaction 
mixture was quenched with water (25 mL) and then extracted with Et2O (2 × 20 mL). The 
combined organic extracts were washed with saturated NaCl solution (35 mL), dried over 
MgSO4 and filtered. The solvent was removed under reduced pressure to obtain the crude 
product as yellow oil. Purification by column chromatography eluting with petrol:Et2O (3:1) 
gave the title compound as a colourless oil (0.59 g, 41%).  
 
Data in agreement with the literature
203 
1H NMR (500 MHz, CDCl3): ʴppm 7.26 (2H, d, J = 8.4 Hz, 6-H), 6.86 (2H, d, J = 8.4 Hz, 7-
H), 5.07 (1H, dd, J = 8.4, 6.8 Hz, 4-H), 3.76 (3H, s, OMe), 3.30 (1H, s, OH), 2.87 (1H, dd, J 
= 8.4, 4.6 Hz, 3-H), 2.84 (1H, dd, J = 6.8, 4.6 Hz, 3-H), 2.15 (3H, s, Me); 
13C NMR (125 
MHz, CDCl3): ʴppm 210.0 (C-2), 158.9 (C-8), 134.9 (C-5), 126.8 (C-6), 113.7 (C-7), 69.4 (C-
4), 55.1 (O-Me), 51.9 (C-3), 30.6 (C-1); LRMS (EI): 194 (100%, [M]
+•), 77 (80%, M
+•-
C6H4); HRMS (EI) observed (M
+•): 194.09452; C11H14O3 requires 194.09375; υmax (film/cm
-
1) 3420 (O-H), 2921 (Ar-H), 1705 (C=O), 1361 (C-OMe).  
 
4-Hydroxy-4-(4-(trifluoromethyl)phenyl)butan-2-one (93) 
 
N,N-Diethylethylenediamine  (20  µL,  0.1  mmol)  was  added  to  a  stirred  mixture  of 
DMSO:acetone (4:1, 5 mL) followed by; acetone (1.00 mL, 14.0 mmol), Mg(ClO4)2 (60 mg, 
0.3  mmol),  and  Et3N  (40  µL,  0.3  mmol).  4-(Trifluoromethyl)benzaldehyde  (30  mg,  1.4 Chapter 4 - Experimental section 
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mmol) was added to a solvent mixture of DMSO:acetone (4:1, 5 mL) and added dropwise to 
the stirred mixture via a syringe pump (1.02 cc/hr). The mixture was stirred for 12 h at room 
temperature under argon, quenched with water (25 mL), and then extracted with Et2O (2 × 20 
mL). The combined organic extracts were washed with saturated NaCl solution (35 mL), 
dried over MgSO4 and filtered. The solvent was removed under reduced pressure to obtain 
the crude product as a colourless oil. Purification by column chromatography eluting with 
petrol:EtOAc (3:1) gave the title compound as a colourless oil (100 mg, 40%).  
 
Data in agreement with the literature
204 
1H NMR (500 MHz, CDCl3): ʴppm 7.60 (2H, d, J = 8.2 Hz, H-7), 7.47 (2H, d, J = 8.2 Hz, H-
6), 5.20 (1H, dd, J = 7.9, 4.4 Hz, H-4), 3.55, (1H, s, OH), 2.83 (2H, dd, J = 8.1, 4.4 Hz, H-3), 
2.20 (3H, s, Me); 
13C NMR (125 MHz, CDCl3): ʴppm 208.8 (C-2), 146.8 (C-5), 129.9 (q, J = 
40.6 Hz, C-8), 126.0 (C-6), 125.5 (C-7), 124.2 (q, J = 40.7 Hz, C-9), 69.3 (C-4), 51.8 (C-3), 
30.8 (C-1); LRMS (CI): 233 (100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 233.07912; 
C11H12O2F3 requires 233.07894; υmax (film/cm
-1) 3431 (O-H), 2918 (C-H), 1711 (C=O).  
 
2-((4-Chlorophenyl)(hydroxy)methyl)-3,4-dihydronaphthalen-1(2H)-one (95) 
 
N,N-Diethylethylenediamine  (0.10  mL,  0.7  mmol)  was  added  to  a  solvent  mixture  of 
DMSO:acetone  (4:1,  5  mL)  and  stirred  followed  by  the  addition  of;  3,4-Dihydro-1(2H)-
naphthalenone (1.00 mL, 7.8 mmol), Mg(ClO4)2 (0.30 g, 0.1 mmol), and Et3N (0.20 mL,    
0.1 mmol). 4-Chlorobenzaldehyde (1.00 g, 7.1 mmol) was added to a solvent mixture of 
DMSO:acetone (4:1, 5 mL) and added dropwise to the stirred mixture via a syringe pump 
(1.59 cc/hr). The mixture was stirred for 12 h at room temperature under argon, quenched 
with  water  (25  mL),  and  then  extracted  with  Et2O  (2  ×  30  mL).  The  combined  organic 
extracts were washed with saturated NaCl solution (35 mL), dried over MgSO4 and filtered. 
The solvent was removed under reduced pressure to obtain the crude product as a yellow oil. 
Purification  by  column  chromatography  eluting  with  petrol:EtOAc  (3:1)  gave  the  title 
compound as a pale yellow oil (0.23 g, 23%).  
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1H NMR (500 MHz, CDCl3): ʴppm 8.06 (1H, d, J = 7.9 Hz, 15-H), 7.50 (1H, d, J = 7.5, Hz, 1-
H), 7.34-7.30 (5H, m, 2-H, 3-H, 13-H, 14-H, 16-H), 7.22 (1H, d, J = 7.5 Hz, 4-H), 4.95, (1H, 
d, J = 8.7 Hz, 11-H), 2.88 (2H, dd, J = 9.1, 4.3 Hz, 9-H), 2.75-2.67 (1H, m, 10-H), 1.70-1.64 
(2H, m, 7-H); 
13C NMR (125 MHz, CDCl3): ʴppm 202.1 (C-8), 144.4 (C-5), 139.8 (C-12), 
134.3 (C-6), 132.3 (C-3), 132.0 (C-17), 128.7 (C-14 and C-16), 127.6 (C-13 and C-15), 127.0 
(C-2),  75.0  (C-11),  54.0  (C-10),  28.8  (C-7),  26.1  (C-9);  LRMS  (CI):  289  (
37Cl,  25%, 
[M+H]
+),  287  (
35Cl,  75%,  [M+H]
+);  HRMS  (CI)  observed  (
35Cl,  [M+H]
+):  287.08263; 
C17H16O2
35Cl requires 287.08388; υmax (film/cm
-1) 3449 (O-H), 2929 (C-H), 1738 (C=O). 
 
9-Amino(9-deoxy)epihydroquinine
133 (96) 
 
Hydroquinine (1.00 g, 3.1 mmol) and triphenylphosphine (960 mg, 3.7 mmol) were dissolved 
in dry THF (20 mL) and the solution was cooled to 0 °C. Diisopropyl azodicarboxylate (0.70 
g, 3.7 mmol) was added in one portion. A solution of diphenyl phosphoryl azide (0.80 mL, 
3.7 mmol) in dry THF (8 mL) was added dropwise at 0 °C. The mixture was allowed to warm 
to room temperature and then stirred for 12 h at this temperature. The mixture was heated to 
50 °C for 2 h and then triphenylphosphine (1.00 g, 4.0 mmol) was slowly added portion-wise, 
the heating was maintained until gas evolution had ceased (2 h). The solution was cooled to 
room temperature, water (2 mL) was added, and the solution was stirred for 3 h. The solvents 
were removed under reduced pressure and the residue was dissolved in CH2Cl2 and 10% HCl 
(1:1, 50 mL). The aqueous phase was washed with CH2Cl2 (4 × 20 mL), basified with excess 
aqueous  NH4OH solution and  washed with  CH2Cl2 (4 ×  20 mL). The  combined organic 
phases were dried over Na2SO4 and concentrated under reduced pressure. The residue was 
purified  by  column  chromatography  eluting  with  EtOAc:MeOH:aq.  NH4OH  (50:50:1) 
affording the title compound as a yellow viscous oil (0.70 g, 70%).   
 
Data in agreement with the literature
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NH2 peak not seen 
1H NMR (500 MHz, CDCl3): ʴppm 8.69 (1H, d, J = 4.7 Hz, 13-H), 7.98 (1H, d, J = 9.2 Hz,   
19-H), 7.61 (1H, d, J = 4.7, Hz, 12-H), 7.42 (1H, s, 16-H), 7.33 (1H, dd, J = 9.2, 2.6 Hz, 18-
H), 4.54 (1H, d, J = 10.9 Hz, 10-H), 3.91 (3H, s, OCH3), 3.38 (1H, dddd, J = 15.6, 10.3, 7.8, 
2.7 Hz, 8-Hb), 3.18 (1H, dd, J = 13.6, 10.0 Hz, 4-Hexo), 3.03-2.98 (1H, m, 9-H), 2.71 (1H, 
ddd, J = 15.6, 13.7, 4.8 Hz, 8-Ha), 2.46 (1H, ddd, J = 13.6, 10.0, 2.7 Hz, 4-Hendo), 2.40-2.35 
(2H, m, 7-Hb), 1.68 (1H, dd, J = 13.4, 10.4 Hz, 5-Hb), 1.60-1.55 (1H, m, 6-H), 1.53 (1H, 
unresolved partly overlapping signal, 7-Ha), 1.53 (1H, ddd, J = 13.4, 10.4, 2.8 Hz, 5-Ha), 
1.40-1.35 (1H, m, 3-H), 1.28-1.20 (1H, m, 2-H), 0.69 (2H, d, J = 7.4 Hz, 1-H); 
13C NMR 
(125 MHz, CDCl3): ʴppm 157.7 (C-17), 147.9 (C-11), 147.3 (C-13), 144.8 (C-14), 141.2 (C-
2), 131.9 (C-19), 128.9 (C-15), 121.3 (C-18), 120.0 (C-12), 112.1 (C-1), 102.0 (C-16), 71.9 
(C-9) 58.0 (C-4), 55.6 (OCH3), 41.1 (C-10), 37.5 (C-8), 28.9 (C-3), 27.7 (C-5), 25.9 (C-7), 
25.3 (C-6).  
 
(1R,2R)-N
1-(4-Chlorobenzyl)cyclohexane-1,2-diamine (99) 
 
(1R,2R)-cyclohexane-1,2-diamine  (0.40  g,  3.6  mmol)  was  added  to  a  solution  of                   
4-Chlorobenzaldehyde (0.50 g, 3.6 mmol) in 15mL of ethanol and stirred for 15 min at room 
temperature.  The  solvent  was  removed  under  reduced  pressure  and  this  procedure  was 
repeated three times to obtain the crude product as a pale yellow oil. The crude mixture was 
dissolved  in  MeOH:THF  (1:1,  6  mL),  then  NaBH4  (0.30  g,  8.4  mmol)  was  added.  The 
mixture was stirred for 1 h at room temperature. The reaction mixture was quenched with 
water (15 mL) and then extracted with Et2O (2 × 10 mL). The combined organic extracts 
were washed with saturated NaCl solution (10 mL), dried over MgSO4 and filtered. The 
solvent was removed under reduced pressure to obtain the crude product as a pale yellow oil. 
Purification by column chromatography eluting with Et2O:MeOH:Et3N (30:9:1) gave the title 
compound as a colourless oil (0.35 g, 70%). 
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NH and NH2 peaks not seen 
1H NMR (300 MHz, CDCl3): ʴppm 7.19-7.15 (4H, m, 9-H, 10-H, 12-H and 13-H), 3.73 (1H, 
dd, J = 13.4, 10.4 Hz, 7-H), 3.50 (1H, dd, J = 11.2, 10.4 Hz, 7-H), 2.29-2.21 (2H, m, 1-H and 
6-H), 2.13-2.08 (2H, m, 2-H), 2.04-1.96 (4H, m, 3-H and 4-H), 1.01-0.8 (2H, m, 5-H); 
13C 
NMR (125 MHz, CDCl3): ʴppm 139.7 (C-1), 132.3 (C-8), 129.4 (C-9 and C-13), 128.4 (C-10 
and C-12), 62.8 (C-1), 60.9 (C-6), 55.3 (C-4), 35.2 (C-5), 31.5 (C-2), 25.23 (C-3), 25.18 (C-
4);  LRMS (CI): 239 (100%,  [M+H]
+); HRMS (CI) observed (
35Cl,  [M+H]
+): 239.13158; 
C13H20N2Cl requires 239.13150; υmax (film/cm
-1) 3299 (N-H), 2925 (C-H). 
 
 (R)-1-Methoxy-3-phenylpropan-2-amine
134 (101) 
 
Potassium hydride (120 mg, 2.9 mmol, 35 wt % oil dispersion) was placed in a flame dried 
flask, washed with pentane (3 × 5 mL) and decanted. Dry THF (4 mL) was added, and a 
solution of (S)-(-)-2-amino-3-phenyl-1-propanol (0.40 g, 2.6 mmol) in dry THF (3 mL) was 
added dropwise. The mixture was stirred overnight at room temperature and then cooled to   
0 °C. A solution of iodomethane (0.20 mL, 2.9 mmol) in THF (10 mL) was added dropwise 
over 30 min. After 1 h of stirring, the mixture was poured into ice, followed by addition of  
water (10 mL). The organic solvent was removed by evaporation, and the aqueous mixture 
was  extracted  with  hexane  (3  ×  10  mL).  The  combined  organic  phases  were  dried  over 
MgSO4 and filtered. The solvent was removed under reduced pressure to obtain the crude 
product  as  a  colourless  oil.  Purification  by  column  chromatography  eluting  with 
petrol:EtOAc (4:1) gave the title compound as a colourless oil (192 mg, 48%). 
 
1H NMR (500 MHz, CDCl3): ʴppm 7.28 (2H, dd, J = 12.1, 5.6 Hz, 3-H), 7.18 (2H, partly 
unresolved, dd, J = 12.1, 5.6, Hz, 2-H), 7.19-7.17 (1H, m, 4-H), 3.37-3.29 (4H, m, 6-H and 8-
H), 3.25-3.18 (2H, m, 7-H), 2.76 (1H, dd, J = 14.1, 5.5 Hz, 5-H), 2.52 (1H, dd, J = 14.1, 7.8 
Hz, 5-H), 1.44 (2H, br, NH2); 
13C NMR (125 MHz, CDCl3): ʴppm 138.8 (C-1), 129.3 (C-3), 
128.5 (C-2), 126.4 (C-4), 77.4 (C-7), 59.0 (C-8), 52.4 (C-6), 40.9 (C-5); LRMS (ES
+): 166 
(100%,  [M+H]
+),  156  (31%),  133  (12%,  [M]
+-NOH3);  HRMS  (ES
+)  observed  [M+H]
+): 
166.1230; C10H16NO requires 166.1232; υmax (film/cm
-1) 3420 (NH2) 2952 (C-H).  
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2-(2-Oxopropyl)cyclohexanone (136)  
 
N-Cyclohexylidenecyclohexanamine (25) (11.00 g, 61.0 mmol) was dissolved in dry THF (40 
mL). Ethylmagnesium bromide (35 ml, 3M in THF) was added to the solution dropwise and 
the reaction  mixture  was  heated at  reflux for 2 h. The solution was  cooled to 0  °C  and 
propylene  oxide  (6.40  mL,  95  mmol)  was  added.  The  resulting  dark  green  solution  was 
stirred at 0 
°C for 1 h, then for 1 h at room temperature. The solution was partitioned between 
Et2O (40 mL) and brine (40 mL). The layers were separated and the aqueous layer was 
extracted twice with Et2O (2 x 30 mL). The combined organic layers were dried (MgSO4), 
filtered and concentrated under reduced pressure to give a yellow residue. Petrol (25 mL) was 
added to the residue and l M acetic acid (35 mL) for 2 h at room temperature. Saturated NaCl 
was added and the layers were separated, the aqueous layer was extracted twice with Et2O (2 
x 25 mL). The combined organic layers were washed with saturated NaHCO3 (25 mL), brine 
(25 mL), dried over MgSO4, filtered and concentrated under reduced pressure to give the 
crude product. Purification by column chromatography eluting with petrol:Et2O (4:1) gave 
the alcohol (132) as a light brown oil (3.37 g, 31%). The alcohol (132) (200 mg, 1.28 mmol) 
was dissolved in CH2Cl2 (10 mL) and cooled to −10 °C. Et3N (0.54 mL, 3.84 mmol) was 
added to the mixture followed by a solution of sulfur trioxide pyridine complex (SO3•Py) 
(0.60 g, 3.83 mmol) in DMSO (0.27 mL). The mixture was stirred for 30 min at −10 °C and 
allowed to warm to room temperature over 30 min. The reaction mixture was quenched with 
saturated NaCl solution (20 mL) and extracted with CH2Cl2 (3 x 15 mL). The combined 
organic extracts were washed with 10% citric acid solution (5 mL), saturated NaCl solution 
(10 mL), dried over MgSO4 and filtered. The solvent was removed under reduced pressure to 
give the crude product as colourless oil. Purification by column chromatography eluting with 
petrol:Et2O (4:1) gave the title compound as colourless oil (84 mg, 42%). 
 
Data in agreement with the literature
205 
1H NMR (300 MHz, CDCl3): ʴppm 2.97 (2H, d, J = 5.4 Hz, 7-H), 2.37 (2H, t, J = 5.9 Hz, 2-
H), 2.20 (3H, s, 9-H), 2.15-2.06 (3H, m, cyclohexyl), 1.45-1.05 (6H, m, 3-H, 4-H and 5-H); 
13C NMR (75 MHz, CDCl3): ʴppm 211.6 (C-1), 207.4 (C-8), 46.5 (C-7), 43.2 (C-6), 41.9 (C-
2), 34.1 (C-9), 30.5 (C-3), 27.7 (C-4), 25.4 (C-5); υmax (film/cm
-1) 1720 (C=O), 1715 (C=O).  Chapter 4 - Experimental section 
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2-(2-Hydroxy-2-methylpropyl)cyclohexanone oxime
88 (141) 
 
Representative procedure using Grignard reagent  
N
1-Cyclohexylidene-N
2,N
2-diethylethane-1,2-diamine (56) (5.00 g, 28.0 mmol) was dissolved 
in dry THF (20 mL). Ethylmagnesium bromide (17.5 mL, 3 M solution in THF) was added to 
the solution dropwise and the reaction mixture was heated at reflux. After 2 h, the solution 
was cooled to 0 °C, and 2,2-dimethyloxiran (4.00 mL, 45.0 mmol) was added. The resulting 
yellow solution was stirred at 0 °C for 1 h, then for 1 h at room temperature. The reaction 
mixture was quenched with saturated NaCl solution (20 mL) and extracted with Et2O (2 × 15 
mL).  The  combined  organic  layers  were  dried  (Na2SO4)  and  filtered.  The  solvent  was 
removed  under  reduced  pressure  to  give  a  brown  residue.  The  residue  was  treated  with 
petroleum ether (25 mL) and l M acetic acid (35 mL) for 2 h at room temperature. Saturated 
NaCl solution was added, the aqueous layer was re-extracted twice with Et2O (2 × 15 mL). 
The combined organic layers were washed with saturated NaHCO3 (25 mL), saturated NaCl 
solution (25 mL), dried over MgSO4 and filtered. The solvent was removed under reduced 
pressure  to  give  the  crude  product.  The  crude  product  was  purified  by  column 
chromatography eluted with EtOAc:Petrol (2:1), to obtain ketone 139 as a light brown oil 
(2.15 g, 43%). Hydroxylamine hydrochloride (0.40 g, 5.76 mmol) was added to a solution 
containing 139 (652 mg, 3.84 mmol), ethanol (15 mL) and pyridine (0.6 mL, 7.59 mmol). 
The mixture was refluxed for 2 h. The reaction mixture was quenched with water (15 mL) 
and then extracted with Et2O (2 x 15 mL). The combined organic extracts were washed with 
saturated NaCl solution (20 mL), dried over MgSO4 and filtered. The solvent was removed 
under reduced pressure to afford the crude oxime product as pale brown oil. Purification by 
column  chromatography  eluting  with  EtOAc:petrol  (4:1)  gave  the  title  compound  as  a 
colourless oil over two steps in a anti:syn ratio of 95:5 as determined by 
1H NMR (235 mg, 
36%).  Chapter 4 - Experimental section 
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Representative procedure using aza enolate methodology 
N
1-Cyclohexylidene-N
2,N
2-diethylethane-1,2-diamine (56) (100 mg, 0.6 mmol) was dissolved 
in dry THF (5 mL). The solution was cooled to 0 °C and Mg(ClO4)2 (0.12 g, 0.6 mmol) was 
added, followed by 2,2-dimethyloxiran (0.06 mL, 0.67 mmol) and Et3N (0.12 mL, 0.8 mmol). 
The resulting solution was stirred at 0 °C for 1 h, then for 12 h at room temperature. The 
reaction mixture was quenched with water (10 mL) then extracted with Et2O (2 × 10 mL). 
The combined organic extracts were washed with saturated NaCl solution (10 mL), dried 
(MgSO4) and filtered. The solvent was removed under reduced pressure to afford the crude 
product.  Hydroxylamine  hydrochloride  (100  mg,  1.32  mmol)  was  added  to  a  solution 
containing 139 (150 mg, 0.88 mmol), ethanol (5 mL) and pyridine (0.14 mL, 1.76 mmol). 
The mixture was refluxed for 2 h. The reaction mixture was quenched with water (15 mL) 
and then extracted with Et2O (2 x 15 mL). The combined organic extracts were washed with 
saturated NaCl solution (20 mL), dried over MgSO4 and filtered. The solvent was removed 
under reduced pressure to obtain the crude oxime product as pale brown oil. Purification by 
column  chromatography  eluting  with  EtOAc:Petrol  (1:1)  gave  the  title  compound  as  a 
mixture of geometric isomers as a colourless oil over two steps in a anti:syn ratio of 95:5 as 
determined by 
1H NMR (20 mg, 20%).  
 
1H NMR (500 MHz, CDCl3): ʴppm 3.37 (1H, ddd, J = 14.4, 4.3, 3.1 Hz, 2-Heq), 2.33 (1H, 
dddd, J = 12.2, 11.0, 4.6, 2.8 Hz, 6-H), 2.07 (1H, dd, J = 11.0, 10.9 Hz, 7-H), 1.83-1.79 (1H, 
m, 3-Heq), 1.77-1.73 (1H, m, 4-Heq), 1.73-1.69 (1H, m, 5-Heq), 1.63 (1H, ddd, J = 14.4, 13.1, 
5.2 Hz, 2-Hax), 1.47-1.43 (1H, m, 4-Hax), 1.42 (1H, dd, J = 10.9, 2.8 Hz, 7`-H), 1.34-1.29 
(1H, m, 3-Hax), 1.28-1.22 (1H, m, 5-Hax), 1.22 (3H, s, 9-H), 1.14 (3H, s, 9`-H); 
13C NMR 
(125 MHz, CDCl3): ʴppm 162.0 (C-1), 69.6 (C-8), 46.5 (C-7), 40.1 (C-6), 36.1 (C-5), 32.1 (C-
9), 27.7 (C-3), 26.0 (C-2), 25.7 (C-4); LRMS (ES
+): 208 (100 %, [M+Na]
+); HRMS (ES
+) 
observed [M+Na]
+): 208.1313; C10H19NO2Na requires 208.1313; υmax (film/cm
-1) 3225 (O-
H), 2900 (C-H), 1670 (C=N). 
 
 
 Chapter 4 - Experimental section 
 
 
126 
 
2-(2-Hydroxypropyl)cyclohexanone oxime (142) 
 
N
1-Cyclohexylidene-N
2,N
2-diethylethane-1,2-diamine (56) (5.00 g, 28.0 mmol) was dissolved 
in dry THF (20 mL). Ethylmagnesium bromide (17.50 ml, 3 M solution in THF) was added 
to the solution dropwise and the reaction mixture was heated at reflux. After 2 h, the solution 
was  cooled to  0 °C,  and 2,2-dimethyloxiran (4 mL, 45 mmol) was  added. The resulting 
yellow solution was stirred at 0 °C for 1 h, then for 1 h at room temperature. The reaction 
mixture was quenched with saturated NaCl solution (20 mL) and extracted with Et2O (2 × 15 
mL).  The  combined  organic  layers  were  dried  (Na2SO4)  and  filtered.  The  solvent  was 
removed  under  reduced  pressure  to  give  a  brown  residue.  The  residue  was  treated  with 
petroleum ether (25 mL) and l M acetic acid (35 mL) for 2 h at room temperature. Saturated 
NaCl solution was added, the aqueous layer was extracted twice with Et2O (2 x 15 mL). The 
combined organic layers were washed with saturated NaHCO3 solution (25 mL), saturated 
NaCl solution (25 mL), dried over MgSO4 and filtered. The solvent was removed under 
reduced  pressure  to  give  the  crude  product.  The  crude  product  was  purified  by  column 
chromatography eluted with EtOAc:Petrol (2:1), to obtain ketone 132 as a brown oil (1.80 g, 
36%). Hydroxylamine hydrochloride (0.40 g, 5.76 mmol) was added to a solution containing 
132 (662 mg, 3.84 mmol), ethanol (15 mL) and pyridine (0.60 mL, 7.59 mmol). The mixture 
was  refluxed for 2 h. The reaction mixture was quenched with  water (15 mL) and then 
extracted with Et2O (2 × 15 mL). The combined organic extracts were washed with saturated 
NaCl solution (20 mL), dried over MgSO4 and filtered. The solvent was removed under 
reduced pressure to afford the crude oxime product as a brown oil. Purification by column 
chromatography eluting with EtOAc:Petrol (4:1) gave the title compound as a colourless oil 
over two steps in a anti:syn ratio of 67:33 as determined by 
1H NMR (159 mg, 24%).  
   
1H NMR (500 MHz, CDCl3): ʴppm 4.33-4.28 (1H, m, 8-H), 3.41 (1H, ddd, J = 14.2, 5.1, 4.1 
Hz, 2-Heq), 2.34 (1H, dddd, J = 12.4, 10.7, 9.1, 6.9 Hz, 6-H), 2.30 (1H, ddd, J = 10.7, 8.9, 7.8 
Hz, 7-H), 1.93-1.90 (1H, m, 3-Heq), 1.80-1.77 (1H, m, 4-Heq), 1.75-1.70 (1H, m, 5-Heq), 1.69-
1.60 (1H, m, 2-Hax), 1.49-1.45 (1H, m, 4-Hax), 1.42 (1H, ddd, J = 9.1, 7.8, 6.6 Hz, 7`-H), 
1.37-1.34 (1H, m, 3-Hax), 1.30-1.27 (1H, m, 5-Hax), 1.22 (3H, d, J = 6.9 Hz, 9-H); 
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(125 MHz, CDCl3): ʴppm 162.6 (C-1), 66.7 (C-8), 40.1 (C-6), 37.2 (C-7), 34.5 (C-5), 26.6 (C-
3), 26.0 (C-4), 25.1 (C-2), 23.5 (C-9); υmax (film/cm
-1) 3223 (O-H), 2900 (C-H), 1670 (C=N). 
 
2-(2-Hydroxyethyl)cyclohexanone (144)  
 
Procedure 1 
N-Cyclohexylidenecyclohexanamine (25) (0.50 g, 2.8 mmol) was added to MeCN (10 mL), 
followed by Mg(ClO4)2 (0.74 g, 3.3 mmol) and DIPEA (1.16 mL, 8.3 mmol). The mixture 
was stirred at −45 °C for 1 h, followed by the addition of a solution of 1,3,2-dioxathiolane 
2,2-dioxide (0.50 g, 2.8 mmol) in MeCN (10 mL). The mixture was stirred for 1 h at −45 °C, 
then allowed to warm to room temperature over 12 h. The reaction mixture was treated with 
1M  AcOH  (6  mL)  and  stirred  for  1  h  at  room  temperature.  The  reaction  mixture  was 
quenched with water (10 mL) and then extracted with Et2O (2 × 20 mL). The combined 
organic extracts were washed with saturated NaCl solution (15 mL), dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to obtain the crude product as a 
yellow oil. Purification by column chromatography eluting with petrol:Et2O (4:1), gave the 
title compound as a pale yellow oil (9 mg, 18%).  
 
Procedure 2 
N-Cyclohexylidenecyclohexanamine (25) (0.50 g, 2.8 mmol) was added to MeCN (10 mL), 
followed by Mg(ClO4)2 (0.74 g, 3.3 mmol) and Et3N (1.16 mL, 8.3 mmol). The mixture was 
stirred at −45 °C for 1 h, followed by the addition of a solution of 1,3,2-dioxathiolane 2,2-
dioxide (0.50 g, 2.77 mmol) in MeCN (10 mL). The mixture was stirred for 1 h at −45 °C, 
then allowed to warm to room temperature over 12 h. The reaction mixture was treated with 
1M  AcOH  (6  mL)  and  stirred  for  1  h  at  room  temperature.  The  reaction  mixture  was 
quenched with water (10 mL) and then extracted with Et2O (2 × 20 mL). The combined 
organic extracts were washed with saturated NaCl solution (15 mL), dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to obtain the crude product as a 
yellow oil. Purification by column chromatography eluting with petrol:Et2O (4:1), gave the 
title compound as a pale yellow oil (155 mg, 31%).  
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Data in agreement with the literature
87,206 
1H NMR (300 MHz, CDCl3): ʴppm 4.60 (1H, s, OH), 3.60-3.40 (2H, m, 8-H), 3.00 (1H, td, J = 
7.4, 4.4 Hz, 6-H), 2.21 (2H, dd, J = 6.5, 4.4 Hz, 4-H), 2.10-2.01 (2H, m, 7-H), 1.97-1.85 (2H, 
m, 2-H), 1.71-1.55 (4H, m, 3-H and 5-H); 
13C NMR (75 MHz, CDCl3): ʴppm 212.5 (C-1), 54.6 
(C-8), 42.9 (C-6), 41.8 (C-2), 26.9 (C-5), 24.7 (C-7), 24.2 (C-3), 17.6 (C-4); LRMS (EI): 142 
(100%, [M-H]
+•); HRMS (EI) observed ([M-H]
+•): 141.09174; C8H13O2 requires 141.09109; 
υmax (film/cm
-1) 3429 (O-H), 2943 (C-H), 1738 (C=O).  
 
5-Hydroxypentan-2-one (145) 
 
Procedure 1 
1,3,2-Dioxathiolane  2,2-dioxide  (1.00  g,  8.1  mmol)  was  added  to  a  stirred  solution  of 
DMSO:acetone  (4:1,  5  mL)  followed  by  N,N-diethylethylenediamine  (82  µL,  0.8  mmol), 
acetone (5.92 mL, 80.6 mmol), Mg(ClO4)2 (0.36 g, 1.61 mmol), and Et3N (0.22 mL, 1.6 
mmol). The mixture was stirred for 12 h at room temperature. The reaction mixture was 
quenched with water (10 mL) and then extracted with Et2O (2 × 10 mL). The combined 
organic extracts were washed with saturated NaCl solution (15 mL), dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to obtain the crude product as 
yellow oil. Purification by column chromatography eluting with petrol:Et2O (4:1) gave the 
title compound as a colourless oil (290 mg, 29%).  
 
Procedure 2 
1,3,2-Dioxathiolane  2,2-dioxide  (1.00  g,  8.1  mmol)  was  added  to  a  stirred  solution  of 
DMSO:acetone (4:1, 5 mL) followed by n-butylamine (80 µL, 0.8 mmol), acetone (5.92 mL, 
80.6 mmol), Mg(ClO4)2 (0.36 g, 1.6 mmol), and Et3N (0.22 mL, 1.6 mmol). The mixture was 
stirred for 12 h at room temperature. The reaction mixture was quenched with water (10 mL) 
and then extracted with Et2O (2 × 10 mL). The combined organic extracts were washed with 
saturated NaCl solution (15 mL), dried over MgSO4 and filtered. The solvent was removed 
under reduced pressure to obtain the crude product as yellow oil. Purification by column 
chromatography eluting with petrol:Et2O (4:1) gave the title compound as a colourless oil 
(210 mg, 21%).  
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Data in agreement with the literature
207   
1H NMR (500 MHz, CDCl3): ʴppm 3.51 (2H, t, J = 6.2 Hz, 5-H), 2.46 (2H, t, J = 6.9 Hz, 3-H), 
2.12 (3H, s, 1-H), 1.79 (2H, tt, J = 6.9, 6.2 Hz, 4-H); 
13C NMR (125 MHz, CDCl3): ʴppm 
207.0 (C-2), 68.8 (C-5), 47.2 (C-3), 30.9 (C-1), 25.4 (C-4); LRMS (EI): 102 (100%, [M]
+•); 
HRMS (EI) observed ([M]
+•): 102.06770; C5H10O2 requires 102.06808; υmax (film/cm
-1) 3459 
(O-H), 2971 (C-H), 1740 (C=O).  
 
Oct-7-en-1-ol
208,209 (167). 
 
BH3.THF solution (1M, 71.50 mL, 65 mmol) was added drop-wise over 30 minutes to a 
stirred solution of octadiene (27 mL, 181 mmol). The solution was left to stir for 1 h at room 
temperature. A solution of 30% H2O2 (42.6 mL, 1810 mmol) in 1M NaOH (70 mL, 1810 
mmol) was added drop-wise to the solution and left to stir for 12 h. The reaction mixture was 
quenched with water (50 mL) and then extracted with Et2O (2 × 50 mL). The combined 
organic extracts were washed with saturated NaCl solution (60 mL), dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to obtain the crude product as a 
colourless oil (9.8 g). Purification by column chromatography eluting with petrol:Et2O (5:1) 
gave the title compound as a colourless oil (8.87 g, 33%).  
 
1H NMR (300 MHz, CDCl3): ʴppm 5.77 (1H, ddt, J = 17.1, 10.2, 6.6 Hz, 2-H), 4.99 (1H, ddt, J 
= 17.1, 2.2, 1.2 Hz, 1-Htrans), 4.93 (1H, ddt, J = 10.2, 2.0, 1.1 Hz, 1-Hcis), 3.75 (2H, t, J = 7.0 
Hz, 8-H), 3.45 (2H, apparent q, J = 7.0 Hz, 3-H), 2.17, (1H, s, O-H), 1.57 (2H, quint, J = 7.0 
Hz, 7-H), 1.36-1.23 (6H, m, 3-H and 5-H); 
13C NMR (75 MHz, CDCl3): ʴppm 139.0 (C-2), 
114.2 (C-1), 62.6 (C-8), 34.8 (C-3), 33.7 (C-7), 28.9 (C-4, C-5 and C-6); LRMS (CI): 129 
(100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 129.12807; C8H17O requires 129.12793; 
υmax (film/cm
-1) 3400 (O-H), 1640 (C=C). 
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2-Allylcyclohexanone
156 (173) 
 
2-Cyclohexylidene-1,1-dimethylhydrazine (168) (2.45 mL, 15.7 mmol) was dissolved in dry 
THF (20 mL) under argon at room temperature. The solution was then cooled to 0 °C, n-BuLi 
(12 mL, 19.2 mmol) was added over 20 min and the mixture was then stirred for 45 min at 0 
°C.  1-Bromoprop-2-ene  (1.72  mL,  19.5  mmol)  was  added  to  the  mixture,  and  then  the 
solution was warmed to room temperature and stirred for 3 h. The reaction mixture was 
quenched with water (20 mL), stirred for 15 min, and then extracted with EtOAc (2 × 30 mL). 
The combined organic extracts were washed with saturated NaCl solution (25 mL), dried 
over MgSO4 and filtered. The solvent was removed under reduced pressure and the residue 
was treated with acetone (20 mL) and wet amberlyst®-15 (2.00 g) and stirred for 12 h at 
room temperature. Amberlyst®-15 was removed by filtration through Celite®, acetone (15 
mL) was added to the reaction mixture. The organic solvent was removed under reduced 
pressure. The residue was partitioned and the aqueous layer was extracted with CH2Cl2 (3 × 
30 mL). The combined organic extracts were washed with saturated NaCl solution (25 mL), 
dried over MgSO4 and filtered. The solvent was removed under reduced pressure to obtain 
the crude product.  Purification by  column  chromatography eluting with petrol:Et2O (2:1) 
gave the title compound as a brown oil (1.32 g, 60%).  
 
1H NMR (500 MHz, CDCl3): ʴppm 5.73 (1H, dddd, J = 17.9, 10.1, 3.7, 1.2 Hz, 8-H), 5.01-4.93 
(2H, m, 9-H), 2.53-2.48 (1H, m, 6-H), 2.38-2.32 (2H, m, 7-H), 2.10-1.80 (8H, complex m, 2-
H, 3-H, 4-H and 5-H); 
13C NMR (125 MHz, CDCl3): ʴppm 212.5 (C-1), 136.4 (C-8), 116.1 (C-
9), 50.2 (C-6), 42.0 (C-2), 33.8 (C-4), 27.9 (C-3), 25.0 (C-5 and C-7); LRMS (EI): 138 
(100%, [M]
+•); HRMS (EI) observed ([M]
+•): 138.10357; C9H14O requires 138.10392; υmax 
(film/cm
-1) 2930 (C-H), 1740 (C=O). 
 Chapter 4 - Experimental section 
 
 
131 
 
2-(But-3-en-1-yl)cyclohexanone
156 (174) 
 
2-Cyclohexylidene-1,1-dimethylhydrazine (168) (2.20 mL, 15.7 mmol) was dissolved in dry 
THF (20 mL) under argon at room temperature. The flask was then cooled to 0 °C, 
nBuLi (12 
mL, 19.2 mmol) was added over 20 min and the mixture was then stirred for 45 min at 0 °C. 
4-Bromobut-1-ene (1.72 mL, 19.5 mmol) was then added to the mixture and the solution was 
warmed to room temperature and stirred for 3 h. The reaction mixture was quenched with 
water (20 mL), stirred for 15 min, and then extracted with EtOAc (2 × 30 mL). The combined 
organic extracts were washed with saturated NaCl solution (25 mL), dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure and the residue was treated with 
acetone (20 mL) and wet amberlsyt®-15 (2 g) and stirred for 12 h at room temperature. 
Amberlyst®-15 was removed by filtration through Celite® and the solution was washed with 
acetone (15 mL). The organic solvent was removed under reduced pressure. The residue was 
partitioned and the aqueous layer was extracted with CH2Cl2 (3 × 30 mL). The combined 
organic extracts were washed with saturated NaCl solution (25 mL), dried over MgSO4 and 
filtered.  The  solvent  was  removed  under  reduced  pressure  to  obtain  the  crude  product. 
Purification  by  column  chromatography  eluting  with  petrol:Et2O  (2:1)  gave  the  title 
compound as a brown oil (1.3 g, 59%).  
 
1H NMR (400 MHz, CDCl3): ʴppm 5.80 (1H, ddt, J = 17.4, 10.4, 6.5 Hz, 9-H), 5.02-4.80 (2H, 
m, 10-H), 2.80-2.70 (1H, m, 6-H), 2.30-1.33 (12H, m, 2-H, 3-H, 4-H, 5-H, 7-H and 8-H); 
13C 
NMR (125 MHz, CDCl3): ʴppm 213.2 (C-1), 138.5 (C-9), 114.7 (C-10), 49.8 (C-6), 42.1 (C-
2),  33.9  (C-5),  31.2  (C-8),  28.5  (C-7),  28.0  (C-3),  24.9  (C-4).  LRMS  (CI):  153  (100%, 
[M+H]
+);  HRMS  (CI)  observed  ([M+H]
+):  153.12831;  C10H17O  requires  153.12794;  υmax 
(film/cm
-1) 2933 (C-H), 1710 (C=O), 1640 (C=C). 
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2-(But-3-enyl)cyclopentanone
210 (175) 
 
2-Cyclopentylidene-1,1-dimethylhydrazine (168) (5 mL, 39 mmol) was dissolved in dry THF 
(35 mL) under argon at room temperature. The solution was then cooled to 0 °C, 
nBuLi (2.49 
mL, 39 mmol) was added over 25 min and the mixture was then stirred for 45 min at 0 °C. 4-
Bromobut-1-ene (4.75 mL, 47 mmol) was then added to the mixture and the solution was 
warmed to room temperature and stirred for 3 h. The reaction mixture was quenched with 
water (25 mL), stirred for 15 min, and then extracted with EtOAc (3 × 20 mL). The combined 
organic extracts were washed with saturated NaCl solution (25 mL), dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure and the residue was treated with 
acetone (20 mL) and wet amberlyst®-15 (1.5 g) and stirred for 12 h at room temperature. 
Amberlyst®-15 was removed by filtration through Celite® and the solution was washed with 
acetone (15 mL). The organic solvent was removed under reduced pressure. The residue was 
partitioned and the aqueous layer was extracted with CH2Cl2 (3 × 30 mL). The combined 
organic extracts were washed with saturated NaCl solution (25 mL), dried over MgSO4 and 
filtered.  The  solvent  was  removed  under  reduced  pressure  to  obtain  the  crude  product. 
Purification  by  column  chromatography  eluting  with  petrol:Et2O  (4:1)  gave  the  title 
compound as a colourless oil (2.7 g, 54%).  
 
1H NMR (300 MHz, CDCl3): ʴppm 5.76 (1H, ddt, J = 16.9, 10.4, 6.7 Hz, 8-H), 5.05-4.90 (2H, 
m, 9-H), 2.33-1.95 (7H, m, 2-H, 3-H, 4-H and 5-H), 1.92-1.65 (2H, m, 7-H), 1.65-1.22 (2H, 
m, 6-H); 
13C NMR (75 MHz, CDCl3): ʴppm 220.5 (C-1), 136.0 (C-8), 115.1 (C-9), 48.5 (C-5), 
38.2 (C-2), 31.6 (C-7), 30.0 (C-4), 28.8 (C-6), 20.7 (C-3); υmax (film/cm
-1) 2927 (C-H), 1740 
(C=O), 1702 (C=C).  
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7-(2-(Oxiran-2-yl)ethyl)oxepan-2-one (176) 
 
2-(But-3-enyl)cyclopentanone (175) (0.20 mL, 1.3 mmol) was dissolved in CH2Cl2 (10 mL) 
and stirred for 5  min at 0 °C. m-CPBA (0.24 g, 1.4 mmol) was added in several portions at 0 
°C over 20 min and the reaction was allowed to warm up to room temperature, then stirred 
for 12 h at this temperature. The reaction mixture was quenched with saturated Na2S2O3 (2 
mL) and stirred for 1 h at room temperature. The mixture was extracted with EtOAc (3 × 15 
mL) and washed with saturated NaHCO3 solution (20 mL). The combined organic extracts 
were dried over MgSO4, filtered, and then concentrated under reduced pressure to give the 
crude product. Purification by column chromatography eluting with petrol:Et2O (4:1) gave 
the title compound as a colourless oil and as a mixture of diastereomers (58 mg, 29%). 
 
1H NMR (600 MHz, CDCl3): ʴppm 4.25 (1H, dddd, J = 12.6, 10.1, 7.9, 4.1 Hz, 6-H), 2.87-2.81 
(1H, m, 9-H), 2.66 (1H, dd, J = 9.6, 4.3 Hz, 10-H), 2.59-2.51 (2H, m, 2-H), 2.39 (1H, dd, J = 
11.1, 4.3 Hz, 10-H), 1.88-1.81 (2H, m, 7-H), 1.80-1.73 (6H, m, 3-H, 4-H and 5-H), 1.71-1.65 
(1H, m, 8-H), 1.64-1.59 (1H, m, 8-H); 
13C NMR (150 MHz, CDCl3): ʴppm 175.7 (C-1), 79.7 
(C-6), 52.2 (C-9), 47.0 (C-10), 34.5 (C-2 and C-5), 33.2 (C-7), 32.4 (C-4), 28.7 (C-8), 23.0 
(C-3);  LRMS  (EI):  183  (100%,  [M-H]
+•);  HRMS  (EI)  observed  ([M-H]
+•):  183.10213; 
C10H15O3 requires 183.10157; υmax (film/cm
-1) 1750 (CO-O), 1230 (epoxide). 
 
2-Allylcyclohexanol
163 (180) 
 
2-Allylcyclohexanone (173) (1.50 g, 11 mmol) was dissolved in a solution of MeOH/THF 
(1:1, 10 mL/10 mL) and cooled to 0 °C. NaBH4 (0.45 g, 12 mmol) was added portion wise 
over 20 min, the resulting solution was stirred at 0 °C for 20 min and allowed to warm up to 
room  temperature,  then  stirred  for  12  h  at  room  temperature.  The  reaction  mixture  was 
quenched with water (25 mL) and extracted with EtOAc (3 × 15 mL). The combined organic 
extracts were washed with saturated NaCl solution (25 mL), dried over MgSO4 and filtered. Chapter 4 - Experimental section 
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The solvent was removed under reduced pressure to obtain the product as a colourless oil in a 
quantitative yield. 
 
1H NMR (500 MHz, CDCl3): ʴppm 5.89-5.77 (1H, m, 8-H), 5.07-4.99 (2H, m, 9-H), 3.91 (1H, 
s, OH), 3.28-3.24 (1H, m, 1-H), 2.45 (1H, dd, J = 13.7, 6.2 Hz, 7-H), 2.19 (1H, dt, J = 14.1, 
13.7 Hz, 7-H), 2.08-1.94 (3H, complex m, 6-H and cyclohexyl), 1.83-1.25 (6H, complex m, 
cyclohexyl); 
13C NMR (125 MHz, CDCl3): ʴppm 137.7 (C-8), 116.2 (C-9), 74.8 (C-1), 45.0 
(C-6), 41.3 (C-2), 37.3 (C-7), 26.5 (C-3), 25.6 (C-5), 25.0 (C-4); LRMS (CI): 123 (100%, 
[M-OH]
+);  HRMS  (CI)  observed  ([M-OH]
+):  123.11616;  C9H15  requires  123.11683;  υmax 
(film/cm
-1) 3377 (O-H), 3000 (C-H), 1640 (C=C). 
 
Octahydrobenzofuran-2-yl methanol (182) 
 
Procedure 1 
2-Allylcyclohexanol (180) (1.00 g, 7.2 mmol) was added to CH2Cl2 (20 mL) and cooled to 0 
°C.  m-CPBA  (1.74  g,  10  mmol)  was  added  portion  wise  over  20  min  and  the  resulting 
solution  was  stirred  at  0  °C  for  2  h.  The  solution  was  allowed  to  warm  up  to  room 
temperature, then stirred for 12 h at room temperature. The reaction mixture was cooled to 0 
°C and quenched with aqueous Na2SO3 (20 mL) and saturated NaHCO3 solution (20 mL). 
The reaction mixture was extracted with CH2Cl2 (3 × 15 mL). The combined organic extracts 
were dried over MgSO4 and filtered, then concentrated under reduced pressure to give the 
crude  product  as  a  colourless  oil.  Purification  by  column  chromatography  eluting  with 
petrol:Et2O  (2:1)  gave  the  title  compound  as  a  colourless  oil  and  as  a  mixture  of 
diastereomers but was not isolated pure as there is an additional unidentified product (66:34) 
(850 mg, 85%).  
 
Procedure 2  
2-Allylcyclohexanol (180) (240 mg, 1.7 mmol) was dissolved in a 1:1 mixture of CH2Cl2 (5 
mL)  and  1M  NaHCO3  solutiin  (5  mL).  The  resulting  solution  was  cooled  to  0  °C  and           
m-CPBA (330 mg, 1.9 mmol) was added portion wise over 20 min, the resulting solution was 
stirred at 0 °C for 2 h and allowed to warm up to room temperature, then stirred for 12 h. The Chapter 4 - Experimental section 
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reaction mixture was cooled to 0 °C and quenched with aqueous H2O (20 mL) and extracted 
with Et2O (2 × 15 mL). The combined organic extracts were dried over MgSO4 and then 
concentrated under reduced pressure to give the crude product as a mixture of diastereomers 
(66:34) (168 mg, 70%), which was compared to the product from procedure 1.  
 
Data in agreement with the literature
162,163 
1H NMR (500 MHz, CDCl3): ʴppm (major diastereomer) 4.22 (1H, dddd, J = 11.7, 7.5, 5.1, 
4.5 Hz, 6-H), 3.68 (1H, dd, J = 11.7, 3.9 Hz, 7-H), 3.64 (1H, dd, J = 4.5, 3.9 Hz, 7-H), 2.10-
1.95 (1H, m, 4-H), 1.92-1.85 (1H, m, 1-H), 1.75 (2H, dd, J = 7.5, 4.2 Hz, 5-H), 1.70-1.35 
(5H, m, 2-H and O-H), 1.34-1.12 (4H, m, 3-H); 
13C NMR (125 MHz, CDCl3): ʴppm 78.0 (C-
4), 77.9 (C-6), 66.0 (C-7), 38.2 (C-1), 34.2 (C-5), 28.2 (C-2), 27.7 (C-2), 24.1 (C-3), 20.6 (C-
3); 
1H NMR (500 MHz, CDCl3): ʴppm (minor diastereomer) 4.14 (1H, dddd, J = 9.0, 6.8, 4.1, 
3.0 Hz, 6-H), 3.93 (1H, dd, J = 9.0, 3.9 Hz, 7-H), 3.85-3.80 (1H, m, 7-H), 3.10-2.99 (1H, m, 
4-H), 2.10-2.40 (1H, m, 1-H), 1.81-1.75 (2H, m, 5-H), 1.70-1.35 (4H, m, 2-H), 1.34-1.12 
(4H, m, 3-H); 
13C NMR (125 MHz, CDCl3): ʴppm 82.6 (C-4), 79.0 (C-6), 65.6 (C-7), 45.9 (C-
1),  33.2  (C-5),  31.3  (C-2),  29.0  (C-2),  25.7  (C-3),  24.4  (C-3);  LRMS  (CI):  157  (100%, 
[M+H]
+); HRMS (CI) observed ([M+H]
+): 157.12241; C9H17O2 requires 157.12285;. υmax 
(film/cm
-1) 3412 (O-H), 2928 (C-H), 1055 (C-O).  
 
Octahydrobenzofuran-2-carbaldehyde (183) 
 
Procedure 1 
DMSO (1.21 mL, 17.1 mmol) was added to dry CH2Cl2 (25 mL), followed by dropwise 
addition of oxalyl chloride (0.36 mL, 8.6 mmol) at -78 °C under argon. The mixture was 
stirred at −78 °C for 20 min. Octahydrobenzofuran-2-yl methanol (182) (1 g, 6.6 mmol) was 
added dropwise over 15 min, followed by 20 min stirring at -78 °C. Triethylamine (4.6 mL, 
33 mmol) was added dropwise over 10 min at −78 °C. The mixture was allowed to warm to 
room temperature for 12 h. The reaction mixture was quenched with water (20 mL), stirred 
for 15 min, and extracted with CH2Cl2 (3 × 15 mL). The combined organic extracts were Chapter 4 - Experimental section 
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washed with saturated NaCl solution (25 mL), dried over MgSO4 and filtered. The solvent 
was removed under reduced pressure to give the crude product as a mixture of diastereomers 
but  was  not  isolated  pure  as  there  is  an  additional  unidentified  product  (500  mg,  50%) 
(66:34).   
 
Procedure 2 
Dry CH2Cl2 (25 mL) was added to activated molecular sieves (4 Å). Octahydrobenzofuran-2-
yl methanol (182) (0.05 g, 0.3 mmol) was added to the mixture followed by pyridinium 
chlorochromate (0.17 g, 0.8 mmol) portion wise over 10 min. The mixture was stirred for 12 
h at room temperature. The reaction mixture was diluted with Et2O (10 mL) with vigorous 
stirring  of  the  reaction  mixture.  The  mixture  was  filtered  through  a  pad  of  Celite®  and 
washed with Et2O (3 × 15 mL). The solvent was removed under reduced pressure to give the 
crude product. Purification by column chromatography eluting with petrol:Et2O (4:1) gave 
the title compound as a colourless oil and a mixture of diastereomers but was not isolated 
pure as there is an additional unidentified product (15 mg, 30%) (66:34). 
 
Data in agreement with the literature
163 
1H NMR (500 MHz, CDCl3): ʴppm (major diastereomer) 9.71 (1H, s, 9-H), 4.35 (1H, dd, J = 
10.7, 8.8 Hz, 8-H), 3.21 (1H, dd, J = 10.7, 3.9 Hz, 1-H), 2.22-2.15 (2H, m, 7-H), 2.13-1.90 
(4H, complex m, 6-H and cyclohexyl), 1.60-1.00 (5H, complex m, cyclohexyl); 
13C NMR 
(125 MHz, CDCl3): ʴppm 204.0 (C-9), 94.9 (C-1), 91.9 (C-8), 46.8 (C-6), 34.3 (C-7 or C-2), 
31.8 (C-7 or C-2), 29.6 (C-5), 27.8 (C-4), 24.4 (C-3). 
1H NMR (500 MHz, CDCl3): ʴppm 
(minor diastereomer) 9.68 (1H, s, 9-H), 4.42 (1H, d, J = 8.3 Hz, 8-H), 3.16 (1H, dd, J = 10.6, 
3.9, Hz, 1-H), 2.00-1.70 (6H, complex m, 6-H, 7-H and cyclohexyl), 1.5-0.8 (5H, complex m, 
cyclohexyl); 
13C NMR (125 MHz, CDCl3): ʴppm 202.0 (C-9), 85.0 (C-1), 81.6 (C-8), 45.5 (C-
6), 32.3 (C-7 or C-2), 31.2 (C-7 or C-2), 29.2 (C-5), 26.8 (C-4), 24.3 (C-3); LRMS (EI): 154 
(100 %, [M]
+•); HRMS (EI) observed ([M]
+•): 154.09812; C9H14O2 requires 154.09883; υmax 
(film/cm
-1) 2933 (C-H), 1715 (C=O), 1058 (C-O).  
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1-(2-Bromophenyl)ethanol
211 (187) 
 
2-bromoacetophenone (5.00 g, 25 mmol) was dissolved in a solution of MeOH:THF (1:1, 10 
mL) and cooled to 0 °C. NaBH4 (1.04 g, 28 mmol) was added portion wise over 20 min and 
the  resulting  solution  was  stirred  at  0  °C  for  20  min  and  allowed  to  warm  up  to  room 
temperature, then stirred for 12 h at room temperature. The reaction mixture was quenched 
with water (20 mL) and extracted with EtOAc (3 x 15 mL). The combined organic extracts 
were washed with saturated NaCl solution (15 mL), dried over MgSO4 and filtered. The 
solvent was removed under reduced pressure to obtain the product as a colourless oil in a 
quantitative yield. 
 
1H NMR (500 MHz, CDCl3 ʴppm 7.55 (1H, d, J = 7.8 Hz, 5-H), 7.49 (1H, d, J = 7.9 Hz, 4-H), 
7.31 (1H, d, J = 7.6 Hz, 2-H), 7.11 (1H, J = 7.6 Hz, 3-H), 5.19 (1H, dq, J = 6.4, 3.2 Hz, 7-H), 
2.78 (1H, d, J = 3.2 Hz, OH), 1.43 (3H, d, J = 6.4 Hz, 8-H); 
13C NMR (125 MHz, CDCl3): 
ʴppm 144.8 (C-1), 132.7 (C-5), 128.9 (C-4), 128.0 (C-3), 126.8 (C-2), 121.7 (C-6), 69.2 (C-7), 
23.7  (C-8);  LRMS  (EI):  199  (100%,  [M]
+•);  HRMS  (EI)  observed  ([M]
+•):  199.98362; 
C8H9OBr requires 199.98313; υmax (film/cm
-1) 3331 (O-H), 740 (C-Br). 
 
2-(Chloromethyl)-4-cyclohexyl-1-oxa-4-azaspiro[4.5]decane (193)  
 
Procedure 1 
N-Cyclohexylidenecyclohexanamine (25) (0.20 g, 1.1 mmol) was added to dry THF (7 mL). 
Ethylmagnesium bromide (0.17 mL, 3M solution in Et2O) was added to the solution dropwise 
and heated at reflux. After 2 h, the solution was cooled to 0 °C; chloromethyloxirane (0.16 
mL, 1.5 mmol) was added. The resulting colourless solution was stirred at 0 °C for 1 h, then 
for 12 h at room temperature. The reaction mixture was quenched with water (20 mL) and 
extracted with Et2O (20 mL). The combined organic extracts were washed with saturated Chapter 4 - Experimental section 
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NaCl solution (25 mL), dried (MgSO4) and filtered. The solvent was removed under reduced 
pressure to give a colourless residue. The residue was stirred with petrol (20 mL) and lM 
acetic acid (25 mL) for 2 h at room temperature. NaCl was added to saturate the aqueous 
layer, the layers were separated, and the aqueous layer was extracted with ether (2 × 20 mL). 
The combined organic layers were washed with saturated NaHCO3 (20 mL), saturated NaCl 
solution (20 mL), and were dried over MgSO4 and concentrated under reduced pressure to 
give the crude product. Purification by column chromatography eluting with petrol:Et2O (2:1) 
gave the title compound as a colourless oil (170 mg, 85%).  
 
Procedure 2 
Cyclohexylamine  (0.23  mL,  2.0  mmol)  was  added  to  THF  (4  mL),  followed  by 
cyclohexanone (0.21 mL, 2.0 mmol), Mg(ClO4)2 (0.46 g, 2.0 mmol), chloromethyloxirane 
(0.16 mL, 2.0 mmol) and Et3N (0.28 mL, 2.0 mmol). The mixture was stirred for 12 h at 
room temperature. The reaction mixture was quenched with water (10 mL) and then extracted 
with Et2O (2 × 15 mL). The combined organic extracts were washed with saturated NaCl 
solution (15 mL), dried over MgSO4 and filtered. The solvent was removed under reduced 
pressure  to  obtain  the  crude  product  as  a  pale  yellow  oil.  Purification  by  column 
chromatography eluting with petrol:EtOAc:MeOH (20:5:1) gave the title compound as a pale 
yellow oil (46 mg, 20%).  
 
1H NMR (600 MHz, CDCl3): ʴppm 4.08 (1H, dddd, J = 12.7, 9.6, 7.7, 5.0 Hz, 10-H), 3.56 (1H, 
dd, J = 9.6, 7.1 Hz, 11-H), 3.30 (1H, dd, J = 12.7, 7.1 Hz, 11-H), 3.22 (1H, dd, J = 7.7, 6.8 
Hz, 9-H), 2.95 (1H, dd, J = 6.8, 5.0 Hz, 9-H), 2.56-2.50 (1H, m, 8-H), 1.77-1.72 (5H, m, 
cyclohexyl), 1.64-1.55 (7H, m, cyclohexyl), 1.49-1.44 (2H, m, cyclohexyl), 1.35-1.20 (6H, 
m, cyclohexyl); 
13C NMR (125 MHz, CDCl3): ʴppm 96.8 (C-1), 74.7 (C-10), 54.3 (C-8), 47.9 
(C-9), 36.8 (C-11), 33.8 (C-5), 33.7 (C-5), 32.7 (2 × C-2), 26.4 (C-4 or C-7), 26.1 (C-4 or C-
7), 25.6 (2 × C-6), 23.7 (C-3), 23.6 (C-3); LRMS (CI): 272 (100%, [M+H]
+); HRMS (CI) 
observed ([M+H]
+): 272.17844; C15H27ONCl requires 272.17812; υmax (film/cm
-1) 2930 (C-
H), 1092 (C-O).  
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2-(Bromomethyl)-4-cyclohexyl-1-oxa-4-azaspiro[4.5]decane (194) 
 
N-Cyclohexylidenecyclohexanamine (25) (0.20 g, 1.1 mmol) was added to dry THF (7 mL). 
Ethylmagnesium bromide (0.17 ml, 3M solution in Et2O) was added to the solution dropwise 
and heated at reflux. After 2 h, the solution was cooled to 0 °C; bromomethyloxirane (0.13 
mL, 1.5 mmol) was added. The resulting colourless solution was stirred at 0 °C for 1 h, then 
for 12 h at room temperature. The reaction mixture was quenched with water (20 mL) and 
extracted with Et2O (2 × 20 mL). The combined organic extracts were washed with saturated 
NaCl solution (25 mL), dried (MgSO4) and filtered. The solvent was removed under reduced 
pressure to give a colourless residue. The residue was stirred with petrol (20 mL) and lM 
acetic acid (25 mL) for 2 h at room temperature. NaCl was added to saturate the aqueous 
layer, the layers were separated, and the aqueous layer was extracted with ether (2 × 20 mL). 
The combined organic layers were washed with saturated NaHCO3 (20 mL), saturated NaCl 
solution (20 mL), dried over MgSO4 and concentrated under reduced pressure to give the 
crude product. Purification by column chromatography eluting with petrol:Et2O (2:1) gave 
the title compound as a colourless oil (178 mg, 89%).  
 
1H NMR (600 MHz, CDCl3): ʴppm 4.12 (1H, dddd, J = 10.4, 9.5, 8.4, 7.1 Hz, 10-H), 3.43 (1H, 
dd, J = 9.5, 6.5 Hz, 11-H), 3.30 (1H, dd, J = 10.4, 6.5 Hz, 11-H), 3.25 (1H, dd, J = 8.4, 6.2 
Hz, 9-H), 2.94 (1H, dd, J = 7.1, 6.2 Hz, 9-H), 2.54-2.52 (1H, m, 8-H), 1.80-1.63 (5H, m, 
cyclohexyl), 1.61-1.48 (7H, m, cyclohexyl), 1.46-1.42 (2H, m, cyclohexyl), 1.28-1.22 (6H, 
m, cyclohexyl); 
13C NMR (125 MHz, CDCl3): ʴppm 97.1 (C-1), 74.8 (C-10), 54.3 (C-8), 48.7 
(C-9), 37.6 (C-11), 35.56 (C-5), 35.07 (C-2), 33.9 (C-4 and C-7), 33.7 (C-6), 32.8 (C-3); 
LRMS  (ES
+):  316  (
79Br,  100%,  [M]
+);  HRMS  (ES
+)  observed  (
79Br,  [M]
+):  316.1276; 
C15H27NO
79Br requires 316.1272; υmax (film/cm
-1) 2970 (C-H), 1092 (C-O). 
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2-(2-(Chloromethyl)-1-oxa-4-azaspiro[4.5]decan-4-yl)-N,N-diethylethanamine (205) 
 
Procedure 1 
N,N-Diethylethylenediamine (0.25 mL, 1.8 mmol) was added to MeCN (4 mL), followed by 
cyclohexanone (0.19 mL, 1.8 mmol), Mg(ClO4)2  (0.4 g, 1.8 mmol),  chloromethyloxirane 
(0.14 mL, 1.8 mmol) and Et3N (0.25 mL, 1.8  mmol). The mixture was stirred for 12 h at 
room temperature. The reaction mixture was quenched with water (10 mL) and then extracted 
with Et2O (2 × 15 mL). The combined organic extracts were washed with saturated NaCl 
solution  (15  mL),  dried  (MgSO4)  and  filtered.  The  solvent  was  removed  under  reduced 
pressure  to  obtain  the  crude  product  as  a  pale  yellow  oil.  Purification  by  column 
chromatography eluting with petrol:EtOAc:MeOH (20:5:1) gave the title compound as a pale 
yellow oil (89 mg, 47%).  
 
Procedure 2  
N,N-Diethylethylenediamine (0.25 mL, 1.8 mmol) was added to MeCN (4 mL), followed by 
cyclohexanone (0.19 mL, 1.8 mmol), Mg(ClO4)2  (0.4 g, 1.8 mmol),  chloromethyloxirane 
(0.14 mL, 1.8 mmol) and Et3N (0.25 mL, 1.8  mmol). The mixture was stirred for 12 h at 
room temperature. The reaction mixture was quenched with water (10 mL) and then extracted 
with Et2O (2 × 15 mL). The combined organic extracts were washed with saturated NaCl 
solution  (15  mL),  dried  (MgSO4)  and  filtered.  The  solvent  was  removed  under  reduced 
pressure  to  obtain  the  crude  product  as  a  pale  yellow  oil.  Purification  by  column 
chromatography eluting with petrol:EtOAc:MeOH (20:5:1) gave the title compound as a pale 
yellow oil (95 mg, 50%).  
 
1H NMR (600 MHz, CDCl3): ʴppm 4.20 (1H, dddd, J = 11.4, 9.8, 8.2, 4.9 Hz, 6-H), 3.57 (1H, 
dd, J = 9.8, 7.2 Hz, 7-H), 3.44 (1H, dd, J = 11.4, 7.2 Hz, 7-H), 3.07 (1H, dd, J = 8.2, 5.9 Hz, 
5-H), 2.95 (1H, dd, J = 5.9, 4.9 Hz, 5-H), 2.64-2.51 (8H, m, 8-H, 9-H and 2 × CH2CH3), 
1.65-1.50  (7H,  m,  cyclohexyl),  1.46-1.42  (2H,  m,  cyclohexyl),  1.36-1.29  (1H,  m, 
cyclohexyl), 1.03 (1H, t, J = 7.2 Hz, 2 × CH2CH3); 
13C NMR (125 MHz, CDCl3): ʴppm 96.9 Chapter 4 - Experimental section 
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(C-1), 74.7 (C-6), 53.4 (C-5), 52.8 (C-9), 47.6 (CH2CH3), 47.2 (C-8), 46.2 (C-7), 34.3 (C-2), 
31.7 (C-2), 25.7 (C-4), 23.4 (C-3), 23.3 (C-3), 11.8 (CH2CH3); LRMS (CI): 289 (100%, 
[M+H]
+);  HRMS  (CI)  observed  ([M+H]
+):  289.20410;  C15H30ON2Cl  requires  289.20467; 
υmax (film/cm
-1) 2970 (C-H), 1091 (C-O). 
 
1-(Cyclohexyl(2-(diethylamino)ethyl)amino)propan-2-ol (207) 
 
N,N-Diethylethylenediamine (0.29 mL, 2.0 mmol) was added to THF (4 mL), followed by 
cyclohexanone (0.21 mL, 2.0 mmol), Mg(ClO4)2 (0.46 g, 2.0 mmol), 2-methyloxirane (0.13 
mL, 2.0 mmol) and Et3N (0.28 mL, 2.0 mmol). The mixture was stirred for 12 h at room 
temperature. The reaction mixture was quenched with water (10 mL) and then extracted with 
Et2O (2 × 15 mL). The combined organic extracts were washed with saturated NaCl solution 
(15 mL), dried over MgSO4 and filtered. The solvent was removed under reduced pressure 
and MeOH:THF (1:1, 6 mL) was added followed by NaBH4 (0.13 g, 4.1 mmol). The mixture 
was stirred for 1.5 h at room temperature. The reaction mixture was quenched with water (10 
mL) and then extracted with Et2O (2 × 15 mL). The combined organic extracts were washed 
with saturated NaCl solution (15 mL), dried over MgSO4 and filtered. Purification by column 
chromatography eluting with petrol:EtOAc:MeOH (4:2:1) gave the title compound as a pale 
yellow oil (105 mg, 50%).  
 
1H NMR (600 MHz, CDCl3): ʴppm 4.08 (1H, s, OH), 3.70-3.64 (1H, m, 6-H), 2.76-2.67 (4H, 
m, 2 × CH2CH3), 2.65 (1H, d, J = 5.9 Hz, 5-H), 2.61 (2H, dt, J = 6.9, 5.1 Hz, 9-H), 2.59-2.54 
(1H, partly unresolved, m, 8-H), 2.57 (4H, t, J = 7.1 Hz, 2 × CH2CH3),  2.53-2.51 (1H, partly 
unresolved, m, 8-H), 2.39-2.33 (1H, m, cyclohexyl), 2.18 (1H, d, J = 9.3 Hz, 5-H), 1.79-1.72 
(3H, m, cyclohexyl), 1.67-1.64 (1H, m, cyclohexyl), 1.60-1.52 (2H, m, cyclohexyl), 1.24-
1.12 (3H, m, cyclohexyl), 1.08 (6H, t, J = 7.1 Hz, 2 × CH2CH3), 1.05 (3H, d, J = 6.5 Hz, 7-
H); 
13C NMR (125 MHz, CDCl3): ʴppm 66.5 (C-6), 61.8 (C-1), 58.2 (C-5), 52.5 (C-9), 47.9 
(C-8), 46.5 (2 × CH2CH3), 29.6 (C-2), 28.7 (C-3), 26.3 (C-4), 20.3 (C-7), 10.3 (2 × CH2CH3); 
LRMS  (ES
+):  257  (100%,  [M]
+);  HRMS  (ES
+)  observed  ([M]
+):  257.2603;  C15H33N2O 
requires 257.2593; υmax (film/cm
-1) 3456 (O-H), 2929 (C-H).  Chapter 4 - Experimental section 
 
 
142 
 
1-((2-(Diethylamino)ethyl)amino)propan-2-ol (208) 
 
N,N-Diethylethylenediamine (0.29 mL, 2.0 mmol) was added to THF (4 mL), followed by 
cyclohexanone (0.21 mL, 2.0 mmol), Mg(ClO4)2 (0.46 g, 2.0 mmol), 2-methyloxirane (0.13 
mL, 2.0 mmol) and Et3N (0.28 mL, 2.0 mmol). The mixture was stirred for 12 h at room 
temperature. The reaction mixture was quenched with water (10 mL) and then extracted with 
Et2O (2 × 15 mL). The combined organic extracts were washed with saturated NaCl solution 
(15 mL), dried (MgSO4) and filtered. The solvent was removed under reduced pressure and 
MeOH:THF (1:1, 6 mL) was added followed by NaBH4 (0.13 g, 4.1 mmol). The mixture was 
stirred for 1.5 h at room temperature. The reaction mixture was quenched with water (10 mL) 
and then extracted with Et2O (2 × 15 mL). The combined organic extracts were washed with 
saturated  NaCl  solution  (15  mL),  dried  (MgSO4)  and  filtered.  Purification  by  column 
chromatography  eluting  with  petrol:EtOAc:MeOH  (4:2:1)  gave  the  title  compound  as  a 
colourless oil (78 mg, 37%).   
 
1H NMR (600 MHz, CDCl3): ʴppm 4.27 (2H, s, OH and NH), 3.85 (1H, dqt, J = 10.9, 9.5, 6.3 
Hz, 4-H), 2.83-2.79 (1H, m, 2-H), 2.73-2.69 (2H, m, 1-H), 2.61 (2H, t, J = 6.3 Hz, 3-H), 2.57 
(4H, q, J = 7.1 Hz, 2 × CH2CH3), 2.48 (1H, dd, J = 10.9, 7.9 Hz, 2-H), 1.13 (3H, d, J = 6.3 
Hz, 5-H), 1.03 (6H, t, J = 7.1 Hz, 2 × CH2CH3); 
13C NMR (125 MHz, CDCl3): ʴppm 65.0 (C-
4), 56.5 (C-3), 51.9 (C-2), 46.9 (2 × CH2CH3), 46.4 (C-1), 20.7 (C-5), 11.4 (2 × CH2CH3); 
LRMS (CI): 175 (100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 175.18040; C9H23ON2 
requires 175.18104; υmax (film/cm
-1) 3456 (O-H), 2971 (C-H).   
 
2-(Cyclohexyl(2-(diethylamino)ethyl)amino)cyclohexanol (211) 
 
N,N-Diethylethylenediamine (0.72 mL, 5.1 mmol) was added to THF (5 mL), followed by 
cyclohexanone (0.53 mL, 5.1 mmol), Mg(ClO4)2 (1.14 g, 5.1 mmol), cyclohexene oxide (0.52 Chapter 4 - Experimental section 
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mL, 5.1 mmol) and Et3N (0.71 mL, 5.1 mmol). The mixture was stirred for 12 h at room 
temperature. MeOH:THF (1:1, 8 mL) was added followed by NaBH4 (0.26 g, 8.2 mmol). The 
mixture was stirred for 1.5 h at room temperature. The reaction mixture was quenched with 
water (10 mL) and then extracted with Et2O (2 × 15 mL). The combined organic extracts 
were washed with saturated NaCl solution (15 mL), dried (MgSO4) and filtered. Purification 
by  column  chromatography  eluting  with  petrol:EtOAc:MeOH  (4:2:1)  gave  the  title 
compound as a colourless oil and as a mixture of diastereomers (2:1) (254 mg, 48%).  
 
1H NMR (600 MHz, CDCl3): ʴppm 4.06 (0.5H, td, J = 10.3, 4.3 Hz, 4-H), 3.45 (0.5H, td, J = 
14.8, 4.3 Hz, 4-H), 2.57-2.43 (8H, m, 1-H, 2-H and 2 × CH2CH3), 2.53 (0.5H, dd, J = 10.3, 
7.2 Hz, 3-H), 2.45 (0.5H, dd, J = 14.8, 7.2 Hz, 3-H), 1.95-1.85 (1H, m, 7-H), 1.80-1.51 (8H, 
m, cyclohexyl), 1.36-1.17 (10H, m, cyclohexyl), 1.07 (3H, t, J = 7.2 Hz, CH2CH3), 0.97 (3H, 
t, J = 7.1 Hz, CH2CH3); 
13C NMR (125 MHz, CDCl3): ʴppm 69.2 (C-5), 69.1 (C-5), 54.3 (C-4), 
54.2 (C-4), 51.8 (C-2), 51.0 (C-2), 48.3 (C-8), 48.3 (C-8), 47.5 (C-3), 47.5 (C-3), 46.39 
(CH2CH3), 46.38 (CH2CH3), 28.5 (C-9), 28.4 (C-9), 25.5 (C-6), 24.4 (C-10), 23.3 (C-7), 22.8 
(C-7), 20.0 (C-7), 19.9 (C-7), 11.9 (CH2CH3), 11.8 (CH2CH3); LRMS (CI): 279 (100%, [M-
OH]
+);  HRMS  (CI)  observed  ([M-OH]
+):  279.27992;  C18H35N2  requires  279.28002;  υmax 
(film/cm
-1) 3460 (O-H), 2924 (C-H). 
 
N
1-Cyclohexyl-N
2,N
2-diethylethane-1,2-diamine (213) 
 
N,N-Diethylethylenediamine (0.72 mL, 5.1 mmol) was added to THF (5 mL), followed by 
cyclohexanone (0.53 mL, 5.1 mmol), Mg(ClO4)2 (1.14 g, 5.1 mmol), 2-phenyloxirane (0.58 
mL, 5.1 mmol) and Et3N (0.71 mL, 5.1 mmol). The mixture was stirred for 12 h at room 
temperature. MeOH:THF (1:1, 8 mL) was added followed by NaBH4 (0.26 g, 8.2 mmol). The 
mixture was stirred for 1.5 h at room temperature. The reaction mixture was quenched with 
water (10 mL) and then extracted with Et2O (2 × 15 mL). The combined organic extracts 
were  washed  with  saturated  NaCl  solution  (15  mL),  dried  over  MgSO4  and  filtered. Chapter 4 - Experimental section 
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Purification by column chromatography eluting with petrol:EtOAc:MeOH (4:2:1) gave the 
title compound as a colourless oil (366 mg, 69%).  
 
Data in agreement with the literature 
1H NMR (600 MHz, CDCl3): ʴppm 4.50 (1H, s, NH), 2.92-2.89 (1H, m, 3-H), 2.72 (2H, t, J = 
6.1 Hz, 2-H), 2.60-2.44 (2H, m, 1-H), 2.54 (2H, dq, J = 13.3, 7.1 Hz, CH2CH3), 2.47 (2H, dq, 
J = 13.2, 7.1 Hz, CH2CH3), 2.01-1.80 (3H, m, cyclohexyl), 1.73-1.61 (2H, m, cyclohexyl), 
1.58-1.56  (2H,  m,  cyclohexyl),  1.46-1.43  (2H,  m,  cyclohexyl),  1.26-1.22  (1H,  m, 
cyclohexyl), 0.99 (6H, t, J = 7.1 Hz, 2 × CH2CH3); 
13C NMR (125 MHz, CDCl3): ʴppm 62.8 
(C-3), 48.9 (C-1), 48.4 (C-2), 46.4 (2 × CH2CH3), 28.7 (2 × C-4), 28.6 (2 × C-5), 25.4 (C-6), 
11.9 (2 × CH2CH3); LRMS (CI): 199 (100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 
199.21783; C12H27N2 requires 199.21742; υmax (film/cm
-1) 3160 (N-H), 2933 (C-H).  
 
N
1,N
1-Diethyl-N
2-(pentan-3-yl)ethane-1,2-diamine (215) 
 
N,N-Diethylethylenediamine (0.72 mL, 5.1 mmol) was added to THF (5 mL), followed by 
pentan-3-one (0.54 mL, 5.1 mmol), Mg(ClO4)2 (1.14 g, 5.1 mmol), 2-methyloxirane (0.28 
mL, 5.1 mmol) and Et3N (0.71 mL, 5.1 mmol). The mixture was stirred for 12 h at room 
temperature. MeOH:THF (1:1, 8 mL) was added followed by NaBH4 (0.26 g, 8.2 mmol). The 
mixture was stirred for 1.5 h at room temperature. The reaction mixture was quenched with 
water (10 mL) and then extracted with Et2O (2 × 15 mL). The combined organic extracts 
were  washed  with  saturated  NaCl  solution  (15  mL),  dried  over  MgSO4  and  filtered. 
Purification by column chromatography eluting with petrol:EtOAc:MeOH (4:2:1) gave the 
title compound as a colourless oil (351 mg, 65%).  
 
1H NMR (600 MHz, CDCl3): ʴppm 4.80 (1H, s, NH), 3.00 (1H, dt, J = 8.5, 5.7 Hz, 3-H), 2.66 
(2H, t, J = 7.8 Hz, 1-H), 2.60 (2H, dq, J = 11.4, 7.2 Hz, CH2CH3), 2.49 (2H, dq, J = 11.4, 7.2 
Hz, CH2CH3), 2.46-2.43 (2H, m, 2-H), 1.56-1.52 (2H, m, 4-H), 1.45-1.40 (2H, m, 4-H), 1.01 
(6H, t, J = 7.2 Hz, CH2CH3), 0.97-0.93 (6H, m, 5-H); 
13C NMR (125 MHz, CDCl3): ʴppm 68.0 
(C-3), 49.8 (C-1), 49.3 (C-2), 46.3 (2 × CH2CH3), 22.9 (C-4), 22.3 (C-4), 11.7 (2 × CH2CH3), Chapter 4 - Experimental section 
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11.5 (C-5), 11.3 (C-5); LRMS (CI): 187 (100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 
187.21705; C11H27N2 requires 187.21742; υmax (film/cm
-1) 3155 (N-H), 2970 (C-H). 
 
N
1-Cyclopentyl-N
2,N
2-diethylethane-1,2-diamine (216)  
 
N,N-Diethylethylenediamine (0.72 mL, 5.1 mmol) was added to THF (5 mL), followed by 
cyclopentanone (0.45 mL, 5.1 mmol), Mg(ClO4)2 (1.14 g, 5.1 mmol), 2-methyloxirane (0.28 
mL, 5.1 mmol) and Et3N (0.71 mL, 5.1 mmol). The mixture was stirred for 12 h at room 
temperature. MeOH:THF (1:1, 8 mL) was added followed by NaBH4 (0.26 g, 8.2 mmol). The 
mixture was stirred for 1.5 h at room temperature. The reaction mixture was quenched with 
water (10 mL) and then extracted with Et2O (2 × 15 mL). The combined organic extracts 
were  washed  with  saturated  NaCl  solution  (15  mL),  dried  over  MgSO4  and  filtered. 
Purification by column chromatography eluting with petrol:EtOAc:MeOH (4:2:1) gave the 
title compound as a colourless oil (284 mg, 63%).  
 
1H NMR (600 MHz, CDCl3): ʴppm 4.38 (1H, s, NH), 3.25 (1H, dt, J = 8.3, 7.1, 3-H), 2.76 
(2H, t, J = 7.8 Hz, 2-H),  2.65 (2H, dq, J = 11.4, 7.4 Hz, CH2CH3), 2.58 (2H, dq, J = 11.4, 7.4 
Hz, CH2CH3), 2.50-2.45 (2H, m, 1-H), 1.70-1.54 (8H, m, 4-H and 5-H), 1.01 (6H, t, J = 7.4 
Hz, 2 × CH2CH3); 
13C NMR (125 MHz, CDCl3): ʴppm 65.1 (C-3), 50.4 (C-2), 49.0 (C-1), 46.5 
(2 × CH2CH3), 29.4 (C-4), 29.3 (C-4), 24.4 (C-5), 24.2 (C-5), 11.90 (2 × CH2CH3); LRMS 
(CI): 185 (100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 185.20164; C11H25N2 requires 
185.20177; υmax (film/cm
-1) 3155 (N-H), 2920 (C-H). 
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1,1'-(Butylazanediyl)bis(propan-2-ol) (219) 
 
Butylamine (0.20 mL, 2.0 mmol) was added to THF (4 mL), followed by acetone (0.15 mL, 
2.0 mmol), Mg(ClO4)2 (0.46 g, 2.0 mmol), 2-methyloxirane (0.13 mL, 2.0 mmol) and Et3N 
(0.28 mL, 2.0 mmol). The mixture was stirred for 12 h at room temperature. The solvent was 
removed under reduced pressure and MeOH:THF (1:1, 6 mL) was added followed by NaBH4 
(0.13 g, 4.1 mmol). The mixture was stirred for 1.5 h at room temperature. The reaction 
mixture was quenched with water (10 mL) and then extracted with Et2O (2 × 15 mL). The 
combined organic extracts were washed with saturated NaCl solution (15 mL), dried over 
MgSO4  and  filtered.  Purification  by  column  chromatography  eluting  with 
petrol:EtOAc:MeOH (4:2:1) gave the title compound as a colourless oil and as a mixture of 
diastereomers (51 mg, 50%).  
 
OH peaks not seen 
1H NMR (600 MHz, CDCl3): ʴppm 3.82-3.74 (4H, m, 6-H), 2.53-2.47 (8H, m, 5-H), 2.38-2.32 
(4H, m, 4-H), 1.44-1.37 (4H, m, 3-H), 1.28-1.21 (4H, m, 2-H), 1.10-1.01 (12H, m, 7-H), 
0.94-0.90 (6H, m, 1-H); 
13C NMR (150 MHz, CDCl3): ʴppm 65.4 (C-6), 64.0 (C-6), 63.9 (C-
5), 62.6 (C-5), 55.6 (C-4), 55.1 (C-4), 29.3 (C-3), 29.2 (C-3), 20.6 (C-7), 20.3 (C-2), 14.1 (C-
1);  LRMS  (CI):  190  (100  %,  [M+H]
+);  HRMS  (CI)  observed  ([M+H]
+):  190.18030; 
C10H24O2N requires 190.18070; υmax (film/cm
-1) 3360 (O-H), 2961 (C-H). 
 
2,2'-(Butylazanediyl)bis(1-phenylethanol) (220) 
 
Butylamine (0.20 mL, 2.0 mmol) was added to THF (4 mL), followed by acetone (0.15 mL, 
2.0 mmol), Mg(ClO4)2 (0.46 g, 2.0 mmol), 2-phenyloxirane (0.25 mL, 2.0 mmol) and Et3N Chapter 4 - Experimental section 
 
 
147 
 
(0.28 mL, 2.0 mmol). The mixture was stirred for 12 h at room temperature. The solvent was 
removed under reduced pressure and MeOH:THF (1:1, 6 mL) was added followed by NaBH4 
(0.13 g, 4.1 mmol). The mixture was stirred for 1.5 h at room temperature. The reaction 
mixture was quenched with water (10 mL) and then extracted with Et2O (2 × 15 mL). The 
combined organic extracts were washed with saturated NaCl solution (15 mL), dried over 
MgSO4  and  filtered.  Purification  by  column  chromatography  eluting  with 
petrol:EtOAc:MeOH  (4:2:1)  gave  the  title  compound  as  a  colourless  oil  as  a  mixture  of 
diastereomers (102 mg, 51%).  
 
OH peaks not seen 
1H NMR (600 MHz, CDCl3): ʴppm 7.36-7.32 (4H, m, 8-H), 7.30-7.25 (6H, m, 9-H and 10-H), 
3.76 (2H, dd, J = 8.6, 4.6 Hz, 6-H), 3.70 (2H, dd, J = 10.8, 4.6 Hz, 5-H), 3.53 (2H, dd, J = 
10.8, 8.6 Hz, 5-H), 2.56-2.50 (1H, m, 4-H), 2.48-2.43 (1H, m, 4-H), 1.49-1.41 (2H, m, 3-H), 
1.35-1.27 (2H, m, 2-H), 0.87 (3H, t, J = 7.3 Hz, 1-H); 
13C NMR (125 MHz, CDCl3): ʴppm 
141.0 (C-7), 128.7 (C-8), 127.6 (C-10), 127.3 (C-9), 66.7 (C-6), 64.7 (C-5), 47.2 (C-4), 32.4 
(C-3),  20.5  (C-2),  14.1  (C-1);  LRMS  (CI):  314  (100%,  [M+H]
+);  HRMS  (CI)  observed 
([M+H]
+): 314.21246; C20H28O2N requires 314.21200; υmax (film/cm
-1) 3285 (O-H), 2928 (C-
H), 1739 (C=C). 
 
1-(Butyl(cyclohexyl)amino)propan-2-ol (221)  
 
Butylamine (0.20 mL, 2.0 mmol) was added to THF (4 mL), followed by cyclohexanone 
(0.21 mL, 2.0 mmol), Mg(ClO4)2 (0.46 g, 2.0 mmol), propylene oxide (0.13 mL, 2.0 mmol) 
and Et3N (0.28 mL, 2.0 mmol). The mixture was stirred for 12 h at room temperature. The 
solvent  was  removed  under  reduced  pressure  and  MeOH:THF  (1:1,  6  mL)  was  added 
followed  by  NaBH4  (0.13  g,  4.1  mmol).  The  mixture  was  stirred  for  1.5  h  at  room 
temperature. The reaction mixture was quenched with water (10 mL) and then extracted with 
Et2O (2 × 15 mL). The combined organic extracts were washed with saturated NaCl solution 
(15 mL), dried over MgSO4 and filtered. Purification by column chromatography eluting with 
petrol:EtOAc:MeOH (4:2:1) gave the title compound as a colourless oil (90 mg, 43%).  Chapter 4 - Experimental section 
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OH peaks not seen 
1H NMR (400 MHz, CDCl3): ʴppm 3.65 (1H, dqd, J = 12.4, 9.4, 6.2 Hz, 6-H), 2.48 (1H, d, J = 
9.4 Hz, 5-H), 2.44 (1H, partly unresolved, d, J = 12.4 Hz, 5-H),  2.44-2.40 (2H, m, 4-H), 
2.20-2.15 (1H, m, 8-H), 1.85-1.61 (6H, m, cyclohexyl), 1.40-1.13 (8H, m, 2-H, 3-H and 
cyclohexyl), 1.10 (3H, d, J = 6.2 Hz, 7-H), 0.90 (3H, t, J = 7.4 Hz, 1-H); 
13C NMR (75 MHz, 
CDCl3): ʴppm 63.0 (C-8), 60.0 (C-6), 58.3 (C-5), 50.6 (C-4), 31.7 (C-3), 31.5 (C-9), 26.9 (C-
11), 26.4 (C-10), 26.2 (C-10), 20.6 (C-7), 19.9 (C-2), 14.2 (C-1); LRMS (CI): 214 (100%, 
[M+H]
+); HRMS (CI) observed ([M+H]
+): 214.21684; C13H28ON requires 214.21709; υmax 
(film/cm
-1) 3458 (O-H), 2928 (C-H).  
 
1-(Cyclohexyl((R)-1-phenylethyl)amino)propan-2-ol (222) 
 
(R)-1-Phenylethanamine  (0.65  mL,  5.1  mmol)  was  added  to  THF  (5  mL),  followed  by 
cyclohexanone (0.54 mL, 5.1 mmol), Mg(ClO4)2 (1.14 g, 5.1 mmol), 2-methyloxirane (0.28 
mL, 5.1 mmol) and Et3N (0.71 mL, 5.1 mmol). The mixture was stirred for 12 h at room 
temperature. MeOH:THF (1:1, 8 mL) was added followed by NaBH4 (0.26 g, 8.2 mmol). The 
mixture was stirred for 1.5 h at room temperature. The reaction mixture was quenched with 
water (10 mL) and then extracted with Et2O (2 × 15 mL). The combined organic extracts 
were  washed  with  saturated  NaCl  solution  (15  mL),  dried  over  MgSO4  and  filtered. 
Purification by column chromatography eluting with petrol:EtOAc:MeOH (4:2:1) gave the 
title compound as a colourless oil and as a mixture of diastereomers (1:1) (265 mg, 49%).  
 
OH peak missing 
1H NMR (600 MHz, CDCl3): ʴppm 7.34 (3H, m, 2-H and 4-H), 7.28-7.20 (2H, m, 3-H), 3.96 
(0.5H, partly unresolved, q, J = 6.9 Hz,  5-H), 3.98-3.94 (0.5H, m, 5-H), 3.68-3.65 (1H, m, 8-
H), 2.47 (1H, dd, J = 10.2, 4.8 Hz, 7-H), 2.35 (1H, dd, J = 10.1, 4.8 Hz, 7-H), 2.28-2.23 (1H, 
m, 10-H), 1.45-1.31 (10H, m, cyclohexyl), 1.03 (3H, d, J = 6.3 Hz, 9-H), 0.9 (3H, d, J = 6.9 
Hz, 6-H); 
13C NMR (125 MHz, CDCl3): ʴppm 143.2 (C-1), 142.6 (C-1), 128.5 (C-2), 128.44 Chapter 4 - Experimental section 
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(C-2) 128.36 (C-3), 128.3 (C-3), 128.0 (C-4), 127.9 (C-4), 64.6 (C-5), 64.3 (C-5), 60.3 (C-7), 
60.2 (C-8), 60.0 (C-8), 59.7 (C-7), 54.5 (C-10), 53.7 (C-10), 34.5 (C-11), 33.0 (C-11), 26.2 
(C-13), 25.3 (C-13), 25.0 (C-12), 24.9 (C-12), 26.2 (C-6), 24.9 (C-6), 20.5 (C-9), 20.4 (C-9); 
LRMS (CI): 262 (100%, [M+H]
+); HRMS (CI) observed ([M+H]
+): 261.20890; C17H28NO 
requires 261.20926; υmax (film/cm
-1) 3425 (O-H), 2931 (C-H). 
 
1-(
tButylamino)propan-2-ol (224) 
 
2-Methylpropan-2-amine  (0.54  mL,  5.1  mmol)  was  added  to  THF  (5  mL),  followed  by 
cyclohexanone (0.54 mL, 5.1 mmol), Mg(ClO4)2 (1.14 g, 5.1 mmol), 2-methyloxirane (0.28 
mL, 5.1 mmol) and Et3N (0.71 mL, 5.1 mmol). The mixture was stirred for 12 h at room 
temperature. MeOH:THF (1:1, 8 mL) was added followed by NaBH4 (0.26 g, 8.2 mmol). The 
mixture was stirred for 1.5 h at room temperature. The reaction mixture was quenched with 
water (10 mL) and then extracted with Et2O (2 × 15 mL). The combined organic extracts 
were  washed  with  saturated  NaCl  solution  (15  mL),  dried  over  MgSO4  and  filtered. 
Purification by column chromatography eluting with petrol:EtOAc:MeOH (4:2:1) gave the 
title compound as a colourless oil (281 mg, 52%).  
 
OH peak missing 
1H NMR (600 MHz, CDCl3): ʴppm 5.54 (1H, s, NH), 4.10 (1H, tq, J = 11.9, 6.3 Hz, 4-H), 3.06 
(1H, dd, J = 11.9, 5.9 Hz, 3-H), 2.85 (1H, d, J = 6.3 Hz, 3-H), 1.38 (9H, s, 1-H), 1.26 (3H, d, 
J = 6.4 Hz, 5-H); 
13C NMR (125 MHz, CDCl3): ʴppm 64.2 (C-4), 60.6 (C-2), 58.3 (C-3), 26.0 
(C-1),  20.9  (C-5);  LRMS  (CI):  132  (100%,  [M+H]
+);  HRMS  (CI)  observed  ([M+H]
+): 
132.13864; C7H18NO requires 132.13884; υmax (film/cm
-1) 3395 (O-H), 3295 (N-H), 2971 
(C-H). Chapter 5 – References 
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Appendix: HPLC data 
 
HPLC data for 4-(4-chlorophenyl)-4-hydroxybutan-2-one (72) using different chiral 
amines 
 
Racemic compound of 72 
HPLC (Daicel Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 
18.5 min (R), tR = 19.7 min (S). 
 Appendix 
 
 
 
 
 Appendix 
 
 
 
 
(R)-1-Phenylethanamine (62) 
HPLC (Daicel Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 
21.9 min (R major), tR = 23.4 min (S minor). 
 Appendix 
 
 
 
 
 Appendix 
 
 
 
 
9-Amino(9-deoxy)epihydroquinine (96) 
HPLC (Daicel Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 
22.0 min (R minor), tR = 23.4 min (S major). 
 Appendix 
 
 
 
 
 
 
 
 
 Appendix 
 
 
 
 
(1R,2R)-N
1-(4-Chlorobenzyl)cyclohexane-1,2-diamine (99) 
HPLC (Daicel Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 
21.7 min (R minor), tR = 23.2 min (S major). 
 Appendix 
 
 
 
 Appendix 
 
 
 
 
(R)-2-Amino-3-phenylpropan-1-ol (100) 
HPLC (Daicel Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 
21.6 min (R major), tR = 23.0 min (S minor). 
 Appendix 
 
 
 
 
 
 
 Appendix 
 
 
 
 
(R)-2-Amino-3-methylbutan-1-ol (102) 
HPLC (Daicel Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 
18.6 min (R major), tR = 20.0 min (S minor). 
 Appendix 
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(1R,2S)-2-Amino-1,2-diphenylethanol (103) 
HPLC (Daicel Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 
19.4 min (R major), tR = 20.6 min (S minor). 
 Appendix 
 
 
 
 
 
 
 Appendix 
 
 
 
 
(R)-2-Amino-4-methylpentan-1-ol (104) 
HPLC (Daicel Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 
17.8 min (R major), tR = 18.8 min (S minor). 
 Appendix 
 
 
 
 
 
 
 Appendix 
 
 
 
 
(R)-2-Amino-3,3-dimethylbutan-1-ol (105) 
HPLC (Daicel Chiralpack AD, hexane/i-PrOH, 80/20, flow rate 1 mL/min, λ = 254 nm), tR = 
18.1 min (R major), tR = 19.2 min (S minor). 
 Appendix 
 
 
 
 
 
 
 